Cinemark Usa S-45 Apr 16Registration of securities issued in business combination transactionsFinancial data

Company Profile

Document and Entity Information

Document and Entity Information	12 Months Ended
Document and Entity Information	Dec. 31, 2015
Document Information [Line Items]
Document Type	S4
Amendment Flag	false
Document Period End Date	Dec. 31, 2015
Trading Symbol	ck0000885975
Entity Registrant Name	CINEMARK USA INC /TX
Entity Central Index Key	885,975
Entity Filer Category	Non-accelerated Filer

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Dec. 31, 2015	Dec. 31, 2014
Current assets
Cash and cash equivalents		$ 588,503	$ 638,841
Inventories		15,954	13,419
Accounts receivable		74,287	47,917
Current income tax receivable		22,877	19,350
Current deferred tax asset			10,518
Prepaid expenses and other		13,494	10,882
Accounts receivable from parent		1,171	12,638
Total current assets		716,286	753,565
Theatre properties and equipment
Land		95,479	95,699
Buildings		453,034	416,680
Property under capital lease		336,666	313,277
Theatre furniture and equipment		929,180	878,453
Leasehold interests and improvements		873,032	844,983
Total		2,687,391	2,549,092
Less accumulated depreciation and amortization		1,182,322	1,098,280
Theatre properties and equipment, net		1,505,069	1,450,812
Other assets
Goodwill	[1]	1,247,548	1,277,383
Intangible assets - net		339,644	348,024
Investments in and advances to affiliates		94,973	77,658
Long-term deferred tax asset		2,114	164
Deferred charges and other assets - net (see Note 2)		38,243	46,571
Total other assets		1,906,277	1,928,739
Total assets		4,127,632	4,133,116
Current liabilities
Current portion of long-term debt		8,405	8,423
Current portion of capital lease obligations		18,780	16,494
Current income tax payable		7,332	6,396
Current deferred tax liability			75
Current liability for uncertain tax positions		9,155	7,283
Accounts payable		108,844	119,170
Accrued film rentals		97,172	86,250
Accrued payroll		45,811	37,457
Accrued property taxes		31,719	29,925
Accrued other current liabilities		111,951	102,410
Total current liabilities		439,169	413,883
Long-term liabilities
Long-term debt, less current portion (see Note 2)		1,772,930	1,783,155
Capital lease obligations, less current portion		208,952	201,978
Long-term deferred tax liability		139,905	140,973
Long-term liability for uncertain tax positions		7,853	8,410
Deferred lease expenses		43,333	46,003
Other long-term liabilities		60,105	66,772
Total long-term liabilities		$ 2,575,212	$ 2,582,510
Commitments and contingencies (see Note 17)
Cinemark USA, Inc.'s stockholder's equity:
Common stock		$ 49,543	$ 49,543
Treasury stock, 57,245 Class B shares at cost		(24,233)	(24,233)
Additional paid-in-capital		1,238,473	1,221,179
Retained earnings		110,049	24,677
Accumulated other comprehensive loss		(271,686)	(144,772)
Total Cinemark USA, Inc. stockholder's equity		1,102,146	1,126,394
Noncontrolling interests		11,105	10,329
Total equity		1,113,251	1,136,723
Total liabilities and equity		4,127,632	4,133,116
NCM
Other assets
Investment in NCM		183,755	178,939
Long-term liabilities
Deferred revenue - NCM		342,134	335,219
Class B Common Stock
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543	49,543
Total equity		$ 49,543	$ 49,543

[1]	Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2015	Dec. 31, 2014
Treasury stock, shares at cost	57,245	57,245
Class A common stock
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	10,000,000	10,000,000
Common stock, shares issued	1,500	1,500
Common stock, shares outstanding	1,500	1,500
Class B Common Stock
Common stock, par value
Common stock, shares authorized	1,000,000	1,000,000
Common stock, shares issued	239,893	239,893
Common stock, shares outstanding	182,648	182,648

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Revenues
Admissions		$ 1,765,519	$ 1,644,169	$ 1,706,145
Concession		936,970	845,376	845,168
Other		150,120	137,445	131,581
Total revenues		2,852,609	2,626,990	2,682,894
Cost of operations
Film rentals and advertising		976,590	883,052	919,511
Concession supplies		144,270	131,985	135,715
Salaries and wages		301,099	273,880	269,353
Facility lease expense		319,761	317,096	307,851
Utilities and other		324,851	308,445	305,703
General and administrative expenses		154,052	148,588	163,134
Depreciation and amortization		189,206	175,656	163,970
Impairment of long-lived assets		8,801	6,647	3,794
(Gain) loss on sale of assets and other		8,143	15,715	(3,845)
Total cost of operations		2,426,773	2,261,064	2,265,186
Operating income		425,836	365,926	417,708
Other income (expense)
Interest expense	[1]	(112,741)	(113,698)	(124,714)
Interest income		8,708	5,599	3,622
Foreign currency exchange loss		(16,793)	(6,192)	(1,616)
Loss on amendment to debt agreement		(925)
Loss on early retirement of debt				(72,302)
Distributions from NCM		18,140	18,541	20,701
Equity in income of affiliates		28,126	22,743	22,682
Total other income (expense)		(75,485)	(73,007)	(151,627)
Income before income taxes		350,351	292,919	266,081
Income taxes		129,960	97,150	114,160
Net income		220,391	195,769	151,921
Less: Net income attributable to noncontrolling interests		1,859	1,389	2,078
Net income attributable to Cinemark USA, Inc.		$ 218,532	$ 194,380	$ 149,843

[1]	Includes amortization of debt issue costs.

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Net income	$ 220,391	$ 195,769	$ 151,921
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes of $1,865, $1,759 and $1,562, net of settlements	2,636	2,846	3,151
Unrealized gain (loss) due to fair value adjustments on available-for-sale securities, net of taxes of $1,223, $1,479 and $572	(957)	2,507	(2,041)
Other comprehensive income (loss) in equity method investments	(3,119)	676	2,386
Foreign currency translation adjustments, net of taxes of $0, $0 and $888	(125,512)	(68,997)	(47,699)
Total other comprehensive loss, net of tax	(126,952)	(62,968)	(44,203)
Total comprehensive income, net of tax	93,439	132,801	107,718
Comprehensive income attributable to noncontrolling interests	(1,821)	(1,374)	(1,996)
Comprehensive income attributable to Cinemark USA, Inc.	$ 91,618	$ 131,427	$ 105,722

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Unrealized gain due to fair value adjustments on interest rate swap agreements, taxes	$ 1,562	$ 1,759	$ 1,865
Unrealized gain (loss) due to fair value adjustments on available-for-sale securities, taxes	572	1,479	1,223
Foreign currency translation adjustments, taxes	$ 888	$ 0	$ 0

Consolidated Statements of Equi

Consolidated Statements of Equity - USD ($) shares in Thousands, $ in Thousands	Total	Class A common stock	Class B Common Stock	Treasury Stock	Additional Paid-in- Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Loss	Total Cinemark USA, Inc.'s Stockholder's Equity	Noncontrolling Interests
Stockholders' equity, Beginning Balance (in shares) at Dec. 31, 2012		2	240	(57)
Stockholders' equity, Beginning Balance at Dec. 31, 2012	$ 1,096,212		$ 49,543	$ (24,233)	$ 1,192,106	$ (94,425)	$ (37,698)	$ 1,085,293	$ 10,919
Share based awards compensation expense	16,046				16,046			16,046
Tax benefit related to stock option exercises and share based award vestings	2,964				2,964			2,964
Purchase of noncontrolling interests' share of Brazilian subsidiary	(5,621)				(4,618)			(4,618)	(1,003)
Dividends paid to parent	(105,150)					(105,150)		(105,150)
Noncash dividends to parent	(4,971)					(4,971)		(4,971)
Dividends paid to noncontrolling interests	(2,917)								(2,917)
Net income	151,921					149,843		149,843	2,078
Other comprehensive loss	(44,203)						(44,121)	(44,121)	(82)
Stockholders' equity, Ending Balance (in shares) at Dec. 31, 2013		2	240	(57)
Stockholders' equity, Ending Balance at Dec. 31, 2013	1,104,281		$ 49,543	$ (24,233)	1,206,498	(54,703)	(81,819)	1,095,286	8,995
Share based awards compensation expense	11,875				11,875			11,875
Tax benefit related to stock option exercises and share based award vestings	2,806				2,806			2,806
Noncontrolling interests' share of acquired subsidiary	346								346
Dividends paid to parent	(115,000)					(115,000)		(115,000)
Dividends paid to noncontrolling interests	(386)								(386)
Net income	195,769					194,380		194,380	1,389
Other comprehensive loss	(62,968)						(62,953)	(62,953)	(15)
Stockholders' equity, Ending Balance (in shares) at Dec. 31, 2014		2	240	(57)
Stockholders' equity, Ending Balance at Dec. 31, 2014	1,136,723		$ 49,543	$ (24,233)	1,221,179	24,677	(144,772)	1,126,394	10,329
Share based awards compensation expense	14,873				14,873			14,873
Tax benefit related to stock option exercises and share based award vestings	2,421				2,421			2,421
Dividends paid to parent	(115,225)					(115,225)		(115,225)
Noncash dividends to parent	(17,935)					(17,935)		(17,935)
Dividends paid to noncontrolling interests	(1,045)								(1,045)
Net income	220,391					218,532		218,532	1,859
Other comprehensive loss	(126,952)						(126,914)	(126,914)	(38)
Stockholders' equity, Ending Balance (in shares) at Dec. 31, 2015		2	240	(57)
Stockholders' equity, Ending Balance at Dec. 31, 2015	$ 1,113,251		$ 49,543	$ (24,233)	$ 1,238,473	$ 110,049	$ (271,686)	$ 1,102,146	$ 11,105

Condensed Consolidated Stateme8

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Operating activities
Net income	$ 220,391	$ 195,769	$ 151,921
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	186,898	173,138	160,071
Amortization of intangible and other assets and favorable/unfavorable leases	2,308	2,518	3,899
Amortization of long-term prepaid rents	2,361	1,542	2,625
Amortization of debt issue costs	5,151	5,245	5,476
Amortization of deferred revenues, deferred lease incentives and other	(17,163)	(13,665)	(11,712)
Amortization of bond discount			482
Impairment of long-lived assets	8,801	6,647	3,794
Share based awards compensation expense	14,873	11,875	16,046
(Gain) loss on sale of assets and other	8,143	15,715	(3,845)
Write-off of unamortized debt issue costs, debt discount and accumulated other comprehensive loss related to early retirement of debt			15,688
Deferred lease expenses	(1,806)	2,536	5,701
Equity in income of affiliates	(28,126)	(22,743)	(22,682)
Deferred income tax expenses	11,095	526	(37,790)
Interest paid on redemption of senior notes			(8,054)
Distributions from equity investees	19,027	19,172	13,658
Changes in other assets and liabilities:
Inventories	(2,535)	400	(1,539)
Accounts receivable	(28,069)	31,027	(15,938)
Income tax receivable	(3,527)	(18,681)	4,060
Prepaid expenses and other	(2,612)	4,066	(3,557)
Deferred charges and other assets - net	8,126	19,713	(17,624)
Accounts payable and accrued expenses	43,859	33,674	48,126
Income tax payable	936	(15,685)	15,035
Liabilities for uncertain tax positions	1,315	(4,437)	(14,345)
Other long-term liabilities	5,779	5,776	(134)
Net cash provided by operating activities	455,225	454,128	309,362
Investing activities
Additions to theatre properties and equipment	(331,726)	(244,705)	(259,670)
Proceeds from sale of theatre properties and equipment and other	9,966	2,545	34,271
Acquisition of theatres in the U.S., net of cash acquired	(2,651)	(7,951)	(259,247)
Acquisition of theatre in Brazil	(2,651)
Proceeds from disposition of Mexico theatres			126,167
Investment in joint ventures and other	(3,711)	(3,228)	(6,222)
Net cash provided by (used for) investing activities	(328,122)	(253,339)	(364,701)
Financing activities
Dividends paid to parent	(115,225)	(115,000)	(105,150)
Payroll taxes paid as a result of restricted stock withholdings	(4,770)	(9,861)	(3,464)
Proceeds from issuance of notes			530,000
Other short term borrowings			1,473
Redemption of senior notes			(461,946)
Repayments of other long-term debt	(8,420)	(9,846)	(9,339)
Payment of debt issue costs	(6,957)		(9,328)
Payments on capital leases	(16,513)	(14,035)	(12,015)
Purchases of non-controlling interests			(5,621)
Other	1,376	2,422	44
Net cash provided by (used for) financing activities	(150,509)	(146,320)	(75,346)
Effect of exchange rates on cash and cash equivalents	(26,932)	(15,522)	(11,516)
Increase (decrease) in cash and cash equivalents	(50,338)	38,947	(142,201)
Cash and cash equivalents:
Beginning of year	638,841	599,894	742,095
End of year	$ 588,503	$ 638,841	$ 599,894

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
Summary of Significant Accounting Policies	Dec. 31, 2015
Summary of Significant Accounting Policies	1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Business Principles of Consolidation Cash and Cash Equivalents Accounts Receivable – Inventories Theatre Properties and Equipment Category Useful Life Buildings on owned land 40 years Buildings on leased land Lesser of lease term or useful life Land and buildings under capital lease (1) Lesser of lease term or useful life Theatre furniture and equipment 3 to 15 years Leasehold improvements Lesser of lease term or useful life (1) Amortization of capital lease assets is included in depreciation and amortization expense on the consolidated statements of income. Accumulated amortization of capital lease assets as of December 31, 2014 and 2015 was $133,022 and $150,968, respectively. The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. The Company considers actual theatre level cash flows, budgeted theatre level cash flows, theatre property and equipment carrying values, amortizing intangible asset carrying values, the age of a recently built theatre, competitive theatres in the marketplace, the impact of recent ticket price changes, available lease renewal options and other factors considered relevant in its assessment of impairment of individual theatre assets. Long-lived assets are evaluated for impairment on an individual theatre basis, which the Company believes is the lowest applicable level for which there are identifiable cash flows. The impairment evaluation is based on the estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. The remainder of the theatre’s useful life correlates with the available remaining lease period, which includes the probability of renewal periods, for leased properties and the lesser of twenty years or the building’s remaining useful life for fee-owned properties. If the estimated undiscounted cash flows are not sufficient to recover a long-lived asset’s carrying value, the Company then compares the carrying value of the asset group (theatre) with its estimated fair value. When estimated fair value is determined to be lower than the carrying value of the asset group (theatre), the asset group (theatre) is written down to its estimated fair value. Significant judgment is involved in estimating cash flows and fair value. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820-10-35, are based on historical and projected operating performance, recent market transactions and current industry trading multiples. Fair value is determined based on a multiple of cash flows, which was six and a half times for the evaluations performed during 2013, 2014 and 2015. The long-lived asset impairment charges recorded during each of the periods presented are specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics, or adverse changes in the development or the conditions of the areas surrounding the theatre. See Note 7. Goodwill and Other Intangible Assets For the year ended December 31, 2015, the Company performed a qualitative goodwill impairment assessment on all reporting units except one, in accordance with ASU 2011-08 Testing Goodwill for Impairment Tradename intangible assets are tested for impairment at least annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value may not be fully recoverable. During 2013 and 2014, the Company estimated the fair value of its tradenames by applying an estimated market royalty rate that could be charged for the use of our tradename to forecasted future revenues, with an adjustment for the present value of such royalties. If the estimated fair value is less than the carrying value, the tradename intangible asset is written down to its estimated fair value. Significant judgment is involved in estimating market royalty rates and long-term revenue forecasts. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected revenue performance and industry trends. As of December 31, 2014, the estimated fair value of the Company’s tradename intangible assets exceeded their carrying values by at least 10%. For the year ended December 31, 2015, the Company performed a qualitative tradename intangible asset impairment assessment in accordance with ASU 2011-08. The qualitative assessment included consideration of the Company’s historical and forecasted revenues and estimated royalty rates for each tradename intangible asset. Based on the qualitative assessment performed, the Company determined that it was not more likely than not that the fair values of tradename intangible assets were less than their carrying values. The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset: Intangible Asset Amortization Method Goodwill Indefinite-lived Tradename Indefinite-lived Vendor contracts Straight-line method over the terms of the underlying contracts. The remaining terms of the underlying contracts range from two to five years. Favorable/unfavorable leases Based on the pattern in which the economic benefits are realized over the terms of the lease agreements. The remaining terms of the lease agreements range from approximately three to twenty-one years. Other intangible assets Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from two to eleven years. Deferred Charges and Other Assets Lease Accounting Deferred Revenues Self-Insurance Reserves — Revenue and Expense Recognition Film rental costs are accrued based on the applicable box office receipts and either firm terms or a sliding scale formula, which are generally established prior to the opening of the film, or estimates of the final rate, which occurs at the conclusion of the film run, subject to the film licensing arrangement. Under a firm terms formula, the Company pays the distributor a percentage of box office receipts, which reflects either an aggregate rate for the life of the film or rates that decline over the term of the run. Under a sliding scale formula, film rental is paid as a percentage of box office revenues using a pre-determined matrix based upon box office performance of the film. The settlement process allows for negotiation of film rental fees upon the conclusion of the film run based upon how the film performs. Estimates are based on the expected success of a film. The success of a film can typically be determined a few weeks after a film is released when initial box office performance of the film is known. Accordingly, final settlements typically approximate estimates since box office receipts are known at the time the estimate is made and the expected success of a film can typically be estimated early in the film’s run. If actual settlements are different than those estimates, film rental costs are adjusted at that time. Accounting for Share Based Awards Income Taxes — Segments Use of Estimates Foreign Currency Translations Fair Value Measurements — Goodwill and Other Intangible Assets Theatre Properties and Equipment Acquisitions

New Accounting Pronouncements

New Accounting Pronouncements	12 Months Ended
New Accounting Pronouncements	Dec. 31, 2015
New Accounting Pronouncements	2. NEW ACCOUNTING PRONOUNCEMENTS In January 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2015-01, Income Statement – Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items In February 2015, the FASB issued Accounting Standards Update 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis, In April 2015, the FASB issued Accounting Standards Update 2015-03 Interest – Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs In April 2015, the FASB issued Accounting Standards Update 2015-05, Intangibles – Goodwill and Other – Internal Use Software (Subtopic 350-40): Customer’s Accounting for Fees Paid in Cloud Computing Arrangement In July 2015, the FASB issued Accounting Standards Update 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory In August 2015, the FASB issued Accounting Standards Update 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, Revenue from Contracts with Customers (Topic 606) In August 2015, the FASB issued Accounting Standards Update 2015-15, Interest – Imputation of Interest (Subtopic 835-30): Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements In September 2015, the FASB issued Accounting Standards Update 2015-16, Business Combinations (Topic 805): Simplifying the Accounting for Measurement-Period Adjustments In November 2015, the FASB issued Accounting Standards Update 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes In January 2016, the FASB issued Accounting Standards Update 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities

Acquisitions and Dispositions

Acquisitions and Dispositions	12 Months Ended
Acquisitions and Dispositions	Dec. 31, 2015
Acquisitions and Dispositions	3. ACQUISITIONS AND DISPOSITIONS Acquisition of Rave Theatres On May 29, 2013, the Company acquired 32 theatres with 483 screens from Rave Real Property Holdco, LLC and certain of its subsidiaries, Rave Cinemas, LLC and RC Processing, LLC (collectively “Rave”) in an asset purchase for approximately $236,875 in cash plus the assumption of certain liabilities (the “Rave Acquisition”). The acquisition resulted in an expansion of the Company’s domestic theatre base into one new state and seven new markets. The transaction was subject to antitrust approval by the Department of Justice or Federal Trade Commission. The Department of Justice required the Company to agree to divest of three of the newly-acquired theatres, which occurred during August 2013 (see discussion below). The Company incurred approximately $500 in transaction costs, which are reflected in general and administrative expenses on the consolidated statement of income for the year ended December 31, 2013. The transaction was accounted for by applying the acquisition method. The following table represents the fair value of the identifiable assets acquired and liabilities assumed as of the acquisition date: Theatre properties and equipment $ 102,977 Tradename 25,000 Favorable leases 17,587 Goodwill 186,418 Unfavorable leases (30,718 ) Deferred revenue (6,634 ) Capital lease liabilities (61,651 ) Other assets, net of other liabilities 3,896 Total $ 236,875 The weighted average amortization period for the intangible assets acquired was approximately 14 years as of the acquisition date. The goodwill is fully deductible for tax purposes. The acquired theatres are reported in the Company’s U.S. segment. The following unaudited pro forma information summarizes our results of operations as if the Rave Acquisition had occurred as of January 1, 2013: Year Ended Total revenues $ 2,777,458 Income before income taxes $ 275,657 Acquisition of Other U.S. Theatres The Company acquired two additional theatres with 30 screens during April 2013 in two separate transactions for an aggregate purchase price of approximately $22,372 in cash plus the assumption of certain liabilities. The transactions were accounted for by applying the acquisition method. The following table represents the aggregate fair values of identifiable assets acquired and the liabilities assumed as of the acquisition date: Theatre properties and equipment $ 17,524 Goodwill 17,409 Capital lease liability (12,173 ) Deferred revenue (388 ) Total $ 22,372 Disposition of Three Rave Theatres In conjunction with the Rave Acquisition, the Company was required to divest of three theatres pursuant to a Hold Separate Agreement with the Department of Justice. On July 17, 2013, the Company entered into a definitive agreement to sell these three theatres to Carmike Cinemas, Inc. The transaction was approved by the Department of Justice and closed on August 16, 2013. Disposition of Mexico Subsidiaries During February 2013, the Company entered into a stock purchase agreement with Grupo Cinemex, S.A. De C.V. pursuant to which the Company would sell its Mexican subsidiaries, which consisted of 31 theatres and 290 screens. The transaction was subject to approval by the Mexican Federal Competition Commission (the “Competition Commission”). During August 2013, the Competition Commission voted three to two to block the transaction and the Company filed an appeal for the Competition Commission to reconsider the sale. During November 2013, the Competition Committee approved the sale and the transaction closed on November 15, 2013. The sales price, which was paid in Mexican pesos, was approximately $126,167, based on the exchange rate at November 15, 2013. The Company recorded a pre-tax gain of approximately $3,521 on the sale during the year ended December 31, 2013.

Investment in National CineMedi

Investment in National CineMedia Llc	12 Months Ended
Investment in National CineMedia Llc	Dec. 31, 2015
NCM
Investment in National CineMedia Llc	4. INVESTMENT IN NATIONAL CINEMEDIA LLC The Company has an investment in National CineMedia, LLC (“NCM”). NCM operates a digital in-theatre network in the U.S. for providing cinema advertising and non-film events. Upon joining NCM, the Company entered into an Exhibitor Services Agreement, or the ESA, with NCM, pursuant to which NCM provides advertising, promotion and event services to our theatres. On February 13, 2007, National CineMedia, Inc. (“NCMI”), an entity that serves as the sole manager of NCM, completed an IPO of its common stock. In connection with the NCMI initial public offering, the Company amended its operating agreement and the ESA with NCMI. The ESA modification reflected a shift from circuit share expense under the prior ESA, which obligated NCM to pay the Company a percentage of revenue, to a monthly theatre access fee, which significantly reduced the contractual amounts paid to us by NCM. The Company recorded the proceeds related to the ESA modification as deferred revenue, which is being amortized into other revenues over the life of the agreement using the units of revenue method. In consideration for NCM’s exclusive access to the Company’s theatre attendees for on-screen advertising and use of off-screen areas within the Company’s theatres for lobby entertainment and lobby promotions, the Company receives a monthly theatre access fee under the modified ESA. The theatre access fee is composed of a fixed payment per patron, initially seven cents, and a fixed payment per digital screen, which may be adjusted for certain reasons outlined in the modified ESA. The payment per theatre patron increases by 8% every five years, with the first such increase taking effect after the end of fiscal 2011, and the payment per digital screen, initially eight hundred dollars per digital screen per year, increases annually by 5%. For 2013, 2014 and 2015, the annual payment per digital screen was one thousand seventy-two dollars, one thousand one hundred twenty-five dollars and one thousand one hundred eight-two dollars, respectively. The theatre access fee paid in the aggregate to Regal Entertainment Group (“Regal”), AMC Entertainment, Inc. (“AMC”) and the Company will not be less than 12% of NCM’s Aggregate Advertising Revenue (as defined in the modified ESA), or it will be adjusted upward to reach this minimum payment. Additionally, with respect to any on-screen advertising time provided to the Company’s beverage concessionaire, the Company is required to purchase such time from NCM at a negotiated rate. The modified ESA has, except with respect to certain limited services, a remaining term of approximately 21 years. As a result of the application of a portion of the proceeds it received from the NCMI initial public offering, the Company had a negative basis in its original membership units in NCM, which is referred to herein as the Company’s Tranche 1 Investment. Following the NCMI IPO, the Company does not recognize undistributed equity in the earnings on its Tranche 1 Investment until NCM’s net earnings, less distributions received, surpass the amount of the excess distribution. The Company recognizes equity in earnings on its Tranche 1 Investment only to the extent it receives cash distributions from NCM. The Company recognizes cash distributions it receives from NCM on its Tranche 1 Investment as a component of earnings as Distributions from NCM. The Company believes that the accounting model provided by ASC 323-10-35-22 for recognition of equity investee losses in excess of an investor’s basis is analogous to the accounting for equity income subsequent to recognizing an excess distribution. Common Unit Adjustments Pursuant to a Common Unit Adjustment Agreement dated as of February 13, 2007 between NCMI and the Company, AMC and Regal, which we refer to collectively as the Founding Members, annual adjustments to the common membership units are made primarily based on increases or decreases in the number of theatre screens operated and theatre attendance generated by each Founding Member. To account for the receipt of additional common units under the Common Unit Adjustment Agreement, we follow the guidance in FASB ASC 323-10-35-29 (formerly EITF 02-18, “Accounting for Subsequent Investments in an Investee after Suspension of Equity Loss Recognition”) by analogy, which also refers to AICPA Technical Practice Aid 2220.14, which indicates that if a subsequent investment is made in an equity method investee that has experienced significant losses, the investor must determine if the subsequent investment constitutes funding of prior losses. We concluded that the construction or acquisition of new theatres that has led to the common unit adjustments equates to making additional investments in NCM. We evaluated the receipt of the additional common units in NCM and the assets exchanged for these additional units and have determined that the right to use our incremental new screens would not be considered funding of prior losses. We account for these additional common units, which we refer to herein as our Tranche 2 Investment, as a separate investment than our Tranche 1 Investment. The common units received are recorded at fair value as an increase in our investment in NCM with an offset to deferred revenue. The deferred revenue is amortized over the remaining term of the ESA. Our Tranche 2 Investment is accounted for following the equity method, with undistributed equity earnings related to our Tranche 2 Investment included as a component of earnings in equity in income of affiliates and distributions received related to our Tranche 2 Investment are recorded as a reduction of our investment basis. In the event that a common unit adjustment is determined to be a negative number, the Founding Member can elect to either transfer and surrender to NCM the number of common units equal to all or part of such Founding Member’s common unit adjustment or to pay to NCM an amount equal to such Founding Member’s common unit adjustment calculated in accordance with the Common Unit Adjustment Agreement. If the Company then elects to surrender common units as part of a negative common unit adjustment, the Company would record a reduction to deferred revenue at the then fair value of the common units surrendered and a reduction of the Company’s Tranche 2 Investment at an amount equal to the weighted average cost for Tranche 2 common units, with the difference between the two values recorded as a gain or loss on sale of assets and other. Below is a summary of common units received by the Company under the Common Unit Adjustment Agreement during the years ended December 31, 2013, 2014 and 2015: Event Date Number of Common Units Fair Value 2013 Annual common unit adjustment 03/28/13 588,024 $ 8,869 2013 Extraordinary common unit adjustment (as result of Rave Acquisition – see Note 3) 05/29/13 5,315,837 $ 89,928 2014 Annual common unit adjustment 03/27/14 557,631 $ 8,216 2015 Annual common unit adjustment 03/31/15 1,074,910 $ 15,421 Each common unit received by the Company is convertible into one share of NCMI common stock. The fair value of the common units received was estimated based on the market price of NCMI stock at the time that the common units were received, adjusted for volatility associated with the estimated period of time it would take to convert the common units and register the respective shares. The fair value measurement used for the common units falls under Level 2 of the U.S. GAAP fair value hierarchy as defined by ASC Topic 820-10-35. The Company records additional common units it receives as part of its Tranche 2 Investment at estimated fair value with a corresponding adjustment to deferred revenue. As of December 31, 2015, the Company owned a total of 25,631,046 common units of NCM, which represented an approximate 19% interest. Each common unit is convertible into one share of NCMI common stock. The estimated fair value of the Company’s investment in NCM was approximately $402,664 as of December 31, 2015, using NCMI’s stock price as of December 31, 2015 of $15.71 per share. Summary of Activity with NCM Below is a summary of activity with NCM included in the Company’s consolidated financial statements for the periods indicated: Investment Deferred Distributions Equity in Other Other Cash Balance as of January 1, 2013 $ 78,123 $ (241,305 ) Receipt of common units due to annual common unit adjustment 8,869 (8,869 ) $ — $ — $ — $ — $ — Receipt of common units due to extraordinary common unit adjustment 89,928 (89,928 ) — — — — — Revenues earned under ESA (1) — — (7,960 ) — 7,960 Receipt of excess cash distributions (13,166 ) — (19,374 ) — — — 32,540 Receipt under tax receivable agreement (492 ) — (1,327 ) — — — 1,819 Equity in earnings (2) 13,753 — — (11,578 ) — — — Equity in other comprehensive income 1,838 — — — — (1,838 ) — Amortization of deferred revenue — 5,673 — — (5,673 ) — — Balance as of and for the period ended December 31, 2013 $ 178,853 $ (334,429 ) $ (20,701 ) $ (11,578 ) $ (13,633 ) $ (1,838 ) $ 42,319 Receipt of common units due to annual common unit adjustment 8,216 (8,216 ) $ — $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (9,249 ) — 9,249 Receipt of excess cash distributions (12,574 ) — (14,778 ) — — — 27,352 Receipt under tax receivable agreement (2,594 ) — (3,763 ) — — — 6,357 Equity in earnings 6,142 — — (6,142 ) — — — Equity in other comprehensive income 896 — — — — (896 ) — Amortization of deferred revenue — 7,426 — — (7,426 ) — — Balance as of and for the period ended December 31, 2014 $ 178,939 $ (335,219 ) $ (18,541 ) $ (6,142 ) $ (16,675 ) $ (896 ) $ 42,958 Receipt of common units due to annual common unit adjustment 15,421 (15,421 ) $ — $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (11,330 ) — 11,330 Receipt of excess cash distributions (14,072 ) — (15,396 ) — — — 29,468 Receipt under tax receivable agreement (2,308 ) — (2,744 ) — — — 5,052 Equity in earnings 8,510 — — (8,510 ) — — — Equity in other comprehensive loss (2,735 ) — — — — 2,735 — Amortization of deferred revenue — 8,506 — — (8,506 ) — — Balance as of and for the period ended December 31, 2015 $ 183,755 $ (342,134 ) $ (18,140 ) $ (8,510 ) $ (19,836 ) $ 2,735 $ 45,850 (1) Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire were approximately $11,958, $11,489 and $9,819 for the years ended December 31, 2013, 2014 and 2015, respectively. (2) A portion of the equity in earnings recorded for the year ended December 31, 2013 was recorded as a reduction in our investment basis in a joint venture (AC JV, LLC) that the Company, along with Regal and AMC, recently formed with NCM. See Note 5. On May 5, 2014, NCMI announced that it had entered into a merger agreement to acquire Screenvision, LLC. On November 3, 2014, the U.S. Department of Justice (“DOJ”) filed an antitrust lawsuit seeking to enjoin the proposed merger between NCMI and Screenvision, LLC. On March 16, 2015, NCMI announced that it had agreed with Screenvision, LLC to terminate the merger agreement. The termination of the merger agreement resulted in a $26.8 million termination payment to Screenvision by NCMI. NCM indemnified NCMI for the termination fee. The impact of the termination payment and related merger costs resulted in NCM not making an excess cash distribution to its shareholders during the second quarter of 2015. The Company made payments to NCM of approximately $124 and $50 during the years ended December 31, 2014 and 2015, respectively, related to installation of certain equipment used for digital advertising, which is included in theatre furniture and equipment on the consolidated balance sheets. The Company paid event fees of $8,249 to NCM for the year ended December 31, 2013, prior to the formation of AC JV, LLC, as discussed in Note 5, which are included in film rentals and advertising costs on the consolidated statements of income. The tables below present summary financial information for NCM for the periods indicated (financial information for the year ended December 31, 2015 is not yet available): Year Ended Nine Months October 1, 2015 December 26, 2013 January 1, 2015 Gross revenues $ 462,815 $ 393,994 $ 310,061 Operating income $ 202,019 $ 159,624 $ 40,442 Net income $ 162,870 $ 96,309 $ 38,519 As of January 1, 2015 As of October 1, 2015 Total assets $ 681,107 $ 700,326 Total liabilities $ 998,529 $ 1,030,243

Other Investments

Other Investments	12 Months Ended
Other Investments	Dec. 31, 2015
Other Investments	5. OTHER INVESTMENTS The Company had the following other investments at December 31: 2014 2015 Digital Cinema Implementation Partners (“DCIP”), equity method investment $ 51,277 $ 71,579 RealD, Inc. (“RealD”), investment in marketable security 14,429 12,900 AC JV, LLC, equity method investment 7,899 7,269 Digital Cinema Distribution Coalition (“DCDC”), equity method investment 2,438 2,562 Other 1,615 663 Total $ 77,658 $ 94,973 Below is a summary of activity for each of the investments for the years ended December 31, 2013, 2014 and 2015: DCIP RealD AC JV, DCDC Other Total Balance at January 1, 2013 $ 23,012 $ 13,707 $ — $ 5 $ 1,477 $ 38,201 Cash contributions 3,232 — 268 2,721 — 6,221 Issuance of promissory note to NCM — — 8,333 — — 8,333 Equity in income (loss) 11,241 — — (137 ) — 11,104 Equity in other comprehensive income 548 — — — — 548 Adjustment for gain recognized by NCM — — (2,175 ) — — (2,175 ) Unrealized holding loss — (3,264 ) — — — (3,264 ) Other — — — — 689 689 Balance at December 31, 2013 $ 38,033 $ 10,443 $ 6,426 $ 2,589 $ 2,166 $ 59,657 Cash contributions 2,188 — — — — 2,188 Equity in income (loss) 15,279 — 1,473 (151 ) — 16,601 Equity in other comprehensive loss (219 ) — — — — (219 ) Unrealized holding gain — 3,986 — — — 3,986 Cash distributions received (4,004 ) — — — — (4,004 ) Other — — — — (551 ) (551 ) Balance at December 31, 2014 $ 51,277 $ 14,429 $ 7,899 $ 2,438 $ 1,615 $ 77,658 Cash contributions 3,211 — — — 500 3,711 Equity in income 18,522 — 970 124 — 19,616 Equity in other comprehensive loss (384 ) — — — — (384 ) Unrealized holding loss — (1,529 ) — — — (1,529 ) Sale of investment in Taiwan (1) — — — — (1,383 ) (1,383 ) Cash distributions received (1,047 ) — (1,600 ) — — (2,647 ) Other — — — — (69 ) (69 ) Balance at December 31, 2015 $ 71,579 $ 12,900 $ 7,269 $ 2,562 $ 663 $ 94,973 (1) The Company sold its investment in a Taiwan joint venture for approximately $2,634, resulting in a gain of $1,251, which is included in (gain) loss on sale of assets and other for the year ended December 31, 2015. Digital Cinema Implementation Partners LLC On February 12, 2007, the Company, AMC and Regal entered into a joint venture known as Digital Cinema Implementation Partners LLC to facilitate the implementation of digital cinema in the Company’s theatres and to establish agreements with major motion picture studios for the financing of digital cinema. On March 10, 2010, the Company signed a master equipment lease agreement and other related agreements (collectively the “Agreements”) with Kasima LLC (“Kasima”), which is an indirect subsidiary of DCIP and a related party to the Company. Upon signing the Agreements, the Company contributed the majority of its U.S. digital projection systems to DCIP, which DCIP then contributed to Kasima. The Company has a variable interest in Kasima through the terms of its master equipment lease agreement; however, the Company has determined that it is not the primary beneficiary of Kasima, as the Company does not have the ability to direct the activities of Kasima that most significantly impact Kasima’s economic performance. As of December 31, 2015, the Company had a 33% voting interest in DCIP and a 24.3% economic interest in DCIP. The Company accounts for its investment in DCIP and its subsidiaries under the equity method of accounting. Below is summary financial information for DCIP as of and for the years ended December 31, 2013, 2014 and 2015. Year ended December 31, 2013 2014 2015 Net operating revenue $ 182,659 $ 170,724 $ 171,203 Operating income $ 116,235 $ 101,956 $ 103,449 Net income $ 48,959 $ 61,293 $ 79,255 As of December 31, 2014 December 31, 2015 Total assets $ 1,097,467 $ 1,004,292 Total liabilities $ 845,319 $ 674,727 As a result of the Agreements, the Company installed digital projection systems to a majority of its first run U.S. theatres. The digital projection systems are being leased from Kasima under an operating lease with an initial term of twelve years that contains ten one-year fair value renewal options. The equipment lease agreement also contains a fair value purchase option. Under the equipment lease agreement, the Company pays annual rent of one thousand dollars per digital projection system. The Company may also be subject to various types of other rent if such digital projection systems do not meet minimum performance requirements as outlined in the agreements. Certain of the other rent payments are subject to either a monthly or an annual maximum. As of December 31, 2015, the Company had 3,781 digital projection systems being leased under the master equipment lease agreement with Kasima. The Company had the following transactions with DCIP during the years ended December 31, 2013, 2014 and 2015: Year Ended December 31, 2013 2014 2015 Equipment lease payments $ 3,853 $ 4,012 $ 4,474 Warranty reimbursements from DCIP $ (1,893 ) $ (3,169 ) $ (4,329 ) RealD, Inc. The Company licenses 3-D systems from RealD. Under its license agreement with RealD, the Company earned options to purchase shares of RealD common stock as it installed a certain number of 3-D systems as outlined in the license agreement. During 2010 and 2011, the Company vested in a total of 1,222,780 RealD options. Upon vesting in these options, the Company recorded an investment in RealD and a deferred lease incentive liability using the estimated fair value of the RealD options at the time of vesting. During March 2011, the Company exercised all of its options to purchase shares of common stock in RealD for $0.00667 per share. The Company owns 1,222,780 shares of RealD and accounts for its investment in RealD as a marketable security. The Company has determined that its RealD shares are available-for-sale securities in accordance with ASC Topic 320-10-35-1, therefore unrealized holding gains and losses are reported as a component of accumulated other comprehensive loss until realized. As of December 31, 2015, the estimated fair value of the Company’s investment in RealD was $12,900, which is based on the closing price of RealD’s common stock of $10.55 per share on December 31, 2015, and falls under Level 1 of the U.S. GAAP fair value hierarchy as defined by ASC Topic 820-10-35. AC JV, LLC During December 2013, the Company, Regal, AMC (the “AC Founding Members”) and NCM entered into a series of agreements that resulted in the formation of AC JV, LLC (“AC”), a new joint venture that now owns “Fathom Events” (consisting of Fathom Events and Fathom Consumer Events) formerly operated by NCM. The Fathom Events business focuses on the marketing and distribution of live and pre-recorded entertainment programming to various theatre operators to provide additional programs to augment their feature film schedule. The Fathom Consumer Events business includes live and pre-recorded concerts featuring contemporary music, opera and symphony, DVD product releases and marketing events, theatrical premieres, Broadway plays, live sporting events and other special events. The Company paid event fees of $9,273 and $11,440 for the years ended December 31, 2014 and 2015, respectively, which are included in film rentals and advertising costs on the consolidated statements of income. AC was formed by the AC Founding Members and NCM. NCM, under a contribution agreement, contributed the assets associated with its Fathom Events division to AC in exchange for 97% ownership of the Class A Units of AC. Under a separate contribution agreement, the Founding Members each contributed cash of approximately $268 to AC in exchange for 1% of the Class A Units of AC. Subsequently, NCM and the Founding Members entered into a Membership Interest Purchase Agreement, under which NCM sold each of the Founding Members 31% of its Class A Units in AC, the aggregate value of which was determined to be $25,000, in exchange for a six-year Promissory Note. Each of the Founding Members’ Promissory Notes were originally for $8,333, bear interest at 5% per annum and require annual principal and interest payments, with the first of such payments made during December 2014. The remaining outstanding balance of the note payable from the Company to AC as of December 31, 2015 was $5,555. Digital Cinema Distribution Coalition The Company is a party to a joint venture with certain exhibitors and distributors called Digital Cinema Distribution Coalition (“DCDC”). DCDC operates a satellite distribution network that distributes all digital content to U.S. theatres via satellite. The Company has an approximate 14.6% ownership in DCDC. The Company paid approximately $741 and $807 to DCDC during the years ended December 31, 2014 and 2015 related to content delivery services provided by DCDC, which is included in film rentals and advertising costs on the consolidated statements of income.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets - Net	12 Months Ended
Goodwill and Other Intangible Assets - Net	Dec. 31, 2015
Goodwill and Other Intangible Assets - Net	6. GOODWILL AND OTHER INTANGIBLE ASSETS — NET The Company’s goodwill was as follows: U.S. Operating Segment International Operating Segment Total Balance at December 31, 2013 (1) $ 1,150,471 $ 137,619 $ 1,288,090 Acquisition of U.S. theatres 6,085 — 6,085 Other acquisitions — 1,108 1,108 Foreign currency translation adjustments — (17,900 ) (17,900 ) Balance at December 31, 2014 (1) $ 1,156,556 $ 120,827 $ 1,277,383 Acquisition of Brazil theatre — 356 356 Foreign currency translation adjustments — (30,191 ) (30,191 ) Balance at December 31, 2015 (1) $ 1,156,556 $ 90,992 $ 1,247,548 (1) Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment. As of December 31, intangible assets-net, consisted of the following: December 31, December 31, 2013 Acquisitions Amortization Other (1) 2014 Intangible assets with finite lives: Gross carrying amount $ 101,617 $ 300 $ — $ (1,995 ) $ 99,922 Accumulated amortization (46,297 ) — (5,947 ) 12 (52,232 ) Total net intangible assets with finite lives $ 55,320 $ 300 $ (5,947 ) $ (1,983 ) $ 47,690 Intangible assets with indefinite lives: Tradename 300,824 — — (490 ) 300,334 Total intangible assets — net $ 356,144 $ 300 $ (5,947 ) $ (2,473 ) $ 348,024 December 31, December 31, 2014 Amortization Other (2) 2015 Intangible assets with finite lives: Gross carrying amount $ 99,922 $ — $ 46 $ 99,968 Accumulated amortization (52,232 ) (5,716 ) (1,758 ) (59,706 ) Total net intangible assets with finite lives $ 47,690 $ (5,716 ) $ (1,712 ) $ 40,262 Intangible assets with indefinite lives: Tradename 300,334 — (952 ) 299,382 Total intangible assets — net $ 348,024 $ (5,716 ) $ (2,664 ) $ 339,644 (1) Activity for 2014 primarily consists of $479 for impairment of a tradename intangible asset related to one U.S. theatre and foreign currency translation adjustments. (2) Activity for 2015 primarily consists of the write-off of intangible assets for closed theatres, the write-off of a vendor contract intangible asset, $992 for impairment of a favorable lease and foreign currency translation adjustments. Estimated aggregate future amortization expense for intangible assets is as follows: For the year ended December 31, 2016 $ 5,389 For the year ended December 31, 2017 4,857 For the year ended December 31, 2018 4,857 For the year ended December 31, 2019 3,977 For the year ended December 31, 2020 4,252 Thereafter 16,930 Total $ 40,262

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets	12 Months Ended
Impairment of Long-Lived Assets	Dec. 31, 2015
Impairment of Long-Lived Assets	7. IMPAIRMENT OF LONG-LIVED ASSETS The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. See Note 1 for discussion of the Company’s impairment policy. The Company’s long-lived asset impairment losses are summarized in the following table: Year Ended December 31, 2013 2014 2015 United States theatre properties $ 1,911 $ 6,168 $ 7,052 International theatre properties 1,175 — 757 Subtotal 3,086 6,168 7,809 Intangible assets (see Note 6) 708 479 992 Impairment of long-lived assets $ 3,794 $ 6,647 $ 8,801 The long-lived asset impairment charges recorded during each of the years presented are specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics, or adverse changes in the development or the conditions of the areas surrounding the theatre. As of December 31, 2015, the estimated aggregate remaining fair value of the long-lived assets impaired during the year ended December 31, 2015 was approximately $8,395.

Deferred Charges and Other Asse

Deferred Charges and Other Assets - Net	12 Months Ended
Deferred Charges and Other Assets - Net	Dec. 31, 2015
Deferred Charges and Other Assets - Net	8. DEFERRED CHARGES AND OTHER ASSETS — NET As of December 31, deferred charges and other assets — net consisted of the following: December 31, 2014 2015 Long-term prepaid rents 7,296 4,278 Construction and other deposits 14,171 8,459 Equipment to be placed in service 14,124 15,388 Other 10,980 10,118 Total $ 46,571 $ 38,243 See Note 2 for discussion of debt issuance costs reclassification upon adoption of ASU 2015-03.

Long-Term Debt

Long-Term Debt	12 Months Ended
Long-Term Debt	Dec. 31, 2015
Long-Term Debt	9. LONG-TERM DEBT As of December 31, long-term debt consisted of the following: December 31, 2014 2015 Cinemark USA, Inc. term loan $ 686,000 $ 679,000 Cinemark USA, Inc. 4.875% senior notes due 2023 530,000 530,000 Cinemark USA, Inc. 5.125% senior notes due 2022 400,000 400,000 Cinemark USA, Inc. 7.375% senior subordinated notes due 2021 200,000 200,000 Other (1) 6,997 5,572 Total long-term debt 1,822,997 1,814,572 Less current portion 8,423 8,405 Less debt issuance costs, net of accumulated amortization of $10,918 and $16,058, respectively (2) 31,419 33,237 Long-term debt, less current portion $ 1,783,155 $ 1,772,930 (1) Primarily represents debt owed to NCM in relation to the recently-formed joint venture AC JV, LLC. See Note 5. (2) See Note 2 for discussion of debt issuance costs reclassification upon adoption of ASU 2015-03. Senior Secured Credit Facility Cinemark USA, Inc. has a senior secured credit facility that includes a seven year $700,000 term loan and a five year $100,000 revolving credit line (the “Senior Secured Credit Facility”). On May 8, 2015, Cinemark USA, Inc., our wholly-owned subsidiary, amended its senior secured credit facility to extend the maturity of the $700,000 term loan from December 2019 to May 2022. Quarterly principal payments in the amount of $1,750 are due on the term loan through March 31, 2022, with the remaining principal of $635,250 due on May 8, 2022. The Company incurred debt issue costs of approximately $6,875 in connection with the amendment. In addition, the Company incurred approximately $925 in legal and other fees that are reflected as loss on amendment to debt agreement on the consolidated statement of income for the year ended December 31, 2015. Interest on the term loan accrues at Cinemark USA, Inc.’s option at: (A) the base rate equal to the higher of (1) the prime lending rate as set forth on the British Banking Association Telerate page 5, or (2) the federal funds effective rate from time to time plus 0.50%, plus a margin of 2.0% per annum, or (B) a “eurodollar rate” plus a margin of 3.0% per annum. Interest on the revolving credit line accrues, at Cinemark USA, Inc.’s option, at: (A) a base rate equal to the higher of (1) the prime lending rate as set forth on the British Banking Association Telerate page 5 and (2) the federal funds effective rate from time to time plus 0.50%, plus a margin that ranges from 1.00% to 1.75% per annum, or (B) a “eurodollar rate” plus a margin that ranges from 2.00% to 2.75% per annum. The margin of the revolving credit line is determined by the consolidated net senior secured leverage ratio as defined in the credit agreement. Cinemark USA, Inc.’s obligations under the Senior Secured Credit Facility are guaranteed by Cinemark Holdings, Inc. and certain of Cinemark USA, Inc.’s domestic subsidiaries and are secured by mortgages on certain fee and leasehold properties and security interests in substantially all of Cinemark USA, Inc.’s and the guarantors’ personal property, including, without limitation, pledges of all of Cinemark USA, Inc.’s capital stock, all of the capital stock of certain of Cinemark USA, Inc.’s domestic subsidiaries and 65% of the voting stock of certain of its foreign subsidiaries. The Senior Secured Credit Facility contains usual and customary negative covenants for agreements of this type, including, but not limited to, restrictions on Cinemark USA, Inc.’s ability, and in certain instances, its subsidiaries’ and Cinemark Holdings, Inc.’s ability, to consolidate or merge or liquidate, wind up or dissolve; substantially change the nature of its business; sell, transfer or dispose of assets; create or incur indebtedness; create liens; pay dividends, and repurchase stock; and make capital expenditures and investments. If Cinemark USA, Inc. has borrowings outstanding on the revolving credit line, it is required to satisfy a consolidated net senior secured leverage ratio covenant as determined in accordance with the Senior Secured Credit Facility. The dividend restriction contained in the Senior Secured Credit Facility prevents the Company and any of its subsidiaries from paying a dividend or otherwise distributing cash to its stockholders unless (1) the Company is not in default, and the distribution would not cause Cinemark USA, Inc. to be in default, under the Senior Secured Credit Facility; and (2) the aggregate amount of certain dividends, distributions, investments, redemptions and capital expenditures made since December 18, 2012, including dividends declared by the board of directors, is less than the sum of (a) the aggregate amount of cash and cash equivalents received by Cinemark Holdings, Inc. or Cinemark USA, Inc. as common equity since December 18, 2012, (b) Cinemark USA, Inc.’s consolidated EBITDA minus 1.75 times its consolidated interest expense, each as defined in the Senior Secured Credit Facility, and (c) certain other defined amounts. As of December 31, 2015, Cinemark USA, Inc. could have distributed up to approximately $1,905,096 to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the Senior Secured Credit Facility, subject to its available cash and other borrowing restrictions outlined in the agreement. At December 31, 2015, there was $679,000 outstanding under the term loan and no borrowings outstanding under the revolving credit line. Cinemark USA, Inc. had $100,000 in available borrowing capacity on the revolving credit line. Cinemark USA, Inc. had no borrowings under the revolving credit line during the years ended December 31, 2014 or 2015. The average interest rate on outstanding term loan borrowings under the Senior Secured Credit Facility at December 31, 2015 was approximately 3.6% per annum. 4.875% Senior Notes On May 24, 2013, Cinemark USA, Inc. issued $530,000 aggregate principal amount of 4.875% senior notes due 2023, at par value, (the “4.875% Senior Notes”). Proceeds, after payment of fees, were used to finance a redemption of the 8.625% Senior Notes due 2019, discussed below. Interest on the 4.875% Senior Notes is payable on June 1 and December 1 of each year, beginning December 1, 2013. The 4.875% Senior Notes mature on June 1, 2023. The 4.875% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or become liable with respect to any of Cinemark USA, Inc.’s or a guarantor’s debt. The 4.875% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior unsecured debt and senior in right of payment to all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior subordinated debt. The 4.875% Senior Notes and the guarantees are effectively subordinated to all of Cinemark USA, Inc.’s and its guarantor’s existing and future secured debt to the extent of the value of the assets securing such debt, including all borrowings under Cinemark USA, Inc.’s senior secured credit facility. The 4.875% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of Cinemark USA, Inc.’s subsidiaries that do not guarantee the 4.875% Senior Notes. The indenture to the 4.875% Senior Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2015, Cinemark USA, Inc. could have distributed up to approximately $2,079,680 to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture to the 4.875% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. Upon a change of control, as defined in the indenture governing the 4.875% Senior Notes, Cinemark USA, Inc. would be required to make an offer to repurchase the 4.875% Senior Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 4.875% Senior Notes allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1 and our actual ratio as of December 31, 2015 was approximately 7.7 to 1. Prior to June 1, 2018, Cinemark USA, Inc. may redeem all or any part of the 4.875% Senior Notes at its option at 100% of the principal amount plus a make-whole premium plus accrued and unpaid interest on the 4.875% Senior Notes to the date of redemption. After June 1, 2018, Cinemark USA, Inc. may redeem the 4.875% Senior Notes in whole or in part at redemption prices specified in the indenture. In addition, prior to June 1, 2016, Cinemark USA, Inc. may redeem up to 35% of the aggregate principal amount of the 4.875% Senior Notes from the net proceeds of certain equity offerings at the redemption price set forth in the indenture. 5.125% Senior Notes On December 18, 2012, Cinemark USA, Inc. issued $400,000 aggregate principal amount of 5.125% senior notes due 2022, at par value (the “5.125% Senior Notes”). A portion of the proceeds were used to refinance a portion of the former senior secured credit facility and to fund the purchase price for the Rave Acquisition (see Note 5 to the consolidated financial statements). Interest on the 5.125% Senior Notes is payable on June 15 and December 15 of each year, beginning June 15, 2013. The 5.125% Senior Notes mature on December 15, 2022. The 5.125% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or become liable with respect to any of Cinemark USA, Inc.’s or a guarantor’s debt. The 5.125% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior unsecured debt and senior in right of payment to all of Cinemark USA, Inc.’s and its guarantor’s existing and future subordinated debt. The 5.125% Senior Notes and the guarantees are effectively subordinated to all of Cinemark USA, Inc.’s and its guarantor’s existing and future secured debt to the extent of the value of the assets securing such debt, including all borrowings under Cinemark USA, Inc.’s senior secured credit facility. The 5.125% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of Cinemark USA, Inc.’s subsidiaries that do not guarantee the 5.125% Senior Notes. The indenture to the 5.125% Senior Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2015, Cinemark USA, Inc. could have distributed up to approximately $2,083,985 to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture to the 5.125% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. Upon a change of control, as defined in the indenture governing the 5.125% Senior Notes, Cinemark USA, Inc. would be required to make an offer to repurchase the 5.125% Senior Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 5.125% Senior Notes allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1 and our actual ratio as of December 31, 2015 was approximately 7.7 to 1. Prior to December 15, 2017, Cinemark USA, Inc. may redeem all or any part of the 5.125% Senior Notes at its option at 100% of the principal amount plus a make-whole premium. After December 15, 2017, Cinemark USA, Inc. may redeem the 5.125% Senior Notes in whole or in part at redemption prices described in the 5.125% Senior Notes. In addition, Cinemark USA, Inc. may redeem up to 35% of the aggregate principal amount of the 5.125% Senior Notes from the net proceeds of certain equity offerings at the redemption price set forth in the 5.125% Senior Notes. 7.375% Senior Subordinated Notes On June 3, 2011, Cinemark USA, Inc. issued $200,000 aggregate principal amount of 7.375% senior subordinated notes due 2021, at par value (the “Senior Subordinated Notes”). Interest on the Senior Subordinated Notes is payable on June 15 and December 15 of each year. The Senior Subordinated Notes mature on June 15, 2021. The Senior Subordinated Notes are fully and unconditionally guaranteed on a joint and several senior subordinated unsecured basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or become liable with respect to any of Cinemark USA, Inc.’s or a guarantor’s other debt. The Senior Subordinated Notes and the guarantees are senior subordinated unsecured obligations and rank equally in right of payment with all of Cinemark USA, Inc.’s and a guarantor’s future senior subordinated indebtedness; are subordinate in right of payment to all of Cinemark USA, Inc.’s and a guarantor’s existing and future senior indebtedness, whether secured or unsecured, including Cinemark USA, Inc.’s obligations under its Senior Secured Credit Facility, its 5.125% Senior Notes and 4.875% Senior Notes; and structurally subordinate to all existing and future indebtedness and other liabilities of Cinemark USA, Inc.’s non-guarantor subsidiaries. The indenture to the Senior Subordinated Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2015, Cinemark USA, Inc. could have distributed up to approximately $2,072,800 to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture to the Senior Subordinated Notes, subject to its available cash and other borrowing restrictions outlined in the indenture governing the Senior Subordinated Notes. Upon a change of control, as defined in the indenture, Cinemark USA, Inc. would be required to make an offer to repurchase the Senior Subordinated Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1, and our actual ratio as of December 31, 2015 was approximately 7.7 to 1. Prior to June 15, 2016, Cinemark USA, Inc. may redeem all or any part of the Senior Subordinated Notes at its option at 100% of the principal amount plus a make-whole premium plus accrued and unpaid interest on the senior subordinated notes to the date of redemption. After June 15, 2016, Cinemark USA, Inc. may redeem the Senior Subordinated Notes in whole or in part at redemption prices specified in the indenture. In addition, prior to June 15, 2014, Cinemark USA, Inc. may redeem up to 35% of the aggregate principal amount of the Senior Subordinated Notes from the net proceeds of certain equity offerings at the redemption price set forth in the indenture. 8.625% Senior Notes On June 29, 2009, Cinemark USA, Inc. issued $470,000 aggregate principal amount of 8.625% senior notes due 2019 (the “8.625% Senior Notes”), with an original issue discount of $11,468, resulting in proceeds of approximately $458,532. On June 24, 2013, Cinemark USA, Inc. redeemed its 8.625% Senior Notes at 112.035% of the principal amount, inclusive of a make-whole premium, plus accrued and unpaid interest, utilizing the proceeds from the issuance of the 4.875% Senior Notes discussed above. As a result of the redemption, we wrote-off approximately $8,054 in unamortized bond discount and $7,634 in unamortized debt issue costs, paid a make-whole premium of approximately $56,564 and paid other fees of $50, all of which are reflected in loss on early retirement of debt during the year ended December 31, 2013. Fair Value of Long Term Debt The Company estimates the fair value of its long-term debt primarily using quoted market prices, which fall under Level 2 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35. The carrying value of the Company’s long term debt was $1,822,997 and $1,814,572 as of December 31, 2014 and 2015, respectively, excluding debt issuance costs of $31,419 and $33,237, respectively. The fair value of the Company’s long term debt was $1,790,987 and $1,806,276 as of December 31, 2014 and 2015, respectively. Covenant Compliance and Debt Maturity As of December 31, 2015, the Company believes it was in full compliance with all agreements, including related covenants, governing its outstanding debt. The Company’s long-term debt, excluding debt issuance costs, at December 31, 2015 matures as follows: 2016 $ 8,405 2017 8,389 2018 8,389 2019 8,389 2020 7,000 Thereafter 1,774,000 Total $ 1,814,572

Interest Rate Swap Agreements

Interest Rate Swap Agreements	12 Months Ended
Interest Rate Swap Agreements	Dec. 31, 2015
Interest Rate Swap Agreements	10. INTEREST RATE SWAP AGREEMENT The Company is currently a party to one interest rate swap agreement that is used to hedge a portion of the interest rate risk associated with the variable interest rates on the Company’s term loan debt and qualifies for cash flow hedge accounting. The fair value of the interest rate swap is recorded on the Company’s consolidated balance sheet as an asset or liability with the effective portion of the interest rate swap’s gains or losses reported as a component of accumulated other comprehensive loss and the ineffective portion reported in earnings. The changes in fair value are reclassified from accumulated other comprehensive loss into earnings in the same period that the hedged item affects earnings. The valuation technique used to determine fair value is the income approach and under this approach, the Company uses projected future interest rates as provided by counterparty to the interest rate swap agreement and the fixed rates that the Company is obligated to pay under the agreement. Therefore, the Company’s measurements use significant unobservable inputs, which fall in Level 3 of the U.S. GAAP hierarchy as defined by FASB ASC Topic 820-10-35. There were no changes in valuation techniques during the period and no transfers in or out of Level 3. See Note 11 for a summary of unrealized gains or losses recorded in accumulated other comprehensive loss and earnings. Below is a summary of the Company’s interest rate swap agreement designated as cash flow hedge as of December 31, 2015: Estimated Notional Amount Effective Date Pay Rate Receive Rate Expiration Date Total Fair Value at (1) $100,000 November 2011 1.7150 % 1-Month LIBOR April 2016 $ 373 (1) Included in accrued other current liabilities on the consolidated balance sheet as of December 31, 2015. The changes in accumulated other comprehensive loss, net of taxes, related to the Company’s interest rate swap agreements for the years ended December 31, 2013, 2014 and 2015 were as follows: 2013 2014 2015 Beginning balances – January 1 $ (8,867 ) $ (5,716 ) $ (2,870 ) Other comprehensive loss before reclassifications, net of taxes (2,668 ) (3,169 ) (2,154 ) Amounts reclassified from accumulated other comprehensive loss to interest expense, net of taxes 5,819 6,015 4,790 Net other comprehensive income 3,151 2,846 2,636 Ending balances – December 31 $ (5,716 ) $ (2,870 ) $ (234 )

Fair Value Measurements

Fair Value Measurements	12 Months Ended
Fair Value Measurements	Dec. 31, 2015
Fair Value Measurements	11. FAIR VALUE MEASUREMENTS The Company determines fair value measurements in accordance with FASB ASC Topic 820, which establishes a fair value hierarchy under which an asset or liability is categorized based on the lowest level of input significant to its fair value measurement. The levels of input defined by FASB ASC Topic 820 are as follows: Level 1 – quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date; Level 2 – other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3 – unobservable and should be used to measure fair value to the extent that observable inputs are not available. Below is a summary of assets and liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of December 31, 2014: Carrying Value Fair Value Description Level 1 Level 2 Level 3 Interest rate swap liabilities – current (see Note 10) $ (4,255 ) $ — $ — $ (4,255 ) Interest rate swap liabilities – long term (see Note 10) $ (317 ) $ — $ — $ (317 ) Investment in RealD (see Note 5) $ 14,429 $ 14,429 $ — $ — Below is a summary of assets and liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of December 31, 2015: Carrying Value Fair Value Description Level 1 Level 2 Level 3 Interest rate swap liabilities – current (see Note 10) $ (373 ) $ — $ — $ (373 ) Investment in RealD (see Note 5) $ 12,900 $ 12,900 $ — $ — Below is a reconciliation of the beginning and ending balance for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3): Liabilities 2014 2015 Beginning balances - January 1 $ 9,176 $ 4,572 Total (gain) loss included in accumulated other comprehensive loss 1,411 (155 ) Settlements (6,015 ) (4,790 ) Ending balances – December 31 $ 4,572 $ 373 The Company also uses the market approach for fair value measurements on a nonrecurring basis in the impairment evaluations of its long-lived assets (see Note 6 and Note 7). Additionally, the Company uses the market approach to estimate the fair value of its long-term debt (see Note 9). There were no changes in valuation techniques during the period. There were no transfers in or out of Level 1, Level 2 or Level 3 during the years ended December 31, 2013, 2014 and 2015.

Foreign Currency Translation

Foreign Currency Translation	12 Months Ended
Foreign Currency Translation	Dec. 31, 2015
Foreign Currency Translation	12. FOREIGN CURRENCY TRANSLATION The accumulated other comprehensive loss account in stockholders’ equity of $144,772 and $271,686 at December 31, 2014 and 2015, respectively, includes the cumulative foreign currency losses of $147,930 and $273,404, respectively, from translating the financial statements of the Company’s international subsidiaries, the change in fair values of the Company’s interest rate swap agreements that are designated as hedges and the change in fair value of the Company’s available-for-sale securities. All foreign countries where the Company has operations are non-highly inflationary and the local currency is the same as the functional currency in all of the locations. Thus, any fluctuation in the currency results in a cumulative foreign currency translation adjustment recorded to accumulated other comprehensive loss. Below is a summary of the impact of translating the financial statements of the Company’s international subsidiaries as of and for the years ended December 31, 2013, 2014 and 2015. Other Comprehensive Country Exchange Rates as of December 31, Income (Loss) For Year Ended December 31, 2013 2014 2015 2013 2014 2015 Brazil 2.36 2.69 3.96 $ (34,451 ) $ (30,723 ) $ (74,559 ) Argentina 6.52 8.55 12.95 (24,845 ) (20,197 ) (30,520 ) Colombia 1,926.83 2,392.46 3,149.47 (2,969 ) (7,632 ) (8,043 ) Chile 525.5 606.2 709.16 (3,570 ) (5,580 ) (6,572 ) Peru 2.84 3.05 3.46 (3,685 ) (2,785 ) (4,882 ) All other (185 ) (2,066 ) (898 ) Sale of Mexico subsidiary 22,088 — — $ (47,617 ) $ (68,983 ) $ (125,474 ) During November 2013, the Company completed the sale of certain of its Mexico subsidiaries. As a result of this sale, the accumulated other comprehensive loss previously unrealized for these Mexico subsidiaries of $22,088 was recognized by the Company as part of the gain on sale. See Note 3 for additional information.

Noncontrolling Interests in Sub

Noncontrolling Interests in Subsidiaries	12 Months Ended
Noncontrolling Interests in Subsidiaries	Dec. 31, 2015
Noncontrolling Interests in Subsidiaries	13. NONCONTROLLING INTERESTS IN SUBSIDIARIES Noncontrolling interests in subsidiaries of the Company were as follows at December 31: December 31, 2014 2015 Cinemark Partners II — 24.6% interest (in one theatre) $ 7,769 $ 7,753 Laredo Theatres – 25% interest (in two theatres) 1,112 1,761 Greeley Ltd. — 49.0% interest (in one theatre) 589 740 Other 859 851 Total $ 10,329 $ 11,105 During August 2013, the Company purchased the 49.9% noncontrolling interest share of one of its Brazilian subsidiaries, Adamark Cinemas S.A. (“Adamark”), for approximately $5,621 in cash. Adamark had investments in two of the Company’s Brazilian theatres. The increase in the Company’s ownership interest in the Brazilian subsidiary was accounted for as an equity transaction in accordance with ASC Topic 810-10-45-23. The Company recorded a decrease in additional paid-in-capital of approximately $4,618, which represented the difference between the cash paid and the book value of the Brazilian subsidiary’s noncontrolling interest account. As a result of this transaction, the Company owns 100% of the shares in Adamark. Below is a summary of the impact of changes in the Company’s ownership interest in its subsidiaries on its equity: Year ended December 31, 2013 2014 2015 Net income attributable to Cinemark USA, Inc. $ 149,843 $ 194,380 $ 218,532 Transfers from noncontrolling interests Decrease in Cinemark USA, Inc. additional paid-in-capital for the buyout of Adamark non-controlling interest (4,618 ) — — Net transfers from non-controlling interests (4,618 ) — — Change from net income attributable to Cinemark USA, Inc. and transfers from noncontrolling interests $ 145,225 $ 194,380 $ 218,532

Capital Stock

Capital Stock	12 Months Ended
Capital Stock	Dec. 31, 2015
Capital Stock	14. CAPITAL STOCK Common and Preferred Stock — The Company has 1,000,000 shares of preferred stock, $1.00 par value, authorized with none issued or outstanding. The rights and preferences of preferred stock will be determined by the Board of Directors at the time of issuance. The Company’s ability to pay dividends is effectively limited by the terms of its senior notes indentures, its senior subordinated notes indenture and its senior secured credit facility, which also significantly restricts the ability of certain of the Company’s subsidiaries to pay dividends directly or indirectly to it. See Note 9. Furthermore, certain of the Company’s foreign subsidiaries currently have a deficit in retained earnings which prevents the Company from declaring and paying dividends from those subsidiaries. Stock Options Year Ended Year Ended December 31, 2013 December 31, 2014 Weighted Weighted Average Average Number of Exercise Number of Exercise Options Price Options Price Outstanding at January 1 22,022 $ 7.63 14,584 $ 7.63 Exercised (7,438 ) $ 7.63 (14,584 ) $ 7.63 Outstanding at December 31 14,584 $ 7.63 — Vested options at December 31 14,584 $ 7.63 — The total intrinsic value of options exercised during the years ended December 2013 and 2014 was $168 and $296, respectively. The Company recognized tax benefits of approximately $71 and $124 related to the options exercised during the year ended December 31, 2013 and 2014, respectively. Restricted Stock Year Ended Year Ended Year Ended December 31, 2013 December 31, 2014 December 31, 2015 Shares of Weighted Shares of Weighted Shares of Weighted Outstanding at January 1 1,534,163 $ 18.85 1,260,913 $ 21.86 878,897 $ 24.92 Granted 271,532 $ 30.09 269,774 $ 28.93 226,212 $ 42.79 Vested (522,129 ) $ 17.27 (625,843 ) $ 20.53 (329,437 ) $ 23.72 Forfeited (22,653 ) $ 22.92 (25,947 ) $ 22.94 (17,897 ) $ 27.58 Outstanding at December 31 1,260,913 $ 21.86 878,897 $ 24.92 757,775 $ 30.73 During the year ended December 31, 2015, Cinemark Holdings, Inc. granted 226,212 shares of restricted stock to its directors and to employees of the Company. The fair value of the restricted stock granted was determined based on the market value of Cinemark Holdings, Inc.’s common stock on the date of grant, which ranged from $40.75 to $43.28 per share. The Company assumed forfeiture rates ranging from 0% to 10% for the restricted stock awards. Restricted stock granted to directors vests over a one-year period. Restricted stock granted to employees vests over periods ranging from one year to four years based on continued service. The recipients of restricted stock are entitled to receive dividends and to vote their respective shares, however, the sale and transfer of the restricted shares is prohibited during the restriction period. Below is a summary of restricted stock award activity recorded for the periods indicated: Year Ended December 31, 2013 2014 2015 Compensation expense recognized during the period (1) $ 11,898 $ 8,591 $ 8,715 Fair value of restricted shares that vested during the period (2) $ 9,161 $ 17,692 $ 13,276 Income tax deduction upon vesting of restricted stock awards (3) $ 3,848 $ 5,171 $ 3,341 (1) Cinemark Holdings, Inc. recorded an additional $840, $943 and $885 of compensation expense related to these restricted stock awards during the years ended December 31, 2013, 2014 and 2015, respectively. (2) The fair value of shares in which Cinemark Holdings, Inc.’s directors vested was $1,000, $1,081 and $1,148 during the years ended December 31, 2013, 2014 and 2015, respectively. (3) Cinemark Holdings, Inc. recognized an additional tax benefit of $420, $454 and $482 on these vested awards during the years ended December 31, 2013, 2014 and 2015, respectively. As of December 31, 2015, the remaining unrecognized compensation expense related to these restricted stock awards was approximately $11,944 of which $11,490 will be recognized by the Company and $454 will be recognized by Cinemark Holdings, Inc. The weighted average period over which this remaining compensation expense will be recognized is approximately two years. Restricted Stock Units At the time of each of the restricted stock unit grants, the Company assumes the IRR level to be reached for the defined measurement period will be the mid-point IRR level in determining the amount of compensation expense to record for such grants. If and when additional information becomes available to indicate that something other than the mid-point IRR level will be achieved, the Company adjusts compensation expense on a prospective basis over the remaining service period. The Company assumed forfeiture rates ranging from 0% to 5% for the restricted stock unit awards granted during 2015. Restricted stock unit award participants are eligible to receive dividend equivalent payments if and at the time the restricted stock unit awards vest. Below is a table summarizing the potential number of shares that could vest under restricted stock unit awards granted during the years ended December 31, 2013, 2014 and 2015 at each of the three levels of financial performance (excluding forfeitures): Granted During the Year Ended December 31, 2013 2014 2015 Number of Value at (1) Number of Value at (1) Number of Value at (1) at IRR of at least 8.5% (7.5% for 2015 grant) 38,366 $ 1,129 65,832 $ 1,879 47,640 $ 2,057 at IRR of at least 10.5% (9.5% for 2015 grant) 76,741 $ 2,259 131,683 $ 3,758 95,282 $ 4,115 at IRR of at least 12.5% (11.5% for 2015 grant) 115,107 $ 3,389 197,515 $ 5,637 142,917 $ 6,173 (1) The weighted average grant date fair values for units issued during the years ended December 31, 2013, 2014, and 2015 were $29.44, $28.54 and $43.19, respectively. Below is a summary of activity for restricted stock unit awards for the periods indicated: Year Ended December 31, 2013 2014 2015 Number of restricted stock unit awards that vested during the period 295,751 395,751 123,769 Fair value of restricted stock unit awards that vested during the period $ 8,723 $ 11,420 $ 5,483 Accumulated dividends paid upon vesting of restricted stock unit awards $ 939 $ 1,352 $ 442 Income tax benefit recognized upon vesting of restricted stock unit awards $ 3,663 $ 4,796 $ 2,303 Compensation expense recognized during the period $ 4,148 $ 3,284 $ 6,158 During the year ended December 31, 2015, the Compensation Committee of the Board of Directors of Cinemark Holdings, Inc. approved a modification to each of the 2013 and 2014 restricted stock unit grants. The modifications resulted in a cap on the foreign currency exchange rate devaluation impact to be used in calculating the IRR for the respective measurement periods. The Company revalued each of the grants based on Cinemark Holdings, Inc.’s stock price at the date of modification, which was $33.02. The modifications resulted in incremental compensation expense of approximately $2,460 for the year ended December 31, 2015. As of December 31, 2015, the Company had restricted stock units outstanding that represented a total 544,076 hypothetical shares of Cinemark Holdings, Inc.’s common stock, net of actual cumulative forfeitures of 22,985 units, assuming the maximum IRR is achieved for all of the outstanding restricted stock unit awards. As of December 31, 2015, the remaining unrecognized compensation expense related to the outstanding restricted stock unit awards was $6,600, which reflects an IRR level of 11.1% that was achieved for the 2012 grants, an IRR level of 12.5% that was achieved for the 2013 and 2014 grants and an IRR level of 9.5% that is estimated to be achieved for the 2015 grant. The weighted average period over which this remaining compensation expense will be recognized is approximately two years.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	12 Months Ended
Supplemental Cash Flow Information	Dec. 31, 2015
Supplemental Cash Flow Information	15. SUPPLEMENTAL CASH FLOW INFORMATION The following is provided as supplemental information to the consolidated statements of cash flows: Year Ended December 31, 2013 2014 2015 Cash paid for interest $ 116,890 $ 107,926 $ 105,155 Cash paid for income taxes, net of refunds received $ 136,124 $ 122,972 $ 108,435 Noncash investing and financing activities: Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (1) $ (7,325 ) $ (1,225 ) $ 2,491 Theatre properties and equipment acquired under capital lease $ 69,541 $ 19,908 $ 36,544 Investment in NCM - receipt of common units (see Note 4) $ 98,797 $ 8,216 $ 15,421 Investment in AC JV, LLC (see Note 5) $ 8,333 $ — $ — Issuance of promissory note related to investment in AC JV, LLC (see Note 5) $ (8,333 ) $ — $ — Noncash distributions to Cinemark Holdings, Inc. $ (4,971 ) $ — $ (17,935 ) Receipt of promissory note related to sale of investment in Taiwan joint venture $ — $ — $ 2,304 (1) Additions to theatre properties and equipment included in accounts payable as of December 31, 2014 and 2015 were $13,235 and $10,744, respectively.

Income Taxes

Income Taxes	12 Months Ended
Income Taxes	Dec. 31, 2015
Income Taxes	16. INCOME TAXES Income before income taxes consisted of the following: Year Ended December 31, 2013 2014 2015 Income before income taxes: U.S. $ 164,904 $ 208,377 $ 262,336 Foreign 101,177 84,542 88,015 Total $ 266,081 $ 292,919 $ 350,351 Current and deferred income taxes were as follows: Year Ended December 31, 2013 2014 2015 Current: Federal $ 98,206 $ 62,686 $ 72,185 Foreign 42,690 27,681 35,874 State 11,056 6,256 10,806 Total current expense $ 151,952 $ 96,623 $ 118,865 Deferred: Federal $ (30,833 ) $ 6,322 $ 10,420 Foreign 2,653 (6,437 ) (3,339 ) State (9,612 ) 642 4,014 Total deferred taxes (37,792 ) 527 11,095 Income taxes $ 114,160 $ 97,150 $ 129,960 A reconciliation between income tax expense and taxes computed by applying the applicable statutory federal income tax rate to income before income taxes follows: Year Ended December 31, 2013 2014 2015 Computed statutory tax expense $ 93,128 $ 102,522 $ 122,623 Foreign inflation adjustments 67 641 (1,295 ) State and local income taxes, net of federal income tax impact 858 4,634 9,640 Foreign losses not benefited and other changes in valuation allowance (2,052 ) (275 ) (2,408 ) Foreign tax rate differential (336 ) (2,125 ) (2,660 ) Foreign dividends 3,294 1,083 — Sale of Mexican subsidiaries and related changes in intangible assets 21,406 (10,065 ) — Changes in uncertain tax positions (2,024 ) (1,540 ) 3,717 Other — net (181 ) 2,275 343 Income taxes $ 114,160 $ 97,150 $ 129,960 The Company reinvests the undistributed earnings of its non-U.S. subsidiaries with the exception of its subsidiary in Ecuador. Accordingly, deferred U.S. federal and state income taxes are provided only on the undistributed earnings of the Company’s subsidiary in Ecuador. As of December 31, 2015, the Company has not provided deferred taxes on approximately $316,000 of undistributed earnings of non-U.S. subsidiaries, as it is the Company’s policy to indefinitely reinvest these earnings in non-U.S. operations. However, the Company may periodically repatriate a portion of these earnings to the extent that it does not incur an additional U.S. tax liability. Quantification of the deferred tax liability, if any, associated with indefinitely reinvested earnings is not practicable. Deferred Income Taxes The tax effects of significant temporary differences and tax loss and tax credit carryforwards comprising the net long-term deferred income tax liabilities as of December 31, 2014 and 2015 consisted of the following: December 31, 2014 2015 Deferred liabilities: Theatre properties and equipment $ 127,010 $ 141,155 Tax impact of items in accumulated other comprehensive income (loss) 55 158 Intangible asset — other 29,342 28,889 Intangible asset — tradenames 111,726 112,413 Investment in partnerships 111,328 108,733 Total deferred liabilities 379,461 391,348 Deferred assets: Deferred lease expenses 27,341 26,966 Exchange loss — 3,736 Deferred revenue - NCM 124,366 128,642 Capital lease obligations 73,306 75,966 Tax loss carryforwards 7,764 7,379 Alternative minimum tax and other credit carryforwards 43,384 41,300 Other expenses, not currently deductible for tax purposes 25,807 20,204 Total deferred assets 301,968 304,193 Net deferred income tax liability before valuation allowance 77,493 87,155 Valuation allowance against deferred assets - current 2,384 — Valuation allowance against deferred assets – non-current 50,489 50,636 Net deferred income tax liability $ 130,366 $ 137,791 Net deferred tax liability — Foreign $ 12,213 $ 4,212 Net deferred tax liability — U.S. 118,153 133,579 Total $ 130,366 $ 137,791 The Company’s foreign tax credit carryforwards began to expire 2015. Some foreign net operating losses will expire in the next reporting period; however, some losses may be carried forward indefinitely. State net operating losses may be carried forward for periods of between five and twenty years with the last expiring year being 2035. During November 2015, the FASB issued ASU 2015-17, which simplifies the presentation of deferred income taxes. ASU 2015-17 requires that deferred tax assets and liabilities be classified as long-term on the balance sheet. The Company elected to early adopt ASU 2015-17 effective December 31, 2015, on a prospective basis. Adoption of ASU 2015-17 resulted in a reclassification of the Company’s net current deferred tax asset to the net long-term deferred tax asset on the Company’s consolidated balance sheet as of December 31, 2015. Balances as of December 31, 2014 have not been recast. Uncertain Tax Positions The following is a reconciliation of the total amounts of unrecognized tax benefits excluding interest and penalties, for the years ended December 31, 2013, 2014 and 2015: Year Ended December 31, 2013 2014 2015 Balance at January 1, $ 33,222 $ 18,780 $ 16,515 Gross increases-tax positions in prior periods 413 10 40 Gross decreases-tax positions in prior periods — (2,379 ) — Gross increases - current period tax positions 1,476 1,324 2,112 Gross decreases - current period tax positions — — — Settlements (15,444 ) (963 ) (871 ) Foreign currency translation adjustments (887 ) (257 ) (663 ) Balance at December 31, $ 18,780 $ 16,515 $ 17,133 The Company had $15,693 and $17,008 of unrecognized tax benefits, including interest and penalties, as of December 31, 2014 and 2015, respectively. Of these amounts, $15,693 and $17,008 represent the amount of unrecognized tax benefits that if recognized would impact the effective income tax rate for the years ended December 31, 2014 and 2015, respectively. The Company had $2,500 and $3,198 accrued for interest and penalties as of December 31, 2014 and 2015, respectively. The Company participates in the consolidated income tax return of Cinemark Holdings, Inc. in the U.S. federal jurisdiction and in certain state and foreign jurisdictions and is routinely under audit by many different tax authorities. The Company believes that its accrual for tax liabilities is adequate for all open audit years based on its assessment of many factors including past experience and interpretations of tax law. This assessment relies on estimates and assumptions and may involve a series of complex judgments about future events. The Company is no longer subject to income tax audits from the Internal Revenue Service for years before 2012. The Company is no longer subject to state income tax examinations by tax authorities in its major state jurisdictions for years before 2011. Certain state returns were amended as a result of the Internal Revenue Service examination closures for 2007 through 2009, and the statutes remain open for those amendments. The Company is no longer subject to non-U.S. income tax examinations by tax authorities in its major non-U.S. tax jurisdictions for years before 2004. The Company is currently under audit in the non-U.S. tax jurisdictions of Brazil and Chile. The Company believes that it is reasonably possible that the Chile audit will be completed within the next twelve months.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
Commitments and Contingencies	Dec. 31, 2015
Commitments and Contingencies	17. COMMITMENTS AND CONTINGENCIES Leases Year Ended December 31, 2013 2014 2015 Fixed rent expense $ 224,056 $ 237,891 $ 240,057 Contingent rent and other facility lease expenses 83,795 79,205 79,704 Total facility lease expense $ 307,851 $ 317,096 $ 319,761 Future minimum lease payments under noncancelable operating and capital leases that have initial or remaining terms in excess of one year at December 31, 2015 are due as follows: Operating Leases Capital Leases 2016 $ 248,498 $ 35,156 2017 236,630 33,640 2018 210,089 34,050 2019 181,967 33,394 2020 161,279 32,441 Thereafter 661,398 155,164 Total $ 1,699,861 323,845 Amounts representing interest payments (96,113 ) Present value of future minimum payments 227,732 Current portion of capital lease obligations (18,780 ) Capital lease obligations, less current portion $ 208,952 Employment Agreements Retirement Savings Plan Litigation Joseph Amey, et al. v. Cinemark USA, Inc. Case No. 3:13cv05669, In the United States District Court for the Northern District of California, San Francisco Division The Company received a Civil Investigative Demand (“CID”) from the Antitrust Division of the United States Department of Justice. The CID relates to an investigation under Sections 1 and 2 of the Sherman Act. The Company also received CIDs from the Antitrust Section of the Office of the Attorney General of the State of Ohio and later from other states regarding similar inquiries under state antitrust laws. The CIDs request the Company to answer interrogatories, and produce documents, or both, related to the investigation of matters including film clearances, potential coordination and/or communication with other major theatre circuits and related joint ventures. The Company intends to fully cooperate with all federal and state government agencies. Although the Company does not believe that it has violated any federal or state antitrust or competition laws, it cannot predict the ultimate scope, duration or outcome of these investigations. From time to time, the Company is involved in other various legal proceedings arising from the ordinary course of its business operations, such as personal injury claims, employment matters, landlord-tenant disputes, patent claims and contractual disputes, some of which are covered by insurance or by indemnification from vendors. The Company believes its potential liability with respect to these types of proceedings currently pending is not material, individually or in the aggregate, to the Company’s financial position, results of operations and cash flows.

Segments

Segments	12 Months Ended
Segments	Dec. 31, 2015
Segments	18. SEGMENTS The Company manages its international market and its U.S. market as separate reportable operating segments. The international segment consists of operations in Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia and Curacao. The Company sold its theatres in Mexico on November 15, 2013. Each segment’s revenue is derived from admissions and concession sales and other ancillary revenues, primarily screen advertising. The measure of segment profit and loss the Company uses to evaluate performance and allocate its resources is Adjusted EBITDA, as defined in the reconciliation table below. The Company does not report asset information by segment because that information is not used to evaluate the performance or allocate resources between segments. Below is a breakdown of select financial information by reportable operating segment: Year Ended December 31, 2013 2014 2015 Revenues: U.S. $ 1,912,674 $ 1,934,990 $ 2,137,733 International 783,053 704,623 728,735 Eliminations (12,833 ) (12,623 ) (13,859 ) Total revenues $ 2,682,894 $ 2,626,990 $ 2,852,609 Year Ended December 31, 2013 2014 2015 Adjusted EBITDA (1) U.S. $ 456,866 $ 438,776 $ 499,138 International 169,834 159,662 166,416 Total Adjusted EBITDA $ 626,700 $ 598,438 $ 665,554 Year Ended December 31, 2013 2014 2015 Capital expenditures: U.S. $ 117,488 $ 148,532 $ 223,213 International 142,182 96,173 108,513 Total capital expenditures $ 259,670 $ 244,705 $ 331,726 (1) Distributions from NCM are reported entirely within the U.S. operating segment The following table sets forth a reconciliation of net income to Adjusted EBITDA: Year Ended December 31, 2013 2014 2015 Net income $ 151,921 $ 195,769 $ 220,391 Add (deduct): Income taxes 114,160 97,150 129,960 Interest expense (1) 124,714 113,698 112,741 Loss on early retirement of debt 72,302 — — Loss on amendment to debt agreement — — 925 Other income (2) (24,688 ) (22,150 ) (20,041 ) Depreciation and amortization 163,970 175,656 189,206 Impairment of long-lived assets 3,794 6,647 8,801 (Gain) loss on sale of assets and other (3,845 ) 15,715 8,143 Deferred lease expenses 5,701 2,536 (1,806 ) Amortization of long-term prepaid rents 2,625 1,542 2,361 Share based awards compensation expense 16,046 11,875 14,873 Adjusted EBITDA $ 626,700 $ 598,438 $ 665,554 (1) Includes amortization of debt issue costs. (2) Includes interest income, foreign currency exchange loss, and equity in income of affiliates and excludes distributions from NCM. Financial Information About Geographic Area Below is a breakdown of select financial information by geographic area: Year Ended December 31, 2013 2014 2015 Revenues U.S. $ 1,912,674 $ 1,934,990 $ 2,137,733 Brazil 325,762 333,919 291,959 Other foreign countries 457,291 370,704 436,776 Eliminations (12,833 ) (12,623 ) (13,859 ) Total $ 2,682,894 $ 2,626,990 $ 2,852,609 December 31, 2014 2015 Theatres properties and equipment, net U.S. $ 1,094,076 $ 1,175,535 Brazil 204,107 163,505 Other foreign countries 152,629 166,029 Total $ 1,450,812 $ 1,505,069

Related Party Transactions

Related Party Transactions	12 Months Ended
Related Party Transactions	Dec. 31, 2015
Related Party Transactions	19. RELATED PARTY TRANSACTIONS The Company manages theatres for Laredo Theatres, Ltd. (“Laredo”). The Company is the sole general partner and owns 75% of the limited partnership interests of Laredo. Lone Star Theatres, Inc. owns the remaining 25% of the limited partnership interests in Laredo and is 100% owned by Mr. David Roberts, Lee Roy Mitchell’s son-in-law. Lee Roy Mitchell is Cinemark Holdings, Inc.’s Chairman of the Board and directly and indirectly owns approximately 9% of Cinemark Holdings, Inc.’s common stock. Under the agreement, management fees are paid by Laredo to the Company at a rate of 5% of annual theatre revenues up to $50,000 and 3% of annual theatre revenues in excess of $50,000. The Company recorded $558, $564 and $567 of management fee revenues during the years ended December 31, 2013, 2014 and 2015, respectively. All such amounts are included in the Company’s consolidated financial statements with the intercompany amounts eliminated in consolidation. The Company also paid distributions to Lone Star Theatres, Inc. of $1,000 during the year ended December 31, 2013. The Company has an Aircraft Time Sharing Agreement with Copper Beech Capital, LLC to use, on occasion, a private aircraft owned by Copper Beech Capital, LLC. Copper Beech Capital, LLC is owned by Mr. Mitchell and his wife, Tandy Mitchell. The private aircraft is used by Mr. Mitchell and other executives who accompany Mr. Mitchell to business meetings for the Company. The Company reimburses Copper Beech Capital, LLC the actual costs of fuel usage and the expenses of the pilots, landing fees, storage fees and similar expenses incurred during the trip. For the years ended December 31, 2013, 2014 and 2015, the aggregate amounts paid to Copper Beech Capital, LLC for the use of the aircraft was approximately $91, $74 and $410, respectively. The Company currently leases 15 theatres and one parking facility from Syufy Enterprises, LP (“Syufy”) or affiliates of Syufy. Raymond Syufy is one of Cinemark Holdings, Inc.’s directors and is an officer of the general partner of Syufy. Of these 16 leases, 15 have fixed minimum annual rent. The one lease without minimum annual rent has rent based upon a specified percentage of gross sales as defined in the lease. For the years ended December 31, 2013, 2014 and 2015, the Company paid total rent of approximately $22,876, $21,040 and $20,581, respectively, to Syufy. The Company has paid certain fees and expenses on behalf of its parent, Cinemark Holdings, Inc. and Cinemark Holdings, Inc. has paid income taxes on behalf of the Company. The Company paid cash dividends to Cinemark Holdings, Inc. of $105,150, $115,000 and $115,225 during the years ended December 31, 2013, 2014 and 2015, respectively. Additionally, the Company made noncash distributions to Cinemark Holdings, Inc. of $4,971, $0 and $17,935 during the years ended December 31, 2013, 2014 and 2015, respectively, related to expenses paid on behalf of Cinemark Holdings, Inc.

Valuation and Qualifying Accoun

Valuation and Qualifying Accounts	12 Months Ended
Valuation and Qualifying Accounts	Dec. 31, 2015
Valuation and Qualifying Accounts	20. VALUATION AND QUALIFYING ACCOUNTS The Company’s valuation allowance for deferred tax assets for the years ended December 31, 2013, 2014 and 2015 were as follows: Valuation for Deferred Tax Assets Balance at January 1, 2013 $ 13,326 Additions 14,162 Deductions (1,777 ) Balance at December 31, 2013 $ 25,711 Additions 28,612 Deductions (1,450 ) Balance at December 31, 2014 $ 52,873 Additions 437 Deductions (2,674 ) Balance at December 31, 2015 $ 50,636

Subsequent Event

Subsequent Event	12 Months Ended
Subsequent Event	Dec. 31, 2015
Subsequent Event	21. SUBSEQUENT EVENT On February 16, 2016, the Compensation Committee of the Cinemark Holdings, Inc.’s board of directors approved the Amended and Restated Employment Agreement of Mark Zoradi, to be effective February 19, 2016 (the “Amended Agreement”). The Amended Agreement amends Section 3.2(c) by providing that the Equity Awards (as defined in the Amended Agreement) shall be at least 200% of Mr. Zoradi’s base salary and providing for an additional amount for personal expenses. The amendments conform the Amended Agreement to the terms of Mr. Zoradi’s employment offer in August 2015.

Condensed Consolidating Financi

Condensed Consolidating Financial Statement Information of Subsidiary Guarantors	12 Months Ended
	Dec. 31, 2015
Condensed Consolidating Financial Statement Information of Subsidiary Guarantors	22. CONDENSED CONSOLIDATING FINANCIAL STATEMENT INFORMATION OF SUBSIDIARY GUARANTORS As of December 31, 2015, the Company had outstanding $400,000 aggregate principal amount of 5.125% senior notes due 2022, or the 5.125% Senior Notes, $530,000 aggregate principal amount of 4.875% senior notes due 2023, or the 4.875% Senior Notes, and $200,000 aggregate principal amount of 7.375% senior subordinated notes due 2021, or the Senior Subordinated Notes (collectively the “Notes”). These Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by the following subsidiaries of Cinemark USA, Inc.: Sunnymead Cinema Corp., Cinemark Properties, Inc., Greeley Holdings, Inc., Cinemark Partners I, Inc., CNMK Investments, Inc., CNMK Texas Properties, LLC., Cinemark Concessions LLC, Century Theatres, Inc., Marin Theatre Management, LLC, Century Theatres NG, LLC, Cinearts LLC, Cinearts Sacramento, LLC, Corte Madera Theatres, LLC, Novato Theatres, LLC, San Rafael Theatres, LLC, Northbay Theatres, LLC, Century Theatres Summit Sierra, LLC and Century Theatres Seattle, LLC. The following supplemental condensed consolidating financial statement information presents: 1. Condensed consolidating balance sheet information as of December 31, 2014 and 2015, condensed consolidating statements of income information, condensed consolidating statements of comprehensive income (loss) information and condensed consolidating statements of cash flows information for the years ended December 31, 2013, 2014 and 2015. 2. Cinemark USA, Inc. (the “Parent” and “Issuer”), combined Guarantor Subsidiaries and combined Non-Guarantor Subsidiaries with their investments in subsidiaries accounted for using the equity method of accounting and therefore, the Parent column reflects the equity income (loss) of its Guarantor Subsidiaries and Non-Guarantor Subsidiaries, which are also separately reflected in the stand-alone Guarantor Subsidiaries and Non-Guarantor Subsidiaries column. Additionally, the Guarantor Subsidiaries column reflects the equity income (loss) of its Non-Guarantor Subsidiaries, which are also separately reflected in the stand-alone Non-Guarantor Subsidiaries column. 3. Elimination entries necessary to consolidate the Parent and all of its Subsidiaries. CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2014 Parent Subsidiary Subsidiary Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 129,505 $ 74,643 $ 434,693 $ — $ 638,841 Other current assets 126,091 18,471 67,826 (110,302 ) 102,086 Accounts receivable from parent or subsidiaries 277,823 — — (265,185 ) 12,638 Total current assets 533,419 93,114 502,519 (375,487 ) 753,565 Theatre properties and equipment - net 498,446 575,652 376,714 — 1,450,812 Investment in subsidiaries 1,260,333 380,365 — (1,640,698 ) — Other assets 1,389,912 140,320 401,783 (3,276 ) 1,928,739 Total assets $ 3,682,110 $ 1,189,451 $ 1,281,016 $ (2,019,461 ) $ 4,133,116 Liabilities and equity Current liabilities Current portion of long-term debt $ 7,000 $ — $ 1,423 $ — $ 8,423 Current portion of capital lease obligations 5,411 9,125 1,958 — 16,494 Accounts payable and accrued expenses 259,973 105,761 125,638 (102,406 ) 388,966 Accounts payable to parent or subsidiaries — 84,555 180,630 (265,185 ) — Total current liabilities 272,384 199,441 309,649 (367,591 ) 413,883 Long-term liabilities Long-term debt, less current portion 1,777,581 — 7,442 (1,868 ) 1,783,155 Capital lease obligations, less current portion 103,786 75,416 22,776 — 201,978 Other long-term liabilities and deferrals 401,965 79,116 125,600 (9,304 ) 597,377 Total long-term liabilities 2,283,332 154,532 155,818 (11,172 ) 2,582,510 Commitments and contingencies Equity Cinemark USA, Inc.’s stockholder’s equity: Common stock 49,543 457,369 10,219 (467,588 ) 49,543 Other stockholder’s equity 1,076,851 378,109 795,001 (1,173,110 ) 1,076,851 Total Cinemark USA, Inc. stockholder’s equity 1,126,394 835,478 805,220 (1,640,698 ) 1,126,394 Noncontrolling interests — — 10,329 — 10,329 Total equity 1,126,394 835,478 815,549 (1,640,698 ) 1,136,723 Total liabilities and equity $ 3,682,110 $ 1,189,451 $ 1,281,016 $ (2,019,461 ) $ 4,133,116 CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2015 Parent Subsidiary Subsidiary Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 141,364 $ 95,865 $ 351,274 $ — $ 588,503 Other current assets 78,797 18,407 61,432 (32,024 ) 126,612 Accounts receivable from parent or subsidiaries 212,299 — — (211,128 ) 1,171 Total current assets 432,460 114,272 412,706 (243,152 ) 716,286 Theatre properties and equipment - net 539,082 614,821 351,166 — 1,505,069 Investment in subsidiaries 1,326,790 293,900 — (1,620,690 ) — Other assets 1,402,062 135,022 475,187 (105,994 ) 1,906,277 Total assets $ 3,700,394 $ 1,158,015 $ 1,239,059 $ (1,969,836 ) $ 4,127,632 Liabilities and equity Current liabilities Current portion of long-term debt $ 7,000 $ — $ 1,405 $ — $ 8,405 Current portion of capital lease obligations 6,426 9,962 2,392 — 18,780 Accounts payable and accrued expenses 197,268 123,759 116,353 (25,396 ) 411,984 Accounts payable to parent or subsidiaries — 23,965 187,163 (211,128 ) — Total current liabilities 210,694 157,686 307,313 (236,524 ) 439,169 Long-term liabilities Long-term debt, less current portion 1,868,763 — 9,534 (105,367 ) 1,772,930 Capital lease obligations, less current portion 114,513 67,440 26,999 — 208,952 Other long-term liabilities and deferrals 404,278 77,774 118,533 (7,255 ) 593,330 Total long-term liabilities 2,387,554 145,214 155,066 (112,622 ) 2,575,212 Commitments and contingencies — — — — — Equity Cinemark USA, Inc.’s stockholder’s equity: Common stock 49,543 457,369 10,240 (467,609 ) 49,543 Other stockholder’s equity 1,052,603 397,746 755,335 (1,153,081 ) 1,052,603 Total Cinemark USA, Inc. stockholder’s equity 1,102,146 855,115 765,575 (1,620,690 ) 1,102,146 Noncontrolling interests — — 11,105 — 11,105 Total equity 1,102,146 855,115 776,680 (1,620,690 ) 1,113,251 Total liabilities and equity $ 3,700,394 $ 1,158,015 $ 1,239,059 $ (1,969,836 ) $ 4,127,632 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2013 Parent Subsidiary Subsidiary Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 816,489 $ 1,099,257 $ 808,972 $ (41,824 ) $ 2,682,894 Cost of operations Theatre operating expenses 650,731 743,531 585,695 (41,824 ) 1,938,133 General and administrative expenses 22,275 78,749 62,110 — 163,134 Depreciation and amortization 43,501 63,234 57,235 — 163,970 Impairment of long-lived assets 2,301 319 1,174 — 3,794 (Gain) loss on sale of assets and other 99 1,870 (5,814 ) — (3,845 ) Total cost of operations 718,907 887,703 700,400 (41,824 ) 2,265,186 Operating income 97,582 211,554 108,572 — 417,708 Other income (expense) Interest expense (110,484 ) (9,915 ) (4,315 ) — (124,714 ) Distributions from NCM 124 — 20,577 — 20,701 Equity in income of affiliates 196,580 54,524 22,682 (251,104 ) 22,682 Loss on early retirement of debt (72,302 ) — — — (72,302 ) Other income (expense) 101 (8 ) 1,913 — 2,006 Total other income (expense) 14,019 44,601 40,857 (251,104 ) (151,627 ) Income before income taxes 111,601 256,155 149,429 (251,104 ) 266,081 Income taxes (38,242 ) 76,938 75,464 — 114,160 Net income 149,843 179,217 73,965 (251,104 ) 151,921 Less: Net income attributable to noncontrolling interests — — 2,078 — 2,078 Net income attributable to Cinemark USA, Inc. $ 149,843 $ 179,217 $ 71,887 $ (251,104 ) $ 149,843 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2014 Parent Subsidiary Subsidiary Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 851,299 $ 1,084,852 $ 733,435 $ (42,596 ) $ 2,626,990 Cost of operations Theatre operating expenses 693,323 739,686 524,045 (42,596 ) 1,914,458 General and administrative expenses 17,978 74,971 55,639 — 148,588 Depreciation and amortization 50,858 67,460 57,338 — 175,656 Impairment of long-lived assets 6,334 313 — — 6,647 Loss on sale of assets and other 8,954 3,278 3,483 — 15,715 Total cost of operations 777,447 885,708 640,505 (42,596 ) 2,261,064 Operating income 73,852 199,144 92,930 — 365,926 Other income (expense) Interest expense (101,224 ) (9,111 ) (3,392 ) 29 (113,698 ) Distributions from NCM 2,375 — 16,166 — 18,541 Equity in income of affiliates 208,900 53,950 22,464 (262,571 ) 22,743 Other income (expense) 79 — (643 ) (29 ) (593 ) Total other income (expense) 110,130 44,839 34,595 (262,571 ) (73,007 ) Income before income taxes 183,982 243,983 127,525 (262,571 ) 292,919 Income taxes (10,398 ) 71,687 35,861 — 97,150 Net income 194,380 172,296 91,664 (262,571 ) 195,769 Less: Net income attributable to noncontrolling interests — — 1,389 — 1,389 Net income attributable to Cinemark USA, Inc. $ 194,380 $ 172,296 $ 90,275 $ (262,571 ) $ 194,380 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2015 Parent Subsidiary Subsidiary Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 959,347 $ 1,178,873 $ 764,631 $ (50,242 ) $ 2,852,609 Cost of operations Theatre operating expenses 767,446 804,236 545,131 (50,242 ) 2,066,571 General and administrative expenses 16,152 81,240 56,660 — 154,052 Depreciation and amortization 59,759 73,708 55,739 — 189,206 Impairment of long-lived assets 6,445 1,600 756 — 8,801 (Gain) loss on sale of assets and other 6,191 3,728 (1,776 ) — 8,143 Total cost of operations 855,993 964,512 656,510 (50,242 ) 2,426,773 Operating income 103,354 214,361 108,121 — 425,836 Other income (expense) Interest expense (100,608 ) (8,500 ) (4,009 ) 376 (112,741 ) Loss on amendment to debt agreement (925 ) — — — (925 ) Distributions from NCM 2,116 — 16,024 — 18,140 Equity in income of affiliates 217,567 55,082 27,262 (271,785 ) 28,126 Other income (expense) 200 20 (7,929 ) (376 ) (8,085 ) Total other income (expense) 118,350 46,602 31,348 (271,785 ) (75,485 ) Income before income taxes 221,704 260,963 139,469 (271,785 ) 350,351 Income taxes 3,172 79,131 47,657 — 129,960 Net income 218,532 181,832 91,812 (271,785 ) 220,391 Less: Net income attributable to noncontrolling interests — — 1,859 — 1,859 Net income attributable to Cinemark USA, Inc. $ 218,532 $ 181,832 $ 89,953 $ (271,785 ) $ 218,532 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2013 Parent Subsidiary Subsidiary Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 149,843 $ 179,217 $ 73,965 $ (251,104 ) $ 151,921 Other comprehensive income (loss), net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes of $1,865, net of settlements 3,151 — — — 3,151 Unrealized loss due to fair value adjustments on available-for-sale securities, net of taxes of $1,223 (2,041 ) — — — (2,041 ) Other comprehensive income in equity method investments 2,386 — 2,386 (2,386 ) 2,386 Foreign currency translation adjustments (47,617 ) — (47,699 ) 47,617 (47,699 ) Total other comprehensive loss, net of tax (44,121 ) — (45,313 ) 45,231 (44,203 ) Total comprehensive income, net of tax $ 105,722 $ 179,217 $ 28,652 $ (205,873 ) $ 107,718 Comprehensive income attributable to noncontrolling interests — — (1,996 ) — (1,996 ) Comprehensive income attributable to Cinemark USA, Inc. $ 105,722 $ 179,217 $ 26,656 $ (205,873 ) $ 105,722 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2014 Parent Subsidiary Subsidiary Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 194,380 $ 172,296 $ 91,664 $ (262,571 ) $ 195,769 Other comprehensive income (loss), net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes of $1,759, net of settlements 2,846 — — — 2,846 Unrealized gain due to fair value adjustments on available-for-sale securities, net of taxes of $1,479 2,507 — — — 2,507 Other comprehensive income in equity method investments 676 — 643 (643 ) 676 Foreign currency translation adjustments (68,982 ) — (68,997 ) 68,982 (68,997 ) Total other comprehensive loss, net of tax (62,953 ) — (68,354 ) 68,339 (62,968 ) Total comprehensive income, net of tax $ 131,427 $ 172,296 $ 23,310 $ (194,232 ) $ 132,801 Comprehensive income attributable to noncontrolling interests — — (1,374 ) — (1,374 ) Comprehensive income attributable to Cinemark USA, Inc. $ 131,427 $ 172,296 $ 21,936 $ (194,232 ) $ 131,427 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS) INFORMATION YEAR ENDED DECEMBER 31, 2015 Parent Subsidiary Subsidiary Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 218,532 $ 181,832 $ 91,812 $ (271,785 ) $ 220,391 Other comprehensive income (loss), net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes of $1,562, net of settlements 2,636 — — — 2,636 Unrealized loss due to fair value adjustments on available-for-sale securities, net of taxes of $572 (957 ) — — — (957 ) Other comprehensive loss in equity method investments (3,119 ) — (3,086 ) 3,086 (3,119 ) Foreign currency translation adjustments, net of taxes of $888 (125,474 ) — (125,512 ) 125,474 (125,512 ) Total other comprehensive loss, net of tax (126,914 ) — (128,598 ) 128,560 (126,952 ) Total comprehensive income (loss), net of tax $ 91,618 $ 181,832 $ (36,786 ) $ (143,225 ) $ 93,439 Comprehensive income attributable to noncontrolling interests — — (1,821 ) — (1,821 ) Comprehensive income (loss) attributable to Cinemark USA, Inc. $ 91,618 $ 181,832 $ (38,607 ) $ (143,225 ) $ 91,618 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2013 Parent Subsidiary Subsidiary Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 149,843 $ 179,217 $ 73,965 $ (251,104 ) $ 151,921 Adjustments to reconcile net income to cash provided by operating activities (174,847 ) 22,276 44,824 251,104 143,357 Changes in assets and liabilities 115,254 (148,810 ) 47,640 — 14,084 Net cash provided by operating activities 90,250 52,683 166,429 — 309,362 Investing activities Additions to theatre properties and equipment (41,948 ) (74,568 ) (143,154 ) — (259,670 ) Proceeds from sale of theatre properties and equipment and other 21,084 8,881 4,306 — 34,271 Acquisition of theatres in the U.S., net of cash acquired (259,247 ) — — — (259,247 ) Proceeds from disposition of Mexico theatres — — 126,167 — 126,167 Dividends received from subsidiaries 2,633 3,000 707 (6,340 ) — Investment in joint ventures and other — — (6,222 ) — (6,222 ) Net cash used for investing activities (277,478 ) (62,687 ) (18,196 ) (6,340 ) (364,701 ) Financing activities Dividends paid to parent (105,150 ) (707 ) (5,633 ) 6,340 (105,150 ) Payroll taxes paid as a result of restricted stock withholdings — (3,464 ) — — (3,464 ) Proceeds from issuance of notes 530,000 — — — 530,000 Redemption of senior notes (461,946 ) — — — (461,946 ) Net repayments of other long-term debt (7,000 ) — (866 ) — (7,866 ) Payments on capital leases (2,910 ) (6,892 ) (2,213 ) — (12,015 ) Payment of debt issue costs (9,328 ) — — — (9,328 ) Purchases of noncontrolling interests — — (5,621 ) — (5,621 ) Other — 2,962 (2,918 ) — 44 Net cash used for financing activities (56,334 ) (8,101 ) (17,251 ) 6,340 (75,346 ) Effect of exchange rate changes on cash and cash equivalents — — (11,516 ) — (11,516 ) Increase (decrease) in cash and cash equivalents (243,562 ) (18,105 ) 119,466 — (142,201 ) Cash and cash equivalents: Beginning of year 305,627 193,863 242,605 — 742,095 End of year $ 62,065 $ 175,758 $ 362,071 $ — $ 599,894 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2014 Parent Subsidiary Subsidiary Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 194,380 $ 172,296 $ 91,664 $ (262,571 ) $ 195,769 Adjustments to reconcile net income to cash provided by (used for) operating activities (134,559 ) 42,620 31,874 262,571 202,506 Changes in assets and liabilities 232,167 (246,598 ) 70,284 — 55,853 Net cash provided by (used for) operating activities 291,988 (31,682 ) 193,822 — 454,128 Investing activities Additions to theatre properties and equipment (93,608 ) (52,896 ) (98,201 ) — (244,705 ) Proceeds from sale of theatre properties and equipment and other 1,109 98 1,338 — 2,545 Acquisition of theatres in the U.S., net of cash acquired (7,951 ) — — — (7,951 ) Dividends received from subsidiaries 1,094 8 — (1,102 ) — Investments in, and loans to, subsidiaries (1,918 ) — — 1,918 — Investment in joint ventures and other — — (3,228 ) — (3,228 ) Net cash used for investing activities (101,274 ) (52,790 ) (100,091 ) 816 (253,339 ) Financing activities Dividends paid to parent (115,000 ) (700 ) (402 ) 1,102 (115,000 ) Repayments of other long-term debt (7,000 ) — (2,846 ) — (9,846 ) Payments on capital leases (4,082 ) (8,000 ) (1,953 ) — (14,035 ) Capital contributions and loans from parent — 1,918 — (1,918 ) — Other 2,808 (9,861 ) (386 ) — (7,439 ) Net cash used for financing activities (123,274 ) (16,643 ) (5,587 ) (816 ) (146,320 ) Effect of exchange rate changes on cash and cash equivalents — — (15,522 ) — (15,522 ) Increase (decrease) in cash and cash equivalents 67,440 (101,115 ) 72,622 — 38,947 Cash and cash equivalents: Beginning of year 62,065 175,758 362,071 — 599,894 End of year $ 129,505 $ 74,643 $ 434,693 $ — $ 638,841 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2015 Parent Subsidiary Subsidiary Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 218,532 $ 181,832 $ 91,812 $ (271,785 ) $ 220,391 Adjustments to reconcile net income to cash provided by operating activities (142,602 ) 39,156 43,223 271,785 211,562 Changes in assets and liabilities 67,253 (67,850 ) 23,869 — 23,272 Net cash provided by operating activities 143,183 153,138 158,904 — 455,225 Investing activities Additions to theatre properties and equipment (98,193 ) (121,605 ) (111,928 ) — (331,726 ) Proceeds from sale of theatre properties and equipment and other 2,737 5,264 1,965 — 9,966 Acquisition of theatre in Brazil — — (2,651 ) — (2,651 ) Dividends received from subsidiaries 1,685 15 — (1,700 ) — Intercompany note issuances (3,500 ) — (100,000 ) 103,500 — Investment in joint ventures and other (518 ) — (3,211 ) 18 (3,711 ) Net cash used for investing activities (97,789 ) (116,326 ) (215,825 ) 101,818 (328,122 ) Financing activities Dividends paid to parent (115,225 ) (1,700 ) — 1,700 (115,225 ) Repayments of long-term debt (8,385 ) — (35 ) — (8,420 ) Payments of debt issue costs (6,957 ) — — — (6,957 ) Payments on capital leases (5,389 ) (9,120 ) (2,004 ) — (16,513 ) Intercompany loan proceeds 100,000 — 3,518 (103,518 ) — Other 2,421 (4,770 ) (1,045 ) — (3,394 ) Net cash provided by (used for) financing activities (33,535 ) (15,590 ) 434 (101,818 ) (150,509 ) Effect of exchange rate changes on cash and cash equivalents — — (26,932 ) — (26,932 ) Increase (decrease) in cash and cash equivalents 11,859 21,222 (83,419 ) — (50,338 ) Cash and cash equivalents: Beginning of year 129,505 74,643 434,693 — 638,841 End of year $ 141,364 $ 95,865 $ 351,274 $ — $ 588,503

Unaudited Supplemental Schedule

Unaudited Supplemental Schedules	12 Months Ended
Unaudited Supplemental Schedules	Dec. 31, 2015
Unaudited Supplemental Schedules	UNAUDITED SUPPLEMENTAL SCHEDULES As required by the indentures governing the Company’s 5.125% Senior Notes, 4.875% Senior Notes and Senior Subordinated Notes (collectively the “Notes”), the Company has included in this filing, financial information for its subsidiaries that have been designated as unrestricted subsidiaries as defined by the indentures. As required by the indentures governing the Notes, the Company has included a condensed consolidating balance sheet and condensed consolidating statements of income, comprehensive income and cash flows for the Company and its subsidiaries. These supplementary schedules separately identify the Company’s restricted subsidiaries and unrestricted subsidiaries as required by the indentures. CINEMARK USA, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2015 (In thousands) Restricted Unrestricted Eliminations Consolidated Assets Current assets Cash and cash equivalents $ 394,852 $ 193,651 $ — $ 588,503 Other current assets 213,164 (85,381 ) — 127,783 Total current assets 608,016 108,270 — 716,286 Theatre properties and equipment, net 1,505,069 — — 1,505,069 Other assets 1,771,028 242,268 (107,019 ) 1,906,277 Total assets $ 3,884,113 $ 350,538 $ (107,019 ) $ 4,127,632 Liabilities and equity Current liabilities Current portion of long-term debt $ 7,016 $ 1,389 $ — $ 8,405 Current portion of capital lease obligations 18,780 — — 18,780 Accounts payable and accrued expenses 411,980 4 — 411,984 Total current liabilities 437,776 1,393 — 439,169 Long-term liabilities Long-term debt, less current portion 1,768,763 4,167 — 1,772,930 Capital lease obligations, less current portion 208,952 — — 208,952 Other long-term liabilities and deferrals 492,519 100,811 — 593,330 Total long-term liabilities 2,470,234 104,978 — 2,575,212 Commitments and contingencies Equity 976,103 244,167 (107,019 ) 1,113,251 Total liabilities and equity $ 3,884,113 $ 350,538 $ (107,019 ) $ 4,127,632 Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes and senior subordinated notes. CINEMARK USA, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2015 (In thousands) Restricted Unrestricted Eliminations Consolidated Revenues $ 2,852,609 $ — $ — $ 2,852,609 Cost of operations Theatre operating costs 2,066,571 — — 2,066,571 General and administrative expenses 154,050 2 — 154,052 Depreciation and amortization 189,206 — — 189,206 Impairment of long-lived assets 8,801 — — 8,801 Loss on sale of assets and other 8,143 — — 8,143 Total cost of operations 2,426,771 2 — 2,426,773 Operating income (loss) 425,838 (2 ) — 425,836 Other income (expense) (118,425 ) 42,940 — (75,485 ) Income before income taxes 307,413 42,938 — 350,351 Income taxes 113,472 16,488 — 129,960 Net income 193,941 26,450 — 220,391 Less: Net income attributable to noncontrolling interests 1,859 — — 1,859 Net income attributable to Cinemark USA, Inc. $ 192,082 $ 26,450 $ — $ 218,532 Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes and senior subordinated notes. CINEMARK USA, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2015 (In thousands) Restricted Unrestricted Eliminations Consolidated Net income $ 193,941 $ 26,450 $ — $ 220,391 Other comprehensive income (loss), net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes of $1,562 2,636 — — 2,636 Unrealized loss due to fair value adjustments on available-for-sale securities, net of taxes of $572 (957 ) — — (957 ) Other comprehensive loss in equity method investments (33 ) (3,086 ) — (3,119 ) Foreign currency translation adjustments, net of taxes of $888 (125,512 ) — — (125,512 ) Total other comprehensive loss, net of tax (123,866 ) (3,086 ) — (126,952 ) Total comprehensive income, net of tax 70,075 23,364 — 93,439 Comprehensive income attributable to noncontrolling interests (1,821 ) — — (1,821 ) Comprehensive income attributable to Cinemark USA, Inc. $ 68,254 $ 23,364 $ — $ 91,618 Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes and senior subordinated notes. CINEMARK USA, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2015 (In thousands) Restricted Unrestricted Eliminations Consolidated Operating activities Net income $ 193,941 $ 26,450 $ — $ 220,391 Adjustments to reconcile net income to cash provided by operating activities 220,661 (9,099 ) — 211,562 Changes in assets and liabilities 15,124 8,148 — 23,272 Net cash provided by operating activities 429,726 25,499 — 455,225 Investing activities Additions to theatre properties and equipment and other (331,726 ) — — (331,726 ) Acquisition of theatre in Brazil (2,651 ) — — (2,651 ) Proceeds from sale of theatre properties and equipment and other 9,966 — — 9,966 Investment in joint ventures and other (500 ) (3,211 ) — (3,711 ) Net cash used for investing activities (324,911 ) (3,211 ) — (328,122 ) Financing activities Dividends paid to parent (115,225 ) — — (115,225 ) Repayments of long-term debt (8,420 ) — — (8,420 ) Payment of debt issue costs (6,957 ) — — (6,957 ) Payments on capital leases (16,513 ) — — (16,513 ) Other (3,394 ) — — (3,394 ) Net cash used for financing activities (150,509 ) — — (150,509 ) Effect of exchange rate changes on cash and cash equivalents (26,932 ) — — (26,932 ) Increase (decrease) in cash and cash equivalents (72,626 ) 22,288 — (50,338 ) Cash and cash equivalents: Beginning of year 467,478 171,363 — 638,841 End of year $ 394,852 $ 193,651 $ — $ 588,503 Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes and senior subordinated notes.

Summary of Significant Accoun32

Summary of Significant Accounting Policies (Policies)	12 Months Ended
Summary of Significant Accounting Policies (Policies)	Dec. 31, 2015
Business	Business
Principles of Consolidation	Principles of Consolidation
Cash and Cash Equivalents	Cash and Cash Equivalents
Accounts Receivable	Accounts Receivable –
Inventories	Inventories
Theatre Properties and Equipment	Theatre Properties and Equipment Category Useful Life Buildings on owned land 40 years Buildings on leased land Lesser of lease term or useful life Land and buildings under capital lease (1) Lesser of lease term or useful life Theatre furniture and equipment 3 to 15 years Leasehold improvements Lesser of lease term or useful life (1) Amortization of capital lease assets is included in depreciation and amortization expense on the consolidated statements of income. Accumulated amortization of capital lease assets as of December 31, 2014 and 2015 was $133,022 and $150,968, respectively. The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. The Company considers actual theatre level cash flows, budgeted theatre level cash flows, theatre property and equipment carrying values, amortizing intangible asset carrying values, the age of a recently built theatre, competitive theatres in the marketplace, the impact of recent ticket price changes, available lease renewal options and other factors considered relevant in its assessment of impairment of individual theatre assets. Long-lived assets are evaluated for impairment on an individual theatre basis, which the Company believes is the lowest applicable level for which there are identifiable cash flows. The impairment evaluation is based on the estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. The remainder of the theatre’s useful life correlates with the available remaining lease period, which includes the probability of renewal periods, for leased properties and the lesser of twenty years or the building’s remaining useful life for fee-owned properties. If the estimated undiscounted cash flows are not sufficient to recover a long-lived asset’s carrying value, the Company then compares the carrying value of the asset group (theatre) with its estimated fair value. When estimated fair value is determined to be lower than the carrying value of the asset group (theatre), the asset group (theatre) is written down to its estimated fair value. Significant judgment is involved in estimating cash flows and fair value. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820-10-35, are based on historical and projected operating performance, recent market transactions and current industry trading multiples. Fair value is determined based on a multiple of cash flows, which was six and a half times for the evaluations performed during 2013, 2014 and 2015. The long-lived asset impairment charges recorded during each of the periods presented are specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics, or adverse changes in the development or the conditions of the areas surrounding the theatre. See Note 7.
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets For the year ended December 31, 2015, the Company performed a qualitative goodwill impairment assessment on all reporting units except one, in accordance with ASU 2011-08 Testing Goodwill for Impairment Tradename intangible assets are tested for impairment at least annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value may not be fully recoverable. During 2013 and 2014, the Company estimated the fair value of its tradenames by applying an estimated market royalty rate that could be charged for the use of our tradename to forecasted future revenues, with an adjustment for the present value of such royalties. If the estimated fair value is less than the carrying value, the tradename intangible asset is written down to its estimated fair value. Significant judgment is involved in estimating market royalty rates and long-term revenue forecasts. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected revenue performance and industry trends. As of December 31, 2014, the estimated fair value of the Company’s tradename intangible assets exceeded their carrying values by at least 10%. For the year ended December 31, 2015, the Company performed a qualitative tradename intangible asset impairment assessment in accordance with ASU 2011-08. The qualitative assessment included consideration of the Company’s historical and forecasted revenues and estimated royalty rates for each tradename intangible asset. Based on the qualitative assessment performed, the Company determined that it was not more likely than not that the fair values of tradename intangible assets were less than their carrying values. The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset: Intangible Asset Amortization Method Goodwill Indefinite-lived Tradename Indefinite-lived Vendor contracts Straight-line method over the terms of the underlying contracts. The remaining terms of the underlying contracts range from two to five years. Favorable/unfavorable leases Based on the pattern in which the economic benefits are realized over the terms of the lease agreements. The remaining terms of the lease agreements range from approximately three to twenty-one years. Other intangible assets Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from two to eleven years.
Deferred Charges and Other Assets	Deferred Charges and Other Assets
Lease Accounting	Lease Accounting
Deferred Revenues	Deferred Revenues
Self-Insurance Reserves	Self-Insurance Reserves —
Revenue and Expense Recognition	Revenue and Expense Recognition Film rental costs are accrued based on the applicable box office receipts and either firm terms or a sliding scale formula, which are generally established prior to the opening of the film, or estimates of the final rate, which occurs at the conclusion of the film run, subject to the film licensing arrangement. Under a firm terms formula, the Company pays the distributor a percentage of box office receipts, which reflects either an aggregate rate for the life of the film or rates that decline over the term of the run. Under a sliding scale formula, film rental is paid as a percentage of box office revenues using a pre-determined matrix based upon box office performance of the film. The settlement process allows for negotiation of film rental fees upon the conclusion of the film run based upon how the film performs. Estimates are based on the expected success of a film. The success of a film can typically be determined a few weeks after a film is released when initial box office performance of the film is known. Accordingly, final settlements typically approximate estimates since box office receipts are known at the time the estimate is made and the expected success of a film can typically be estimated early in the film’s run. If actual settlements are different than those estimates, film rental costs are adjusted at that time.
Accounting for Share Based Awards	Accounting for Share Based Awards
Income Taxes	Income Taxes —
Segments	Segments
Use of Estimates	Use of Estimates
Foreign Currency Translations	Foreign Currency Translations
Fair Value Measurements	Fair Value Measurements — Goodwill and Other Intangible Assets Theatre Properties and Equipment
Acquisitions	Acquisitions

Summary of Significant Accoun33

Summary of Significant Accounting Policies (Tables)	12 Months Ended
Summary of Significant Accounting Policies (Tables)	Dec. 31, 2015
Estimated Useful Life of Assets	Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows: Category Useful Life Buildings on owned land 40 years Buildings on leased land Lesser of lease term or useful life Land and buildings under capital lease (1) Lesser of lease term or useful life Theatre furniture and equipment 3 to 15 years Leasehold improvements Lesser of lease term or useful life (1) Amortization of capital lease assets is included in depreciation and amortization expense on the consolidated statements of income. Accumulated amortization of capital lease assets as of December 31, 2014 and 2015 was $133,022 and $150,968, respectively.
Intangible Assets and Amortization Method Used	The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset: Intangible Asset Amortization Method Goodwill Indefinite-lived Tradename Indefinite-lived Vendor contracts Straight-line method over the terms of the underlying contracts. The remaining terms of the underlying contracts range from two to five years. Favorable/unfavorable leases Based on the pattern in which the economic benefits are realized over the terms of the lease agreements. The remaining terms of the lease agreements range from approximately three to twenty-one years. Other intangible assets Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from two to eleven years.

Acquisitions and Dispositions (

Acquisitions and Dispositions (Tables)	12 Months Ended
Acquisitions and Dispositions (Tables)	Dec. 31, 2015
Rave Theatres
Fair Value of Identifiable Assets Acquired and Liabilities Assumed as of Acquisition Date	The following table represents the fair value of the identifiable assets acquired and liabilities assumed as of the acquisition date: Theatre properties and equipment $ 102,977 Tradename 25,000 Favorable leases 17,587 Goodwill 186,418 Unfavorable leases (30,718 ) Deferred revenue (6,634 ) Capital lease liabilities (61,651 ) Other assets, net of other liabilities 3,896 Total $ 236,875
Unaudited Pro Forma Information of Results of Operations as Rave Acquisition Had Occurred	The following unaudited pro forma information summarizes our results of operations as if the Rave Acquisition had occurred as of January 1, 2013: Year Ended Total revenues $ 2,777,458 Income before income taxes $ 275,657
Additional Theatres
Fair Value of Identifiable Assets Acquired and Liabilities Assumed as of Acquisition Date	The following table represents the aggregate fair values of identifiable assets acquired and the liabilities assumed as of the acquisition date: Theatre properties and equipment $ 17,524 Goodwill 17,409 Capital lease liability (12,173 ) Deferred revenue (388 ) Total $ 22,372

Investment in National CineMe35

Investment in National CineMedia Llc (Tables) - NCM	12 Months Ended
Investment in National CineMedia Llc (Tables) - NCM	Dec. 31, 2015
Summary of Common Units Received Under Common Unit Adjustment Agreement	Below is a summary of common units received by the Company under the Common Unit Adjustment Agreement during the years ended December 31, 2013, 2014 and 2015: Event Date Number of Common Units Fair Value 2013 Annual common unit adjustment 03/28/13 588,024 $ 8,869 2013 Extraordinary common unit adjustment (as result of Rave Acquisition – see Note 3) 05/29/13 5,315,837 $ 89,928 2014 Annual common unit adjustment 03/27/14 557,631 $ 8,216 2015 Annual common unit adjustment 03/31/15 1,074,910 $ 15,421
Summary of Activity with NCM Included in Company's Condensed Consolidated Financial Statements	Below is a summary of activity with NCM included in the Company’s consolidated financial statements for the periods indicated: Investment Deferred Distributions Equity in Other Other Cash Balance as of January 1, 2013 $ 78,123 $ (241,305 ) Receipt of common units due to annual common unit adjustment 8,869 (8,869 ) $ — $ — $ — $ — $ — Receipt of common units due to extraordinary common unit adjustment 89,928 (89,928 ) — — — — — Revenues earned under ESA (1) — — (7,960 ) — 7,960 Receipt of excess cash distributions (13,166 ) — (19,374 ) — — — 32,540 Receipt under tax receivable agreement (492 ) — (1,327 ) — — — 1,819 Equity in earnings (2) 13,753 — — (11,578 ) — — — Equity in other comprehensive income 1,838 — — — — (1,838 ) — Amortization of deferred revenue — 5,673 — — (5,673 ) — — Balance as of and for the period ended December 31, 2013 $ 178,853 $ (334,429 ) $ (20,701 ) $ (11,578 ) $ (13,633 ) $ (1,838 ) $ 42,319 Receipt of common units due to annual common unit adjustment 8,216 (8,216 ) $ — $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (9,249 ) — 9,249 Receipt of excess cash distributions (12,574 ) — (14,778 ) — — — 27,352 Receipt under tax receivable agreement (2,594 ) — (3,763 ) — — — 6,357 Equity in earnings 6,142 — — (6,142 ) — — — Equity in other comprehensive income 896 — — — — (896 ) — Amortization of deferred revenue — 7,426 — — (7,426 ) — — Balance as of and for the period ended December 31, 2014 $ 178,939 $ (335,219 ) $ (18,541 ) $ (6,142 ) $ (16,675 ) $ (896 ) $ 42,958 Receipt of common units due to annual common unit adjustment 15,421 (15,421 ) $ — $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (11,330 ) — 11,330 Receipt of excess cash distributions (14,072 ) — (15,396 ) — — — 29,468 Receipt under tax receivable agreement (2,308 ) — (2,744 ) — — — 5,052 Equity in earnings 8,510 — — (8,510 ) — — — Equity in other comprehensive loss (2,735 ) — — — — 2,735 — Amortization of deferred revenue — 8,506 — — (8,506 ) — — Balance as of and for the period ended December 31, 2015 $ 183,755 $ (342,134 ) $ (18,140 ) $ (8,510 ) $ (19,836 ) $ 2,735 $ 45,850 (1) Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire were approximately $11,958, $11,489 and $9,819 for the years ended December 31, 2013, 2014 and 2015, respectively. (2) A portion of the equity in earnings recorded for the year ended December 31, 2013 was recorded as a reduction in our investment basis in a joint venture (AC JV, LLC) that the Company, along with Regal and AMC, recently formed with NCM. See Note 5.

Other Investments (Tables)

Other Investments (Tables)	12 Months Ended
Other Investments (Tables)	Dec. 31, 2015
Other Investments	The Company had the following other investments at December 31: 2014 2015 Digital Cinema Implementation Partners (“DCIP”), equity method investment $ 51,277 $ 71,579 RealD, Inc. (“RealD”), investment in marketable security 14,429 12,900 AC JV, LLC, equity method investment 7,899 7,269 Digital Cinema Distribution Coalition (“DCDC”), equity method investment 2,438 2,562 Other 1,615 663 Total $ 77,658 $ 94,973
Summary of Activity for Each of Investments	Below is a summary of activity for each of the investments for the years ended December 31, 2013, 2014 and 2015: DCIP RealD AC JV, DCDC Other Total Balance at January 1, 2013 $ 23,012 $ 13,707 $ — $ 5 $ 1,477 $ 38,201 Cash contributions 3,232 — 268 2,721 — 6,221 Issuance of promissory note to NCM — — 8,333 — — 8,333 Equity in income (loss) 11,241 — — (137 ) — 11,104 Equity in other comprehensive income 548 — — — — 548 Adjustment for gain recognized by NCM — — (2,175 ) — — (2,175 ) Unrealized holding loss — (3,264 ) — — — (3,264 ) Other — — — — 689 689 Balance at December 31, 2013 $ 38,033 $ 10,443 $ 6,426 $ 2,589 $ 2,166 $ 59,657 Cash contributions 2,188 — — — — 2,188 Equity in income (loss) 15,279 — 1,473 (151 ) — 16,601 Equity in other comprehensive loss (219 ) — — — — (219 ) Unrealized holding gain — 3,986 — — — 3,986 Cash distributions received (4,004 ) — — — — (4,004 ) Other — — — — (551 ) (551 ) Balance at December 31, 2014 $ 51,277 $ 14,429 $ 7,899 $ 2,438 $ 1,615 $ 77,658 Cash contributions 3,211 — — — 500 3,711 Equity in income 18,522 — 970 124 — 19,616 Equity in other comprehensive loss (384 ) — — — — (384 ) Unrealized holding loss — (1,529 ) — — — (1,529 ) Sale of investment in Taiwan (1) — — — — (1,383 ) (1,383 ) Cash distributions received (1,047 ) — (1,600 ) — — (2,647 ) Other — — — — (69 ) (69 ) Balance at December 31, 2015 $ 71,579 $ 12,900 $ 7,269 $ 2,562 $ 663 $ 94,973 (1) The Company sold its investment in a Taiwan joint venture for approximately $2,634, resulting in a gain of $1,251, which is included in (gain) loss on sale of assets and other for the year ended December 31, 2015.
Transactions with DCIP	The Company had the following transactions with DCIP during the years ended December 31, 2013, 2014 and 2015: Year Ended December 31, 2013 2014 2015 Equipment lease payments $ 3,853 $ 4,012 $ 4,474 Warranty reimbursements from DCIP $ (1,893 ) $ (3,169 ) $ (4,329 )
NCM
Summary of Financial Information	The tables below present summary financial information for NCM for the periods indicated (financial information for the year ended December 31, 2015 is not yet available): Year Ended Nine Months October 1, 2015 December 26, 2013 January 1, 2015 Gross revenues $ 462,815 $ 393,994 $ 310,061 Operating income $ 202,019 $ 159,624 $ 40,442 Net income $ 162,870 $ 96,309 $ 38,519 As of January 1, 2015 As of October 1, 2015 Total assets $ 681,107 $ 700,326 Total liabilities $ 998,529 $ 1,030,243
Digital Cinema Implementation Partners LLC
Summary of Financial Information	Below is summary financial information for DCIP as of and for the years ended December 31, 2013, 2014 and 2015. Year ended December 31, 2013 2014 2015 Net operating revenue $ 182,659 $ 170,724 $ 171,203 Operating income $ 116,235 $ 101,956 $ 103,449 Net income $ 48,959 $ 61,293 $ 79,255 As of December 31, 2014 December 31, 2015 Total assets $ 1,097,467 $ 1,004,292 Total liabilities $ 845,319 $ 674,727

Goodwill and Other Intangible37

Goodwill and Other Intangible Assets - Net (Tables)	12 Months Ended
Goodwill and Other Intangible Assets - Net (Tables)	Dec. 31, 2015
Summary of Goodwill	The Company’s goodwill was as follows: U.S. Operating Segment International Operating Segment Total Balance at December 31, 2013 (1) $ 1,150,471 $ 137,619 $ 1,288,090 Acquisition of U.S. theatres 6,085 — 6,085 Other acquisitions — 1,108 1,108 Foreign currency translation adjustments — (17,900 ) (17,900 ) Balance at December 31, 2014 (1) $ 1,156,556 $ 120,827 $ 1,277,383 Acquisition of Brazil theatre — 356 356 Foreign currency translation adjustments — (30,191 ) (30,191 ) Balance at December 31, 2015 (1) $ 1,156,556 $ 90,992 $ 1,247,548 (1) Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.
Intangible Assets	As of December 31, intangible assets-net, consisted of the following: December 31, December 31, 2013 Acquisitions Amortization Other (1) 2014 Intangible assets with finite lives: Gross carrying amount $ 101,617 $ 300 $ — $ (1,995 ) $ 99,922 Accumulated amortization (46,297 ) — (5,947 ) 12 (52,232 ) Total net intangible assets with finite lives $ 55,320 $ 300 $ (5,947 ) $ (1,983 ) $ 47,690 Intangible assets with indefinite lives: Tradename 300,824 — — (490 ) 300,334 Total intangible assets — net $ 356,144 $ 300 $ (5,947 ) $ (2,473 ) $ 348,024 December 31, December 31, 2014 Amortization Other (2) 2015 Intangible assets with finite lives: Gross carrying amount $ 99,922 $ — $ 46 $ 99,968 Accumulated amortization (52,232 ) (5,716 ) (1,758 ) (59,706 ) Total net intangible assets with finite lives $ 47,690 $ (5,716 ) $ (1,712 ) $ 40,262 Intangible assets with indefinite lives: Tradename 300,334 — (952 ) 299,382 Total intangible assets — net $ 348,024 $ (5,716 ) $ (2,664 ) $ 339,644 (1) Activity for 2014 primarily consists of $479 for impairment of a tradename intangible asset related to one U.S. theatre and foreign currency translation adjustments. (2) Activity for 2015 primarily consists of the write-off of intangible assets for closed theatres, the write-off of a vendor contract intangible asset, $992 for impairment of a favorable lease and foreign currency translation adjustments.
Estimated Aggregate Future Amortization Expense for Intangible Assets	Estimated aggregate future amortization expense for intangible assets is as follows: For the year ended December 31, 2016 $ 5,389 For the year ended December 31, 2017 4,857 For the year ended December 31, 2018 4,857 For the year ended December 31, 2019 3,977 For the year ended December 31, 2020 4,252 Thereafter 16,930 Total $ 40,262

Impairment of Long-Lived Asse38

Impairment of Long-Lived Assets (Tables)	12 Months Ended
Impairment of Long-Lived Assets (Tables)	Dec. 31, 2015
Long-Lived Asset Impairment Losses	The Company’s long-lived asset impairment losses are summarized in the following table: Year Ended December 31, 2013 2014 2015 United States theatre properties $ 1,911 $ 6,168 $ 7,052 International theatre properties 1,175 — 757 Subtotal 3,086 6,168 7,809 Intangible assets (see Note 6) 708 479 992 Impairment of long-lived assets $ 3,794 $ 6,647 $ 8,801

Deferred Charges and Other As39

Deferred Charges and Other Assets - Net (Tables)	12 Months Ended
Deferred Charges and Other Assets - Net (Tables)	Dec. 31, 2015
Deferred Charges and Other Assets Net	As of December 31, deferred charges and other assets — net consisted of the following: December 31, 2014 2015 Long-term prepaid rents 7,296 4,278 Construction and other deposits 14,171 8,459 Equipment to be placed in service 14,124 15,388 Other 10,980 10,118 Total $ 46,571 $ 38,243

Long-Term Debt (Tables)

Long-Term Debt (Tables)	12 Months Ended
Long-Term Debt (Tables)	Dec. 31, 2015
Components of Long-Term Debt	As of December 31, long-term debt consisted of the following: December 31, 2014 2015 Cinemark USA, Inc. term loan $ 686,000 $ 679,000 Cinemark USA, Inc. 4.875% senior notes due 2023 530,000 530,000 Cinemark USA, Inc. 5.125% senior notes due 2022 400,000 400,000 Cinemark USA, Inc. 7.375% senior subordinated notes due 2021 200,000 200,000 Other (1) 6,997 5,572 Total long-term debt 1,822,997 1,814,572 Less current portion 8,423 8,405 Less debt issuance costs, net of accumulated amortization of $10,918 and $16,058, respectively (2) 31,419 33,237 Long-term debt, less current portion $ 1,783,155 $ 1,772,930 (1) Primarily represents debt owed to NCM in relation to the recently-formed joint venture AC JV, LLC. See Note 5. (2) See Note 2 for discussion of debt issuance costs reclassification upon adoption of ASU 2015-03.
Maturities of Long-Term Debt	The Company’s long-term debt, excluding debt issuance costs, at December 31, 2015 matures as follows: 2016 $ 8,405 2017 8,389 2018 8,389 2019 8,389 2020 7,000 Thereafter 1,774,000 Total $ 1,814,572

Interest Rate Swap Agreements (

Interest Rate Swap Agreements (Tables)	12 Months Ended
Interest Rate Swap Agreements (Tables)	Dec. 31, 2015
Interest Rate Swap Agreement Designated as Hedge Agreement	Below is a summary of the Company’s interest rate swap agreement designated as cash flow hedge as of December 31, 2015: Estimated Notional Amount Effective Date Pay Rate Receive Rate Expiration Date Total Fair Value at (1) $100,000 November 2011 1.7150 % 1-Month LIBOR April 2016 $ 373 (1) Included in accrued other current liabilities on the consolidated balance sheet as of December 31, 2015.
Interest Rate Swap
Changes in Accumulated Other Comprehensive Loss, Net of Taxes, Related to Interest Rate Swap Agreements	The changes in accumulated other comprehensive loss, net of taxes, related to the Company’s interest rate swap agreements for the years ended December 31, 2013, 2014 and 2015 were as follows: 2013 2014 2015 Beginning balances – January 1 $ (8,867 ) $ (5,716 ) $ (2,870 ) Other comprehensive loss before reclassifications, net of taxes (2,668 ) (3,169 ) (2,154 ) Amounts reclassified from accumulated other comprehensive loss to interest expense, net of taxes 5,819 6,015 4,790 Net other comprehensive income 3,151 2,846 2,636 Ending balances – December 31 $ (5,716 ) $ (2,870 ) $ (234 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
Fair Value Measurements (Tables)	Dec. 31, 2015
Fair Value Measurement of Assets and Liabilities on Recurring Basis	Below is a summary of assets and liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of December 31, 2014: Carrying Value Fair Value Description Level 1 Level 2 Level 3 Interest rate swap liabilities – current (see Note 10) $ (4,255 ) $ — $ — $ (4,255 ) Interest rate swap liabilities – long term (see Note 10) $ (317 ) $ — $ — $ (317 ) Investment in RealD (see Note 5) $ 14,429 $ 14,429 $ — $ — Below is a summary of assets and liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of December 31, 2015: Carrying Value Fair Value Description Level 1 Level 2 Level 3 Interest rate swap liabilities – current (see Note 10) $ (373 ) $ — $ — $ (373 ) Investment in RealD (see Note 5) $ 12,900 $ 12,900 $ — $ —
Reconciliation of Beginning and Ending Balance for Liabilities Measured at Fair Value	Below is a reconciliation of the beginning and ending balance for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3): Liabilities 2014 2015 Beginning balances - January 1 $ 9,176 $ 4,572 Total (gain) loss included in accumulated other comprehensive loss 1,411 (155 ) Settlements (6,015 ) (4,790 ) Ending balances – December 31 $ 4,572 $ 373

Foreign Currency Translation (T

Foreign Currency Translation (Tables)	12 Months Ended
Foreign Currency Translation (Tables)	Dec. 31, 2015
Summary of Impact of Translating Financial Statements of Certain of Company's International Subsidiaries	Below is a summary of the impact of translating the financial statements of the Company’s international subsidiaries as of and for the years ended December 31, 2013, 2014 and 2015. Other Comprehensive Country Exchange Rates as of December 31, Income (Loss) For Year Ended December 31, 2013 2014 2015 2013 2014 2015 Brazil 2.36 2.69 3.96 $ (34,451 ) $ (30,723 ) $ (74,559 ) Argentina 6.52 8.55 12.95 (24,845 ) (20,197 ) (30,520 ) Colombia 1,926.83 2,392.46 3,149.47 (2,969 ) (7,632 ) (8,043 ) Chile 525.5 606.2 709.16 (3,570 ) (5,580 ) (6,572 ) Peru 2.84 3.05 3.46 (3,685 ) (2,785 ) (4,882 ) All other (185 ) (2,066 ) (898 ) Sale of Mexico subsidiary 22,088 — — $ (47,617 ) $ (68,983 ) $ (125,474 )

Noncontrolling Interests in S44

Noncontrolling Interests in Subsidiaries (Tables)	12 Months Ended
Noncontrolling Interests in Subsidiaries (Tables)	Dec. 31, 2015
Noncontrolling Interests in Subsidiaries	Noncontrolling interests in subsidiaries of the Company were as follows at December 31: December 31, 2014 2015 Cinemark Partners II — 24.6% interest (in one theatre) $ 7,769 $ 7,753 Laredo Theatres – 25% interest (in two theatres) 1,112 1,761 Greeley Ltd. — 49.0% interest (in one theatre) 589 740 Other 859 851 Total $ 10,329 $ 11,105
Summary of Impact of Changes in Company's Ownership Interest in its Subsidiaries on Its Equity	Below is a summary of the impact of changes in the Company’s ownership interest in its subsidiaries on its equity: Year ended December 31, 2013 2014 2015 Net income attributable to Cinemark USA, Inc. $ 149,843 $ 194,380 $ 218,532 Transfers from noncontrolling interests Decrease in Cinemark USA, Inc. additional paid-in-capital for the buyout of Adamark non-controlling interest (4,618 ) — — Net transfers from non-controlling interests (4,618 ) — — Change from net income attributable to Cinemark USA, Inc. and transfers from noncontrolling interests $ 145,225 $ 194,380 $ 218,532

Capital Stock (Tables)

Capital Stock (Tables)	12 Months Ended
Capital Stock (Tables)	Dec. 31, 2015
Summary of Stock Option Activity	Stock Options Year Ended Year Ended December 31, 2013 December 31, 2014 Weighted Weighted Average Average Number of Exercise Number of Exercise Options Price Options Price Outstanding at January 1 22,022 $ 7.63 14,584 $ 7.63 Exercised (7,438 ) $ 7.63 (14,584 ) $ 7.63 Outstanding at December 31 14,584 $ 7.63 — Vested options at December 31 14,584 $ 7.63 —
Summary of Restricted Stock Activity	Restricted Stock Year Ended Year Ended Year Ended December 31, 2013 December 31, 2014 December 31, 2015 Shares of Weighted Shares of Weighted Shares of Weighted Outstanding at January 1 1,534,163 $ 18.85 1,260,913 $ 21.86 878,897 $ 24.92 Granted 271,532 $ 30.09 269,774 $ 28.93 226,212 $ 42.79 Vested (522,129 ) $ 17.27 (625,843 ) $ 20.53 (329,437 ) $ 23.72 Forfeited (22,653 ) $ 22.92 (25,947 ) $ 22.94 (17,897 ) $ 27.58 Outstanding at December 31 1,260,913 $ 21.86 878,897 $ 24.92 757,775 $ 30.73
Number of Shares Vested Under Restricted Stock Unit Awards	Below is a table summarizing the potential number of shares that could vest under restricted stock unit awards granted during the years ended December 31, 2013, 2014 and 2015 at each of the three levels of financial performance (excluding forfeitures): Granted During the Year Ended December 31, 2013 2014 2015 Number of Value at (1) Number of Value at (1) Number of Value at (1) at IRR of at least 8.5% (7.5% for 2015 grant) 38,366 $ 1,129 65,832 $ 1,879 47,640 $ 2,057 at IRR of at least 10.5% (9.5% for 2015 grant) 76,741 $ 2,259 131,683 $ 3,758 95,282 $ 4,115 at IRR of at least 12.5% (11.5% for 2015 grant) 115,107 $ 3,389 197,515 $ 5,637 142,917 $ 6,173 (1) The weighted average grant date fair values for units issued during the years ended December 31, 2013, 2014, and 2015 were $29.44, $28.54 and $43.19, respectively.
Restricted Stock
Summary of Restricted Stock Award Activity	Below is a summary of restricted stock award activity recorded for the periods indicated: Year Ended December 31, 2013 2014 2015 Compensation expense recognized during the period (1) $ 11,898 $ 8,591 $ 8,715 Fair value of restricted shares that vested during the period (2) $ 9,161 $ 17,692 $ 13,276 Income tax deduction upon vesting of restricted stock awards (3) $ 3,848 $ 5,171 $ 3,341 (1) Cinemark Holdings, Inc. recorded an additional $840, $943 and $885 of compensation expense related to these restricted stock awards during the years ended December 31, 2013, 2014 and 2015, respectively. (2) The fair value of shares in which Cinemark Holdings, Inc.’s directors vested was $1,000, $1,081 and $1,148 during the years ended December 31, 2013, 2014 and 2015, respectively. (3) Cinemark Holdings, Inc. recognized an additional tax benefit of $420, $454 and $482 on these vested awards during the years ended December 31, 2013, 2014 and 2015, respectively.
Restricted Stock Units
Summary of Restricted Stock Unit Award Activity	Below is a summary of activity for restricted stock unit awards for the periods indicated: Year Ended December 31, 2013 2014 2015 Number of restricted stock unit awards that vested during the period 295,751 395,751 123,769 Fair value of restricted stock unit awards that vested during the period $ 8,723 $ 11,420 $ 5,483 Accumulated dividends paid upon vesting of restricted stock unit awards $ 939 $ 1,352 $ 442 Income tax benefit recognized upon vesting of restricted stock unit awards $ 3,663 $ 4,796 $ 2,303 Compensation expense recognized during the period $ 4,148 $ 3,284 $ 6,158

Supplemental Cash Flow Inform46

Supplemental Cash Flow Information (Tables)	12 Months Ended
Supplemental Cash Flow Information (Tables)	Dec. 31, 2015
Supplemental Information to Condensed Consolidated Statements of Cash Flows	The following is provided as supplemental information to the consolidated statements of cash flows: Year Ended December 31, 2013 2014 2015 Cash paid for interest $ 116,890 $ 107,926 $ 105,155 Cash paid for income taxes, net of refunds received $ 136,124 $ 122,972 $ 108,435 Noncash investing and financing activities: Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (1) $ (7,325 ) $ (1,225 ) $ 2,491 Theatre properties and equipment acquired under capital lease $ 69,541 $ 19,908 $ 36,544 Investment in NCM - receipt of common units (see Note 4) $ 98,797 $ 8,216 $ 15,421 Investment in AC JV, LLC (see Note 5) $ 8,333 $ — $ — Issuance of promissory note related to investment in AC JV, LLC (see Note 5) $ (8,333 ) $ — $ — Noncash distributions to Cinemark Holdings, Inc. $ (4,971 ) $ — $ (17,935 ) Receipt of promissory note related to sale of investment in Taiwan joint venture $ — $ — $ 2,304 (1) Additions to theatre properties and equipment included in accounts payable as of December 31, 2014 and 2015 were $13,235 and $10,744, respectively.

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
Income Taxes (Tables)	Dec. 31, 2015
Income Before Income Taxes	Income before income taxes consisted of the following: Year Ended December 31, 2013 2014 2015 Income before income taxes: U.S. $ 164,904 $ 208,377 $ 262,336 Foreign 101,177 84,542 88,015 Total $ 266,081 $ 292,919 $ 350,351
Current and Deferred Income Taxes	Current and deferred income taxes were as follows: Year Ended December 31, 2013 2014 2015 Current: Federal $ 98,206 $ 62,686 $ 72,185 Foreign 42,690 27,681 35,874 State 11,056 6,256 10,806 Total current expense $ 151,952 $ 96,623 $ 118,865 Deferred: Federal $ (30,833 ) $ 6,322 $ 10,420 Foreign 2,653 (6,437 ) (3,339 ) State (9,612 ) 642 4,014 Total deferred taxes (37,792 ) 527 11,095 Income taxes $ 114,160 $ 97,150 $ 129,960
Reconciliation Between Income Tax Expense and Taxes Computed	A reconciliation between income tax expense and taxes computed by applying the applicable statutory federal income tax rate to income before income taxes follows: Year Ended December 31, 2013 2014 2015 Computed statutory tax expense $ 93,128 $ 102,522 $ 122,623 Foreign inflation adjustments 67 641 (1,295 ) State and local income taxes, net of federal income tax impact 858 4,634 9,640 Foreign losses not benefited and other changes in valuation allowance (2,052 ) (275 ) (2,408 ) Foreign tax rate differential (336 ) (2,125 ) (2,660 ) Foreign dividends 3,294 1,083 — Sale of Mexican subsidiaries and related changes in intangible assets 21,406 (10,065 ) — Changes in uncertain tax positions (2,024 ) (1,540 ) 3,717 Other — net (181 ) 2,275 343 Income taxes $ 114,160 $ 97,150 $ 129,960
Tax Effects of Significant Temporary Differences and Tax Loss and Tax Credit Carryforwards	The tax effects of significant temporary differences and tax loss and tax credit carryforwards comprising the net long-term deferred income tax liabilities as of December 31, 2014 and 2015 consisted of the following: December 31, 2014 2015 Deferred liabilities: Theatre properties and equipment $ 127,010 $ 141,155 Tax impact of items in accumulated other comprehensive income (loss) 55 158 Intangible asset — other 29,342 28,889 Intangible asset — tradenames 111,726 112,413 Investment in partnerships 111,328 108,733 Total deferred liabilities 379,461 391,348 Deferred assets: Deferred lease expenses 27,341 26,966 Exchange loss — 3,736 Deferred revenue - NCM 124,366 128,642 Capital lease obligations 73,306 75,966 Tax loss carryforwards 7,764 7,379 Alternative minimum tax and other credit carryforwards 43,384 41,300 Other expenses, not currently deductible for tax purposes 25,807 20,204 Total deferred assets 301,968 304,193 Net deferred income tax liability before valuation allowance 77,493 87,155 Valuation allowance against deferred assets - current 2,384 — Valuation allowance against deferred assets – non-current 50,489 50,636 Net deferred income tax liability $ 130,366 $ 137,791 Net deferred tax liability — Foreign $ 12,213 $ 4,212 Net deferred tax liability — U.S. 118,153 133,579 Total $ 130,366 $ 137,791
Reconciliation of Unrecognized Tax Benefits Excluding Interest and Penalties	The following is a reconciliation of the total amounts of unrecognized tax benefits excluding interest and penalties, for the years ended December 31, 2013, 2014 and 2015: Year Ended December 31, 2013 2014 2015 Balance at January 1, $ 33,222 $ 18,780 $ 16,515 Gross increases-tax positions in prior periods 413 10 40 Gross decreases-tax positions in prior periods — (2,379 ) — Gross increases - current period tax positions 1,476 1,324 2,112 Gross decreases - current period tax positions — — — Settlements (15,444 ) (963 ) (871 ) Foreign currency translation adjustments (887 ) (257 ) (663 ) Balance at December 31, $ 18,780 $ 16,515 $ 17,133

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
Commitments and Contingencies (Tables)	Dec. 31, 2015
Rent Expenses	Theatre rent expense was as follows: Year Ended December 31, 2013 2014 2015 Fixed rent expense $ 224,056 $ 237,891 $ 240,057 Contingent rent and other facility lease expenses 83,795 79,205 79,704 Total facility lease expense $ 307,851 $ 317,096 $ 319,761
Estimated Future Minimum Lease Payments	Future minimum lease payments under noncancelable operating and capital leases that have initial or remaining terms in excess of one year at December 31, 2015 are due as follows: Operating Leases Capital Leases 2016 $ 248,498 $ 35,156 2017 236,630 33,640 2018 210,089 34,050 2019 181,967 33,394 2020 161,279 32,441 Thereafter 661,398 155,164 Total $ 1,699,861 323,845 Amounts representing interest payments (96,113 ) Present value of future minimum payments 227,732 Current portion of capital lease obligations (18,780 ) Capital lease obligations, less current portion $ 208,952

Segments (Tables)

Segments (Tables)	12 Months Ended
Segments (Tables)	Dec. 31, 2015
Selected Financial Information by Reportable Operating Segment	Below is a breakdown of select financial information by reportable operating segment: Year Ended December 31, 2013 2014 2015 Revenues: U.S. $ 1,912,674 $ 1,934,990 $ 2,137,733 International 783,053 704,623 728,735 Eliminations (12,833 ) (12,623 ) (13,859 ) Total revenues $ 2,682,894 $ 2,626,990 $ 2,852,609 Year Ended December 31, 2013 2014 2015 Adjusted EBITDA (1) U.S. $ 456,866 $ 438,776 $ 499,138 International 169,834 159,662 166,416 Total Adjusted EBITDA $ 626,700 $ 598,438 $ 665,554 Year Ended December 31, 2013 2014 2015 Capital expenditures: U.S. $ 117,488 $ 148,532 $ 223,213 International 142,182 96,173 108,513 Total capital expenditures $ 259,670 $ 244,705 $ 331,726 (1) Distributions from NCM are reported entirely within the U.S. operating segment
Reconciliation of Net Income to Adjusted EBITDA	The following table sets forth a reconciliation of net income to Adjusted EBITDA: Year Ended December 31, 2013 2014 2015 Net income $ 151,921 $ 195,769 $ 220,391 Add (deduct): Income taxes 114,160 97,150 129,960 Interest expense (1) 124,714 113,698 112,741 Loss on early retirement of debt 72,302 — — Loss on amendment to debt agreement — — 925 Other income (2) (24,688 ) (22,150 ) (20,041 ) Depreciation and amortization 163,970 175,656 189,206 Impairment of long-lived assets 3,794 6,647 8,801 (Gain) loss on sale of assets and other (3,845 ) 15,715 8,143 Deferred lease expenses 5,701 2,536 (1,806 ) Amortization of long-term prepaid rents 2,625 1,542 2,361 Share based awards compensation expense 16,046 11,875 14,873 Adjusted EBITDA $ 626,700 $ 598,438 $ 665,554 (1) Includes amortization of debt issue costs. (2) Includes interest income, foreign currency exchange loss, and equity in income of affiliates and excludes distributions from NCM.
Selected Financial Information by Geographic Area	Below is a breakdown of select financial information by geographic area: Year Ended December 31, 2013 2014 2015 Revenues U.S. $ 1,912,674 $ 1,934,990 $ 2,137,733 Brazil 325,762 333,919 291,959 Other foreign countries 457,291 370,704 436,776 Eliminations (12,833 ) (12,623 ) (13,859 ) Total $ 2,682,894 $ 2,626,990 $ 2,852,609 December 31, 2014 2015 Theatres properties and equipment, net U.S. $ 1,094,076 $ 1,175,535 Brazil 204,107 163,505 Other foreign countries 152,629 166,029 Total $ 1,450,812 $ 1,505,069

Valuation and Qualifying Acco50

Valuation and Qualifying Accounts (Tables)	12 Months Ended
Valuation and Qualifying Accounts (Tables)	Dec. 31, 2015
Valuation Allowance for Deferred Tax Assets	The Company’s valuation allowance for deferred tax assets for the years ended December 31, 2013, 2014 and 2015 were as follows: Valuation for Deferred Tax Assets Balance at January 1, 2013 $ 13,326 Additions 14,162 Deductions (1,777 ) Balance at December 31, 2013 $ 25,711 Additions 28,612 Deductions (1,450 ) Balance at December 31, 2014 $ 52,873 Additions 437 Deductions (2,674 ) Balance at December 31, 2015 $ 50,636

Condensed Consolidating Finan51

Condensed Consolidating Financial Statement Information of Subsidiary Guarantors (Tables)	12 Months Ended
	Dec. 31, 2015
Condensed Consolidating Balance Sheet Information	CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2014 Parent Subsidiary Subsidiary Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 129,505 $ 74,643 $ 434,693 $ — $ 638,841 Other current assets 126,091 18,471 67,826 (110,302 ) 102,086 Accounts receivable from parent or subsidiaries 277,823 — — (265,185 ) 12,638 Total current assets 533,419 93,114 502,519 (375,487 ) 753,565 Theatre properties and equipment - net 498,446 575,652 376,714 — 1,450,812 Investment in subsidiaries 1,260,333 380,365 — (1,640,698 ) — Other assets 1,389,912 140,320 401,783 (3,276 ) 1,928,739 Total assets $ 3,682,110 $ 1,189,451 $ 1,281,016 $ (2,019,461 ) $ 4,133,116 Liabilities and equity Current liabilities Current portion of long-term debt $ 7,000 $ — $ 1,423 $ — $ 8,423 Current portion of capital lease obligations 5,411 9,125 1,958 — 16,494 Accounts payable and accrued expenses 259,973 105,761 125,638 (102,406 ) 388,966 Accounts payable to parent or subsidiaries — 84,555 180,630 (265,185 ) — Total current liabilities 272,384 199,441 309,649 (367,591 ) 413,883 Long-term liabilities Long-term debt, less current portion 1,777,581 — 7,442 (1,868 ) 1,783,155 Capital lease obligations, less current portion 103,786 75,416 22,776 — 201,978 Other long-term liabilities and deferrals 401,965 79,116 125,600 (9,304 ) 597,377 Total long-term liabilities 2,283,332 154,532 155,818 (11,172 ) 2,582,510 Commitments and contingencies Equity Cinemark USA, Inc.’s stockholder’s equity: Common stock 49,543 457,369 10,219 (467,588 ) 49,543 Other stockholder’s equity 1,076,851 378,109 795,001 (1,173,110 ) 1,076,851 Total Cinemark USA, Inc. stockholder’s equity 1,126,394 835,478 805,220 (1,640,698 ) 1,126,394 Noncontrolling interests — — 10,329 — 10,329 Total equity 1,126,394 835,478 815,549 (1,640,698 ) 1,136,723 Total liabilities and equity $ 3,682,110 $ 1,189,451 $ 1,281,016 $ (2,019,461 ) $ 4,133,116 CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2015 Parent Subsidiary Subsidiary Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 141,364 $ 95,865 $ 351,274 $ — $ 588,503 Other current assets 78,797 18,407 61,432 (32,024 ) 126,612 Accounts receivable from parent or subsidiaries 212,299 — — (211,128 ) 1,171 Total current assets 432,460 114,272 412,706 (243,152 ) 716,286 Theatre properties and equipment - net 539,082 614,821 351,166 — 1,505,069 Investment in subsidiaries 1,326,790 293,900 — (1,620,690 ) — Other assets 1,402,062 135,022 475,187 (105,994 ) 1,906,277 Total assets $ 3,700,394 $ 1,158,015 $ 1,239,059 $ (1,969,836 ) $ 4,127,632 Liabilities and equity Current liabilities Current portion of long-term debt $ 7,000 $ — $ 1,405 $ — $ 8,405 Current portion of capital lease obligations 6,426 9,962 2,392 — 18,780 Accounts payable and accrued expenses 197,268 123,759 116,353 (25,396 ) 411,984 Accounts payable to parent or subsidiaries — 23,965 187,163 (211,128 ) — Total current liabilities 210,694 157,686 307,313 (236,524 ) 439,169 Long-term liabilities Long-term debt, less current portion 1,868,763 — 9,534 (105,367 ) 1,772,930 Capital lease obligations, less current portion 114,513 67,440 26,999 — 208,952 Other long-term liabilities and deferrals 404,278 77,774 118,533 (7,255 ) 593,330 Total long-term liabilities 2,387,554 145,214 155,066 (112,622 ) 2,575,212 Commitments and contingencies — — — — — Equity Cinemark USA, Inc.’s stockholder’s equity: Common stock 49,543 457,369 10,240 (467,609 ) 49,543 Other stockholder’s equity 1,052,603 397,746 755,335 (1,153,081 ) 1,052,603 Total Cinemark USA, Inc. stockholder’s equity 1,102,146 855,115 765,575 (1,620,690 ) 1,102,146 Noncontrolling interests — — 11,105 — 11,105 Total equity 1,102,146 855,115 776,680 (1,620,690 ) 1,113,251 Total liabilities and equity $ 3,700,394 $ 1,158,015 $ 1,239,059 $ (1,969,836 ) $ 4,127,632
Condensed Consolidating Statement of Income Information	CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2013 Parent Subsidiary Subsidiary Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 816,489 $ 1,099,257 $ 808,972 $ (41,824 ) $ 2,682,894 Cost of operations Theatre operating expenses 650,731 743,531 585,695 (41,824 ) 1,938,133 General and administrative expenses 22,275 78,749 62,110 — 163,134 Depreciation and amortization 43,501 63,234 57,235 — 163,970 Impairment of long-lived assets 2,301 319 1,174 — 3,794 (Gain) loss on sale of assets and other 99 1,870 (5,814 ) — (3,845 ) Total cost of operations 718,907 887,703 700,400 (41,824 ) 2,265,186 Operating income 97,582 211,554 108,572 — 417,708 Other income (expense) Interest expense (110,484 ) (9,915 ) (4,315 ) — (124,714 ) Distributions from NCM 124 — 20,577 — 20,701 Equity in income of affiliates 196,580 54,524 22,682 (251,104 ) 22,682 Loss on early retirement of debt (72,302 ) — — — (72,302 ) Other income (expense) 101 (8 ) 1,913 — 2,006 Total other income (expense) 14,019 44,601 40,857 (251,104 ) (151,627 ) Income before income taxes 111,601 256,155 149,429 (251,104 ) 266,081 Income taxes (38,242 ) 76,938 75,464 — 114,160 Net income 149,843 179,217 73,965 (251,104 ) 151,921 Less: Net income attributable to noncontrolling interests — — 2,078 — 2,078 Net income attributable to Cinemark USA, Inc. $ 149,843 $ 179,217 $ 71,887 $ (251,104 ) $ 149,843 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2014 Parent Subsidiary Subsidiary Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 851,299 $ 1,084,852 $ 733,435 $ (42,596 ) $ 2,626,990 Cost of operations Theatre operating expenses 693,323 739,686 524,045 (42,596 ) 1,914,458 General and administrative expenses 17,978 74,971 55,639 — 148,588 Depreciation and amortization 50,858 67,460 57,338 — 175,656 Impairment of long-lived assets 6,334 313 — — 6,647 Loss on sale of assets and other 8,954 3,278 3,483 — 15,715 Total cost of operations 777,447 885,708 640,505 (42,596 ) 2,261,064 Operating income 73,852 199,144 92,930 — 365,926 Other income (expense) Interest expense (101,224 ) (9,111 ) (3,392 ) 29 (113,698 ) Distributions from NCM 2,375 — 16,166 — 18,541 Equity in income of affiliates 208,900 53,950 22,464 (262,571 ) 22,743 Other income (expense) 79 — (643 ) (29 ) (593 ) Total other income (expense) 110,130 44,839 34,595 (262,571 ) (73,007 ) Income before income taxes 183,982 243,983 127,525 (262,571 ) 292,919 Income taxes (10,398 ) 71,687 35,861 — 97,150 Net income 194,380 172,296 91,664 (262,571 ) 195,769 Less: Net income attributable to noncontrolling interests — — 1,389 — 1,389 Net income attributable to Cinemark USA, Inc. $ 194,380 $ 172,296 $ 90,275 $ (262,571 ) $ 194,380 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2015 Parent Subsidiary Subsidiary Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 959,347 $ 1,178,873 $ 764,631 $ (50,242 ) $ 2,852,609 Cost of operations Theatre operating expenses 767,446 804,236 545,131 (50,242 ) 2,066,571 General and administrative expenses 16,152 81,240 56,660 — 154,052 Depreciation and amortization 59,759 73,708 55,739 — 189,206 Impairment of long-lived assets 6,445 1,600 756 — 8,801 (Gain) loss on sale of assets and other 6,191 3,728 (1,776 ) — 8,143 Total cost of operations 855,993 964,512 656,510 (50,242 ) 2,426,773 Operating income 103,354 214,361 108,121 — 425,836 Other income (expense) Interest expense (100,608 ) (8,500 ) (4,009 ) 376 (112,741 ) Loss on amendment to debt agreement (925 ) — — — (925 ) Distributions from NCM 2,116 — 16,024 — 18,140 Equity in income of affiliates 217,567 55,082 27,262 (271,785 ) 28,126 Other income (expense) 200 20 (7,929 ) (376 ) (8,085 ) Total other income (expense) 118,350 46,602 31,348 (271,785 ) (75,485 ) Income before income taxes 221,704 260,963 139,469 (271,785 ) 350,351 Income taxes 3,172 79,131 47,657 — 129,960 Net income 218,532 181,832 91,812 (271,785 ) 220,391 Less: Net income attributable to noncontrolling interests — — 1,859 — 1,859 Net income attributable to Cinemark USA, Inc. $ 218,532 $ 181,832 $ 89,953 $ (271,785 ) $ 218,532
Condensed Consolidating Statement of Comprehensive Income Information	CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2013 Parent Subsidiary Subsidiary Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 149,843 $ 179,217 $ 73,965 $ (251,104 ) $ 151,921 Other comprehensive income (loss), net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes of $1,865, net of settlements 3,151 — — — 3,151 Unrealized loss due to fair value adjustments on available-for-sale securities, net of taxes of $1,223 (2,041 ) — — — (2,041 ) Other comprehensive income in equity method investments 2,386 — 2,386 (2,386 ) 2,386 Foreign currency translation adjustments (47,617 ) — (47,699 ) 47,617 (47,699 ) Total other comprehensive loss, net of tax (44,121 ) — (45,313 ) 45,231 (44,203 ) Total comprehensive income, net of tax $ 105,722 $ 179,217 $ 28,652 $ (205,873 ) $ 107,718 Comprehensive income attributable to noncontrolling interests — — (1,996 ) — (1,996 ) Comprehensive income attributable to Cinemark USA, Inc. $ 105,722 $ 179,217 $ 26,656 $ (205,873 ) $ 105,722 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2014 Parent Subsidiary Subsidiary Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 194,380 $ 172,296 $ 91,664 $ (262,571 ) $ 195,769 Other comprehensive income (loss), net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes of $1,759, net of settlements 2,846 — — — 2,846 Unrealized gain due to fair value adjustments on available-for-sale securities, net of taxes of $1,479 2,507 — — — 2,507 Other comprehensive income in equity method investments 676 — 643 (643 ) 676 Foreign currency translation adjustments (68,982 ) — (68,997 ) 68,982 (68,997 ) Total other comprehensive loss, net of tax (62,953 ) — (68,354 ) 68,339 (62,968 ) Total comprehensive income, net of tax $ 131,427 $ 172,296 $ 23,310 $ (194,232 ) $ 132,801 Comprehensive income attributable to noncontrolling interests — — (1,374 ) — (1,374 ) Comprehensive income attributable to Cinemark USA, Inc. $ 131,427 $ 172,296 $ 21,936 $ (194,232 ) $ 131,427 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS) INFORMATION YEAR ENDED DECEMBER 31, 2015 Parent Subsidiary Subsidiary Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 218,532 $ 181,832 $ 91,812 $ (271,785 ) $ 220,391 Other comprehensive income (loss), net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes of $1,562, net of settlements 2,636 — — — 2,636 Unrealized loss due to fair value adjustments on available-for-sale securities, net of taxes of $572 (957 ) — — — (957 ) Other comprehensive loss in equity method investments (3,119 ) — (3,086 ) 3,086 (3,119 ) Foreign currency translation adjustments, net of taxes of $888 (125,474 ) — (125,512 ) 125,474 (125,512 ) Total other comprehensive loss, net of tax (126,914 ) — (128,598 ) 128,560 (126,952 ) Total comprehensive income (loss), net of tax $ 91,618 $ 181,832 $ (36,786 ) $ (143,225 ) $ 93,439 Comprehensive income attributable to noncontrolling interests — — (1,821 ) — (1,821 ) Comprehensive income (loss) attributable to Cinemark USA, Inc. $ 91,618 $ 181,832 $ (38,607 ) $ (143,225 ) $ 91,618
Condensed Consolidating Statement of Cash Flows Information	CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2013 Parent Subsidiary Subsidiary Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 149,843 $ 179,217 $ 73,965 $ (251,104 ) $ 151,921 Adjustments to reconcile net income to cash provided by operating activities (174,847 ) 22,276 44,824 251,104 143,357 Changes in assets and liabilities 115,254 (148,810 ) 47,640 — 14,084 Net cash provided by operating activities 90,250 52,683 166,429 — 309,362 Investing activities Additions to theatre properties and equipment (41,948 ) (74,568 ) (143,154 ) — (259,670 ) Proceeds from sale of theatre properties and equipment and other 21,084 8,881 4,306 — 34,271 Acquisition of theatres in the U.S., net of cash acquired (259,247 ) — — — (259,247 ) Proceeds from disposition of Mexico theatres — — 126,167 — 126,167 Dividends received from subsidiaries 2,633 3,000 707 (6,340 ) — Investment in joint ventures and other — — (6,222 ) — (6,222 ) Net cash used for investing activities (277,478 ) (62,687 ) (18,196 ) (6,340 ) (364,701 ) Financing activities Dividends paid to parent (105,150 ) (707 ) (5,633 ) 6,340 (105,150 ) Payroll taxes paid as a result of restricted stock withholdings — (3,464 ) — — (3,464 ) Proceeds from issuance of notes 530,000 — — — 530,000 Redemption of senior notes (461,946 ) — — — (461,946 ) Net repayments of other long-term debt (7,000 ) — (866 ) — (7,866 ) Payments on capital leases (2,910 ) (6,892 ) (2,213 ) — (12,015 ) Payment of debt issue costs (9,328 ) — — — (9,328 ) Purchases of noncontrolling interests — — (5,621 ) — (5,621 ) Other — 2,962 (2,918 ) — 44 Net cash used for financing activities (56,334 ) (8,101 ) (17,251 ) 6,340 (75,346 ) Effect of exchange rate changes on cash and cash equivalents — — (11,516 ) — (11,516 ) Increase (decrease) in cash and cash equivalents (243,562 ) (18,105 ) 119,466 — (142,201 ) Cash and cash equivalents: Beginning of year 305,627 193,863 242,605 — 742,095 End of year $ 62,065 $ 175,758 $ 362,071 $ — $ 599,894 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2014 Parent Subsidiary Subsidiary Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 194,380 $ 172,296 $ 91,664 $ (262,571 ) $ 195,769 Adjustments to reconcile net income to cash provided by (used for) operating activities (134,559 ) 42,620 31,874 262,571 202,506 Changes in assets and liabilities 232,167 (246,598 ) 70,284 — 55,853 Net cash provided by (used for) operating activities 291,988 (31,682 ) 193,822 — 454,128 Investing activities Additions to theatre properties and equipment (93,608 ) (52,896 ) (98,201 ) — (244,705 ) Proceeds from sale of theatre properties and equipment and other 1,109 98 1,338 — 2,545 Acquisition of theatres in the U.S., net of cash acquired (7,951 ) — — — (7,951 ) Dividends received from subsidiaries 1,094 8 — (1,102 ) — Investments in, and loans to, subsidiaries (1,918 ) — — 1,918 — Investment in joint ventures and other — — (3,228 ) — (3,228 ) Net cash used for investing activities (101,274 ) (52,790 ) (100,091 ) 816 (253,339 ) Financing activities Dividends paid to parent (115,000 ) (700 ) (402 ) 1,102 (115,000 ) Repayments of other long-term debt (7,000 ) — (2,846 ) — (9,846 ) Payments on capital leases (4,082 ) (8,000 ) (1,953 ) — (14,035 ) Capital contributions and loans from parent — 1,918 — (1,918 ) — Other 2,808 (9,861 ) (386 ) — (7,439 ) Net cash used for financing activities (123,274 ) (16,643 ) (5,587 ) (816 ) (146,320 ) Effect of exchange rate changes on cash and cash equivalents — — (15,522 ) — (15,522 ) Increase (decrease) in cash and cash equivalents 67,440 (101,115 ) 72,622 — 38,947 Cash and cash equivalents: Beginning of year 62,065 175,758 362,071 — 599,894 End of year $ 129,505 $ 74,643 $ 434,693 $ — $ 638,841 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2015 Parent Subsidiary Subsidiary Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 218,532 $ 181,832 $ 91,812 $ (271,785 ) $ 220,391 Adjustments to reconcile net income to cash provided by operating activities (142,602 ) 39,156 43,223 271,785 211,562 Changes in assets and liabilities 67,253 (67,850 ) 23,869 — 23,272 Net cash provided by operating activities 143,183 153,138 158,904 — 455,225 Investing activities Additions to theatre properties and equipment (98,193 ) (121,605 ) (111,928 ) — (331,726 ) Proceeds from sale of theatre properties and equipment and other 2,737 5,264 1,965 — 9,966 Acquisition of theatre in Brazil — — (2,651 ) — (2,651 ) Dividends received from subsidiaries 1,685 15 — (1,700 ) — Intercompany note issuances (3,500 ) — (100,000 ) 103,500 — Investment in joint ventures and other (518 ) — (3,211 ) 18 (3,711 ) Net cash used for investing activities (97,789 ) (116,326 ) (215,825 ) 101,818 (328,122 ) Financing activities Dividends paid to parent (115,225 ) (1,700 ) — 1,700 (115,225 ) Repayments of long-term debt (8,385 ) — (35 ) — (8,420 ) Payments of debt issue costs (6,957 ) — — — (6,957 ) Payments on capital leases (5,389 ) (9,120 ) (2,004 ) — (16,513 ) Intercompany loan proceeds 100,000 — 3,518 (103,518 ) — Other 2,421 (4,770 ) (1,045 ) — (3,394 ) Net cash provided by (used for) financing activities (33,535 ) (15,590 ) 434 (101,818 ) (150,509 ) Effect of exchange rate changes on cash and cash equivalents — — (26,932 ) — (26,932 ) Increase (decrease) in cash and cash equivalents 11,859 21,222 (83,419 ) — (50,338 ) Cash and cash equivalents: Beginning of year 129,505 74,643 434,693 — 638,841 End of year $ 141,364 $ 95,865 $ 351,274 $ — $ 588,503

Estimated Useful Lives of Asset

Estimated Useful Lives of Assets (Detail)	12 Months Ended
Estimated Useful Lives of Assets (Detail)	Dec. 31, 2015
Buildings On Owned Land
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	P40Y
Buildings On Leased Land
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	Lesser of lease term or useful life
Land and Buildings under Capital Lease
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	Lesser of lease term or useful life	[1]
Theatre Furniture and Equipment \| Minimum
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	3 years
Theatre Furniture and Equipment \| Maximum
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	15 years
Leasehold Improvements
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	Lesser of lease term or useful life

[1]	Amortization of capital lease assets is included in depreciation and amortization expense on the consolidated statements of income. Accumulated amortization of capital lease assets as of December 31, 2014 and 2015 was $133,022 and $150,968, respectively.

Summary of Significant Accoun53

Summary of Significant Accounting Policies - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2015USD ($)SegmentCountryCommunity	Dec. 31, 2014USD ($)Unit	Dec. 31, 2013USD ($)Unit
Summary Of Significant Accounting Policies [Line Items]
Lease period of fee owned properties	20 years
Multiple of cash flows used to estimate fair value of long-lived assets	6.5	6.5	6.5
Multiplication Value to Cash flows for the determination of fair value of Reporting units \| Unit		8	8
Reporting unit percentage of fair value in excesses of carrying value amount		10.00%
Requirements to be classified as capital lease, minimum amount of present value of future minimum lease payments against estimated fair value, percentage	90.00%
Requirements to be classified as capital lease, minimum length of lease term against estimated useful life, percentage	75.00%
General liability claim per occurrence	$ 100	$ 100	$ 250
Annual cap per policy year	2,900	2,670	2,600
Medical claim per occurrence	125
Insurance Reserves	9,039	7,675
Unredeemed gift cards and other advances	11,786	12,233	$ 10,684
Liabilities for advanced sale-type certificates	$ 68,158	$ 63,209
Number of reportable operating segments \| Segment	2
Minimum
Summary Of Significant Accounting Policies [Line Items]
Amortization period of deferred charges and other assets	1 year
Maximum
Summary Of Significant Accounting Policies [Line Items]
Amortization period of deferred charges and other assets	10 years
Trade Names
Summary Of Significant Accounting Policies [Line Items]
Fair value in excess of carrying value percentage		10.00%
U.S. Operating Segment
Summary Of Significant Accounting Policies [Line Items]
Number of reporting unit \| Community	19
International Operating Segment
Summary Of Significant Accounting Policies [Line Items]
Number of reporting unit \| Country	7

Summary of Significant Accoun54

Summary of Significant Accounting Policies - Additional Information (Parenthetical) (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Summary Of Significant Accounting Policies [Line Items]
Accumulated depreciation and amortization	$ 1,182,322	$ 1,098,280
Property Under Capital Lease
Summary Of Significant Accounting Policies [Line Items]
Accumulated depreciation and amortization	$ 150,968	$ 133,022

Intangible Assets and Amortizat

Intangible Assets and Amortization Method (Detail)	12 Months Ended
Intangible Assets and Amortization Method (Detail)	Dec. 31, 2015
Finite-Lived Intangible Assets [Line Items]
Goodwill	Indefinite-lived
Tradename	Indefinite-lived
Vendor Contracts
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Amortization Method	Straight-line method over the terms of the underlying contracts. The remaining terms of the underlying contracts range from two to five years.
Vendor Contracts \| Minimum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	2 years
Vendor Contracts \| Maximum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	5 years
Favorable Unfavorable Leases
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Amortization Method	Based on the pattern in which the economic benefits are realized over the terms of the lease agreements. The remaining terms of the lease agreements range from approximately three to twenty-one years.
Favorable Unfavorable Leases \| Minimum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	3 years
Favorable Unfavorable Leases \| Maximum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	21 years
Other Intangible Assets
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Amortization Method	Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from two to eleven years.
Other Intangible Assets \| Minimum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	2 years
Other Intangible Assets \| Maximum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	11 years

New Accounting Pronouncements -

New Accounting Pronouncements - Additional Information (Detail) - USD ($) $ in Thousands		Dec. 31, 2015	Dec. 31, 2014
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Debt issue costs, net of accumulated amortization	[1]	$ 33,237	$ 31,419

[1]	See Note 2 for discussion of debt issuance costs reclassification upon adoption of ASU 2015-03.

Acquisitions and Dispositions -

Acquisitions and Dispositions - Additional Information (Detail) $ in Thousands	Nov. 15, 2013USD ($)TheatreScreens	Aug. 16, 2013Theatre	May. 29, 2013USD ($)TheatreStateMarketScreens	Apr. 30, 2013USD ($)TheatreScreens	Dec. 31, 2013USD ($)
Rave Theatres
Business Acquisition [Line Items]
Number of theatres acquired \| Theatre			32
Number of screens acquired \| Screens			483
Number of states \| State			1
Purchase price of acquisition			$ 236,875
Number of markets \| Market			7
Transaction costs					$ 500
Weighted average amortization period for the intangible assets acquired			14 years
Rave Divestitures
Business Acquisition [Line Items]
Number of theatres sold \| Theatre		3
Other US Theatres
Business Acquisition [Line Items]
Number of theatres acquired \| Theatre				2
Number of screens acquired \| Screens				30
Purchase price of acquisition				$ 22,372
Mexico Screens Theatre
Business Acquisition [Line Items]
Number of theatres operated by subsidiary \| Theatre	31
Number of screens operated by subsidiary \| Screens	290
Stock purchase agreement, sale of subsidiaries	$ 126,167
Pre-tax gain on sale of subsidiaries					$ 3,521

Fair Value of Identifiable Asse

Fair Value of Identifiable Assets Acquired and Liabilities Assumed as of Acquisition Date (Detail) - USD ($) $ in Thousands	Dec. 31, 2014	May. 29, 2013	Apr. 30, 2013
Business Acquisition [Line Items]
Finite intangible assets	$ 300
Rave Theatres
Business Acquisition [Line Items]
Theatre properties and equipment		$ 102,977
Goodwill		186,418
Capital lease liabilities		(61,651)
Deferred revenue		(6,634)
Total		236,875
Other assets, net of other liabilities		3,896
Rave Theatres \| Favorable leases
Business Acquisition [Line Items]
Finite intangible assets		17,587
Rave Theatres \| Unfavorable leases
Business Acquisition [Line Items]
Finite intangible assets		(30,718)
Rave Theatres \| Trade Names
Business Acquisition [Line Items]
Indefinite intangible assets		$ 25,000
Other US Theatres
Business Acquisition [Line Items]
Theatre properties and equipment			$ 17,524
Goodwill			17,409
Capital lease liabilities			(12,173)
Deferred revenue			(388)
Total			$ 22,372

Unaudited Pro Forma Information

Unaudited Pro Forma Information of Results of Operations as Rave Acquisition had Occurred (Detail) - Rave Theatres $ in Thousands	12 Months Ended
	Dec. 31, 2013USD ($)
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Total revenues	$ 2,777,458
Income before income taxes	$ 275,657

Investment in National CineMe60

Investment in National CineMedia LLC - Additional Information (Detail) $ / shares in Units, $ in Thousands	Feb. 13, 2007USD ($)	Dec. 31, 2015USD ($)$ / shares$ / Customershares	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)
Schedule of Equity Method Investments [Line Items]
Theatre access fees per patron \| $ / Customer		0.07
Increase in percentage of payment per theatre patron		8.00%
Duration of percentage increase in theatre access fees per patron		5 years
Payment per digital screen	$ 800	$ 1,182	$ 1,125	$ 1,072
Percentage of annual increase in payment per digital screen		5.00%
Minimum percentage of aggregate advertising revenue for payment of fees		12.00%
Remaining term of exhibitor services agreement		21 years
Number of common units of NCM owned by Company \| shares		25,631,046
Interest in common units of NCM owned by Company		19.00%
NCM
Schedule of Equity Method Investments [Line Items]
Contract termination costs incurred by NCM		$ 26,800
NCM \| Film rentals and advertising
Schedule of Equity Method Investments [Line Items]
Event fees				$ 8,249
NCM \| Theatre Furniture and Equipment
Schedule of Equity Method Investments [Line Items]
Payment for installation of certain equipment used for digital advertising		$ 50	$ 124
Investment In NCM
Schedule of Equity Method Investments [Line Items]
Common unit convertible into share of NCMI common stock, conversion ratio		1
Estimated fair value of investment using NCMI's stock price		$ 402,664
NCMI stock price \| $ / shares		$ 15.71

Summary of Common Units Receive

Summary of Common Units Received Under Adjustment Agreement (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Schedule of Equity Method Investments [Line Items]
Fair Value of Common Units Received	$ 15,421	$ 8,216	$ 98,797
Annual Common Unit Adjustment
Schedule of Equity Method Investments [Line Items]
Fair Value of Common Units Received	$ 15,421	$ 8,216	$ 8,869
Number of Common Units Received	1,074,910	557,631	588,024
Date Common Units Received	Mar. 31, 2015	Mar. 27, 2014	Mar. 28, 2013
Extraordinary Common Unit Adjustment
Schedule of Equity Method Investments [Line Items]
Fair Value of Common Units Received			$ 89,928
Number of Common Units Received			5,315,837
Date Common Units Received			May 29, 2013

Summary of Activity with NCM In

Summary of Activity with NCM Included in Company's Condensed Consolidated Financial Statements (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Schedule of Equity Method Investments [Line Items]
Receipt of common units due to extraordinary common unit adjustment		$ (15,421)	$ (8,216)	$ (98,797)
Equity in earnings		(28,126)	(22,743)	(22,682)
Equity in other comprehensive income		3,119	(676)	(2,386)
Other Comprehensive Income (Loss)
Schedule of Equity Method Investments [Line Items]
Ending Balance		2,735	(896)	(1,838)
NCM
Schedule of Equity Method Investments [Line Items]
Beginning Balance		178,939
Ending Balance		183,755	178,939
Beginning Balance		(335,219)
Ending Balance		(342,134)	(335,219)
NCM \| Other Comprehensive Income (Loss)
Schedule of Equity Method Investments [Line Items]
Equity in other comprehensive income		2,735	(896)	(1,838)
Investment In NCM
Schedule of Equity Method Investments [Line Items]
Beginning Balance		178,939	178,853	78,123
Value of common units received due to annual common unit adjustment		15,421	8,216	8,869
Receipt of excess cash distributions		(14,072)	(12,574)	(13,166)
Receipt under tax receivable agreement		(2,308)	(2,594)	(492)
Equity in earnings		8,510	6,142	13,753	[1]
Equity in other comprehensive income		(2,735)	896	1,838
Ending Balance		183,755	178,939	178,853
Investment In NCM \| Extraordinary Common Unit Adjustment
Schedule of Equity Method Investments [Line Items]
Receipt of common units due to extraordinary common unit adjustment				89,928
Deferred Revenue
Schedule of Equity Method Investments [Line Items]
Value of common units received due to annual common unit adjustment		(15,421)	(8,216)	(8,869)
Beginning Balance		(335,219)	(334,429)	(241,305)
Ending Balance		(342,134)	(335,219)	(334,429)
Deferred Revenue \| Extraordinary Common Unit Adjustment
Schedule of Equity Method Investments [Line Items]
Receipt of common units due to extraordinary common unit adjustment				(89,928)
Deferred Revenue \| NCM
Schedule of Equity Method Investments [Line Items]
Amortization of deferred revenue		8,506	7,426	5,673
Distributions from NCM
Schedule of Equity Method Investments [Line Items]
Receipt of excess cash distributions		(15,396)	(14,778)	(19,374)
Receipt under tax receivable agreement		(2,744)	(3,763)	(1,327)
Ending Balance		(18,140)	(18,541)	(20,701)
Equity in Earnings
Schedule of Equity Method Investments [Line Items]
Ending Balance		(8,510)	(6,142)	(11,578)
Equity in Earnings \| NCM
Schedule of Equity Method Investments [Line Items]
Equity in earnings		(8,510)	(6,142)	(11,578)	[1]
Other Revenue
Schedule of Equity Method Investments [Line Items]
Revenues earned under ESA	[2]	(11,330)	(9,249)	(7,960)
Ending Balance		(19,836)	(16,675)	(13,633)
Other Revenue \| NCM
Schedule of Equity Method Investments [Line Items]
Amortization of deferred revenue		(8,506)	(7,426)	(5,673)
Cash Received
Schedule of Equity Method Investments [Line Items]
Receipt of excess cash distributions		29,468	27,352	32,540
Receipt under tax receivable agreement		5,052	6,357	1,819
Revenues earned under ESA	[2]	11,330	9,249	7,960
Ending Balance		$ 45,850	$ 42,958	$ 42,319

[1]	A portion of the equity in earnings recorded for the year ended December 31, 2013 was recorded as a reduction in our investment basis in a joint venture (AC JV, LLC) that the Company, along with Regal and AMC, recently formed with NCM. See Note 5.
[2]	Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company's beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company's beverage concessionaire were approximately $11,958, $11,489 and $9,819 for the years ended December 31, 2013, 2014 and 2015, respectively.

Summary of Activity with NCM 63

Summary of Activity with NCM Included in Company's Condensed Consolidated Financial Statements (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Schedule of Equity Method Investments [Line Items]
Company's beverage concessionaire advertising costs	$ 9,819	$ 11,489	$ 11,958

Summary Financial Information f

Summary Financial Information for National Cinemedia (Detail) - NCM - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Oct. 01, 2015	Dec. 31, 2014	Dec. 26, 2013
Schedule of Equity Method Investments [Line Items]
Revenues	$ 310,061	$ 393,994	$ 462,815
Operating income	40,442	159,624	202,019
Net income	38,519	96,309	$ 162,870
Total assets	700,326	681,107
Total liabilities	$ 1,030,243	$ 998,529

Other Investments (Detail)

Other Investments (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Investments in and Advances to Affiliates [Line Items]
Investments in and advances to affiliates	$ 94,973	$ 77,658
Other Affiliates
Investments in and Advances to Affiliates [Line Items]
Investments in and advances to affiliates	94,973	77,658	$ 59,657	$ 38,201
Digital Cinema Implementation Partners LLC \| Other Affiliates
Investments in and Advances to Affiliates [Line Items]
Investments in and advances to affiliates	71,579	51,277	38,033	23,012
RealD
Investments in and Advances to Affiliates [Line Items]
Investments in and advances to affiliates	12,900	14,429
RealD \| Other Affiliates
Investments in and Advances to Affiliates [Line Items]
Investments in and advances to affiliates	12,900	14,429	10,443	13,707
AC JV, LLC \| Other Affiliates
Investments in and Advances to Affiliates [Line Items]
Investments in and advances to affiliates	7,269	7,899	6,426
Digital Cinema Distribution Coalition \| Other Affiliates
Investments in and Advances to Affiliates [Line Items]
Investments in and advances to affiliates	2,562	2,438	2,589	5
Other Investment \| Other Affiliates
Investments in and Advances to Affiliates [Line Items]
Investments in and advances to affiliates	$ 663	$ 1,615	$ 2,166	$ 1,477

Summary of Activity for Each of

Summary of Activity for Each of Investment (Detail) - USD ($) $ in Thousands		1 Months Ended	12 Months Ended
		Dec. 31, 2013	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Schedule of Equity Method Investments [Line Items]
Investments, beginning balance			$ 77,658
Equity in income (loss)			28,126	$ 22,743	$ 22,682
Equity in other comprehensive income(loss)			(3,119)	676	2,386
Investments, ending balance			94,973	77,658
Cash distributions received			(19,027)	(19,172)	(13,658)
RealD
Schedule of Equity Method Investments [Line Items]
Investments, beginning balance			14,429
Investments, ending balance			12,900	14,429
Other Affiliates
Schedule of Equity Method Investments [Line Items]
Investments, beginning balance			77,658	59,657	38,201
Cash contributions			3,711	2,188	6,221
Issuance of promissory note to NCM					8,333
Equity in income (loss)			19,616	16,601	11,104
Equity in other comprehensive income(loss)			(384)	(219)	548
Adjustment for gain recognized by NCM					(2,175)
Unrealized holding gain			(1,529)	3,986	(3,264)
Other changes in investments and joint ventures			(69)	(551)	689
Investments, ending balance		$ 59,657	94,973	77,658	59,657
Cash distributions received			(2,647)	(4,004)
Sale of investment in Taiwan	[1]		(1,383)
Other Affiliates \| Digital Cinema Implementation Partners LLC
Schedule of Equity Method Investments [Line Items]
Investments, beginning balance			51,277	38,033	23,012
Cash contributions			3,211	2,188	3,232
Equity in income (loss)			18,522	15,279	11,241
Equity in other comprehensive income(loss)			(384)	(219)	548
Investments, ending balance		38,033	71,579	51,277	38,033
Cash distributions received			(1,047)	(4,004)
Other Affiliates \| RealD
Schedule of Equity Method Investments [Line Items]
Investments, beginning balance			14,429	10,443	13,707
Unrealized holding gain			(1,529)	3,986	(3,264)
Investments, ending balance		10,443	12,900	14,429	10,443
Other Affiliates \| AC JV, LLC
Schedule of Equity Method Investments [Line Items]
Investments, beginning balance			7,899	6,426
Cash contributions		268			268
Issuance of promissory note to NCM					8,333
Equity in income (loss)			970	1,473
Adjustment for gain recognized by NCM					(2,175)
Investments, ending balance		6,426	7,269	7,899	6,426
Cash distributions received			(1,600)
Other Affiliates \| Digital Cinema Distribution Coalition
Schedule of Equity Method Investments [Line Items]
Investments, beginning balance			2,438	2,589	5
Cash contributions					2,721
Equity in income (loss)			124	(151)	(137)
Investments, ending balance		2,589	2,562	2,438	2,589
Other Affiliates \| Other Investment
Schedule of Equity Method Investments [Line Items]
Investments, beginning balance			1,615	2,166	1,477
Cash contributions			500
Other changes in investments and joint ventures			(69)	(551)	689
Investments, ending balance		$ 2,166	663	$ 1,615	$ 2,166
Sale of investment in Taiwan	[1]		$ (1,383)

[1]	The Company sold its investment in a Taiwan joint venture for approximately $2,634, resulting in a gain of $1,251, which is included in (gain) loss on sale of assets and other for the year ended December 31, 2015.

Summary of Activity for Each 67

Summary of Activity for Each of Investment (Parenthetical) (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2015USD ($)
Schedule of Equity Method Investments [Line Items]
Proceeds from sale of investment in joint venture	$ 2,634
Gain (loss) on sale of assets and other	$ 1,251

Other Investments - Additional

Other Investments - Additional Information (Detail)	1 Months Ended		12 Months Ended
Other Investments - Additional Information (Detail)	Dec. 31, 2013USD ($)	Mar. 31, 2011$ / shares	Dec. 31, 2015USD ($)ProjectionSystemRenewalOptions$ / sharesshares	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)	Dec. 31, 2012USD ($)
Schedule of Equity Method Investments [Line Items]
Number of shares owned in RealD \| shares			1,222,780
Exercise price of options, shares \| $ / shares		$ 0.00667
Book value of investment			$ 94,973,000	$ 77,658,000
Other Affiliates
Schedule of Equity Method Investments [Line Items]
Book value of investment	$ 59,657,000		94,973,000	77,658,000	$ 59,657,000	$ 38,201,000
Cash contributions			$ 3,711,000	2,188,000	6,221,000
Digital Cinema Implementation Partners LLC
Schedule of Equity Method Investments [Line Items]
Percentage of voting interest			33.00%
Economic interest in Digital Cinema Implementation Partners			24.30%
Digital projection systems leased under operating lease, initial term			12 years
Number of equipment being leased under master equipment lease agreement \| ProjectionSystem			3,781
Number of one-year fair value renewal options \| RenewalOptions			10
Minimum annual rent per digital projection system			$ 1,000
Digital Cinema Implementation Partners LLC \| Other Affiliates
Schedule of Equity Method Investments [Line Items]
Book value of investment	38,033,000		71,579,000	51,277,000	38,033,000	23,012,000
Cash contributions			3,211,000	2,188,000	3,232,000
AC JV, LLC \| Other Affiliates
Schedule of Equity Method Investments [Line Items]
Book value of investment	$ 6,426,000		7,269,000	7,899,000	6,426,000
Ownership of class A units sold to Founding Members	97.00%
Cash contributions	$ 268,000				$ 268,000
Ownership of class A units	1.00%
Ownership of class A units					31.00%
Aggregate value of Class A units					$ 25,000,000
Promissory note term					6 years
Original principal value of promissory note with NCM					$ 8,333,000
Annual Interest rate on promissory note	5.00%				5.00%
Remaining outstanding balance of note payable			5,555,000
AC JV, LLC \| Film rentals and advertising
Schedule of Equity Method Investments [Line Items]
Event fees			$ 11,440,000	9,273,000
Digital Cinema Distribution Coalition
Schedule of Equity Method Investments [Line Items]
Percentage of voting interest			14.60%
Payments for content delivery services			$ 807,000	741,000
Digital Cinema Distribution Coalition \| Other Affiliates
Schedule of Equity Method Investments [Line Items]
Book value of investment	$ 2,589,000		$ 2,562,000	2,438,000	$ 2,589,000	5,000
Cash contributions					2,721,000
RealD
Schedule of Equity Method Investments [Line Items]
Common stock price \| $ / shares			$ 10.55
Book value of investment			$ 12,900,000	14,429,000
RealD \| Other Affiliates
Schedule of Equity Method Investments [Line Items]
Book value of investment	$ 10,443,000		$ 12,900,000	$ 14,429,000	$ 10,443,000	$ 13,707,000

Summary Financial Information69

Summary Financial Information for DCIP (Detail) - Digital Cinema Implementation Partners LLC - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Schedule of Equity Method Investments [Line Items]
Net operating revenue	$ 171,203	$ 170,724	$ 182,659
Operating income	103,449	101,956	116,235
Net income	79,255	61,293	$ 48,959
Total assets	1,004,292	1,097,467
Total liabilities	$ 674,727	$ 845,319

Transactions with DCIP (Detail)

Transactions with DCIP (Detail) - Digital Cinema Implementation Partners LLC - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Schedule of Equity Method Investments [Line Items]
Equipment lease payments	$ 4,474	$ 4,012	$ 3,853
Warranty reimbursements from DCIP	$ (4,329)	$ (3,169)	$ (1,893)

Summary of Goodwill (Detail)

Summary of Goodwill (Detail) - USD ($) $ in Thousands		12 Months Ended
Summary of Goodwill (Detail) - USD ($) $ in Thousands		Dec. 31, 2015	Dec. 31, 2014
Goodwill [Line Items]
Beginning Balance	[1]	$ 1,277,383	$ 1,288,090
Acquisitions of theatres		356	6,085
Other acquisitions			1,108
Foreign currency translation adjustments		(30,191)	(17,900)
Ending Balance	[1]	1,247,548	1,277,383
U.S. Operating Segment
Goodwill [Line Items]
Beginning Balance	[1]	1,156,556	1,150,471
Acquisitions of theatres			6,085
Ending Balance	[1]	1,156,556	1,156,556
International Operating Segment
Goodwill [Line Items]
Beginning Balance	[1]	120,827	137,619
Acquisitions of theatres		356
Other acquisitions			1,108
Foreign currency translation adjustments		(30,191)	(17,900)
Ending Balance	[1]	$ 90,992	$ 120,827

[1]	Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.

Summary of Goodwill (Parentheti

Summary of Goodwill (Parenthetical) (Detail) $ in Thousands	Dec. 31, 2015USD ($)
U.S. Operating Segment
Goodwill [Line Items]
Accumulated impairment losses	$ 214,031
International Operating Segment
Goodwill [Line Items]
Accumulated impairment losses	$ 27,622

Intangible Assets (Detail)

Intangible Assets (Detail) - USD ($) $ in Thousands	12 Months Ended
Intangible Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2015		Dec. 31, 2014
Intangible Assets [Line Items]
Intangible assets with finite lives, Beginning balance	$ 99,922		$ 101,617
Net intangible assets with finite lives, Beginning balance	47,690		55,320
Intangible assets with finite lives, Accumulated amortization, Ending balance	(59,706)		(52,232)
Other Accumulated Amortization of Intangible Assets	(1,758)	[1]	12	[2]
Accumulated amortization	(5,716)		(5,947)
Intangible assets with finite lives, Accumulated amortization, Beginning balance	(52,232)		(46,297)
Accumulated amortization acquisitions			0
Other, Gross carrying amount	46	[1]	(1,995)	[2]
Intangible assets with finite lives, Ending balance	99,968		99,922
Intangible assets with finite lives, acquisitions			300
Amortization, intangible assets	(5,716)		(5,947)
Other, Finite lived intangible assets	(1,712)	[1]	(1,983)	[2]
Net intangible assets with finite lives, Ending balance	40,262		47,690
Indefinite-lived Intangible Assets, Trade name, Beginning Balance	300,334		300,824
Intangible Assets, Trade name, acquisitions			0
Other, Trade name	(952)	[1]	(490)	[2]
Indefinite-lived Intangible Assets, Trade name, Ending Balance	299,382		300,334
Total intangible assets - net, Beginning balance	348,024		356,144
Total intangible assets - net, acquisitions			300
Accumulated amortization	(5,716)		(5,947)
Other, Total intangible assets - net	(2,664)	[1]	(2,473)	[2]
Total intangible assets - net, Ending balance	$ 339,644		$ 348,024

[1]	Activity for 2015 primarily consists of the write-off of intangible assets for closed theatres, the write-off of a vendor contract intangible asset, $992 for impairment of a favorable lease and foreign currency translation adjustments.
[2]	Activity for 2014 primarily consists of $479 for impairment of a tradename intangible asset related to one U.S. theatre and foreign currency translation adjustments.

Intangible Assets (Parenthetica

Intangible Assets (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Intangible Assets [Line Items]
Impairment of finite lived assets	$ 992	$ 479	$ 708

Estimated Aggregate Future Amor

Estimated Aggregate Future Amortization Expense for Intangible Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]
For the year ended December 31, 2016	$ 5,389
For the year ended December 31, 2017	4,857
For the year ended December 31, 2018	4,857
For the year ended December 31, 2019	3,977
For the year ended December 31, 2020	4,252
Thereafter	16,930
Total	$ 40,262	$ 47,690	$ 55,320

Long-Lived Asset Impairment Cha

Long-Lived Asset Impairment Charges (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Impaired Long-Lived Assets Held and Used [Line Items]
Theatre properties	$ 7,809	$ 6,168	$ 3,086
Intangible assets	992	479	708
Impairment of long-lived assets	8,801	6,647	3,794
U.S. Operating Segment
Impaired Long-Lived Assets Held and Used [Line Items]
Theatre properties	7,052	$ 6,168	1,911
International Operating Segment
Impaired Long-Lived Assets Held and Used [Line Items]
Theatre properties	$ 757		$ 1,175

Impairment of Long-Lived Asse77

Impairment of Long-Lived Assets - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2015USD ($)
Indefinite-lived Intangible Assets [Line Items]
Estimated aggregate fair value of long-lived assets impaired during current period	$ 8,395

Deferred Charges and Other As78

Deferred Charges and Other Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Other Noncurrent Assets Disclosure [Line Items]
Long-term prepaid rents	$ 4,278	$ 7,296
Construction and other deposits	8,459	14,171
Equipment to be placed in service	15,388	14,124
Other	10,118	10,980
Total	$ 38,243	$ 46,571

Long-Term Debt (Detail)

Long-Term Debt (Detail) - USD ($) $ in Thousands		Dec. 31, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Cinemark USA, Inc. term loan		$ 679,000	$ 686,000
Other	[1]	5,572	6,997
Total long-term debt		1,814,572	1,822,997
Less current portion		8,405	8,423
Less debt issuance costs, net of accumulated amortization of $10,918 and $16,058, respectively	[2]	33,237	31,419
Long-term debt, less current portion		1,772,930	1,783,155
4.875 % Senior Notes Due May 2023
Debt Instrument [Line Items]
Senior notes		530,000	530,000
5.125% Senior Notes Due 2022
Debt Instrument [Line Items]
Senior notes		400,000	400,000
7.375% Senior Subordinated Notes Due 2021
Debt Instrument [Line Items]
Senior subordinated notes		$ 200,000	$ 200,000

[1]	Primarily represents debt owed to NCM in relation to the recently-formed joint venture AC JV, LLC. See Note 5.
[2]	See Note 2 for discussion of debt issuance costs reclassification upon adoption of ASU 2015-03.

Long-Term Debt (Parenthetical)

Long-Term Debt (Parenthetical) (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Debt issuance costs, accumulated amortization	$ 16,058	$ 10,918

Long-Term Debt - Additional Inf

Long-Term Debt - Additional Information (Detail)	May. 08, 2015USD ($)	Jun. 24, 2013USD ($)	May. 24, 2013USD ($)	Jun. 29, 2009USD ($)	Jun. 03, 2011USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)	Dec. 31, 2012	Dec. 18, 2012USD ($)
Debt Instrument [Line Items]
Incurred debt issue costs						$ 6,957,000		$ 9,328,000
Loss on amendment to debt agreement						$ 925,000
Percentage voting stock of foreign subsidiaries						65.00%
Multiple consolidated interest expense under subcondition two of condition two under dividend restriction						1.75
Amount outstanding under the term loan						$ 679,000,000	$ 686,000,000
Loss on early retirement of debt								$ 72,302,000
Carrying value of long-term debt						1,814,572,000	1,822,997,000
Fair value of long-term debt						1,806,276,000	1,790,987,000
Debt issuance cost						33,237,000	31,419,000
Senior Secured Credit Facility \| Term Loan Credit Facility
Debt Instrument [Line Items]
Aggregate principal amount issued						$ 700,000
Maturity period						7 years
Percentage of Variable rate added to federal funds effective rate						0.50%
Senior Secured Credit Facility \| Term Loan Credit Facility \| Minimum
Debt Instrument [Line Items]
Percentage of Variable margin rate added to federal funds effective rate						1.00%
Percentage of variable margin rate added to eurodollar rate						2.00%
Senior Secured Credit Facility \| Term Loan Credit Facility \| Maximum
Debt Instrument [Line Items]
Percentage of Variable margin rate added to federal funds effective rate						1.75%
Percentage of variable margin rate added to eurodollar rate						2.75%
Senior Secured Credit Facility \| Revolving Credit Line
Debt Instrument [Line Items]
Aggregate principal amount issued						$ 100,000
Maturity period						5 years
Percentage of Variable rate added to federal funds effective rate						0.50%
Senior Secured Credit Facility \| Revolving Credit Line \| Minimum
Debt Instrument [Line Items]
Percentage of Variable margin rate added to federal funds effective rate						1.00%
Percentage of variable margin rate added to eurodollar rate						2.00%
Senior Secured Credit Facility \| Revolving Credit Line \| Maximum
Debt Instrument [Line Items]
Percentage of Variable margin rate added to federal funds effective rate						1.75%
Percentage of variable margin rate added to eurodollar rate						2.75%
Amended Senior Secured Credit Facility
Debt Instrument [Line Items]
Quarterly principal payments due	$ 1,750,000
Last Quarterly Payment date	Mar. 31, 2022
Remaining principal	$ 635,250,000
Incurred debt issue costs						$ 6,875,000
Loss on amendment to debt agreement						925,000
Amended senior secured credit facility, dividend that could have distributed						1,905,096,000
Amended Senior Secured Credit Facility \| Term Loan Credit Facility
Debt Instrument [Line Items]
Aggregate principal amount issued	$ 700,000,000
Maturity latest date	May 8, 2022
Amount outstanding under the term loan						$ 679,000,000
Average interest rate on outstanding borrowings						3.60%
Amended Senior Secured Credit Facility \| Revolving Credit Line
Debt Instrument [Line Items]
Available borrowing capacity						$ 100,000,000
Amount outstanding under the revolving credit line						$ 0	$ 0
4.875 % Senior Notes Due May 2023
Debt Instrument [Line Items]
Aggregate principal amount issued			$ 530,000,000
Interest rate			4.875%
Debt instrument, maturity date			Jun. 1, 2023
Debt instrument, interest payment date			Dec. 1, 2013
Price to repurchase the senior subordinated notes as a percentage of the aggregate principal amount outstanding plus accrued and unpaid interest in case of change of control						101.00%
Debt covenants, required minimum coverage ratio						200.00%
Actual coverage ratio						7.70%
Senior notes indenture, amount that could have distributed						$ 2,079,680
Maximum percentage of principal amount of the senior subordinated notes that can be redeemed prior to specific date						35.00%
Price to repurchase the senior notes as a percentage of principal amount plus a make-whole premium in case of redemption at option of company prior to specific date						100.00%
5.125% Senior Notes Due 2022
Debt Instrument [Line Items]
Aggregate principal amount issued										$ 400,000,000
Interest rate										5.125%
Price to repurchase the senior subordinated notes as a percentage of the aggregate principal amount outstanding plus accrued and unpaid interest in case of change of control						101.00%
Debt covenants, required minimum coverage ratio						200.00%
Actual coverage ratio						7.70%
Senior notes indenture, amount that could have distributed						$ 2,083,985
Maximum percentage of principal amount of the senior subordinated notes that can be redeemed prior to specific date						35.00%
Price to repurchase the senior notes as a percentage of principal amount plus a make-whole premium in case of redemption at option of company prior to specific date						100.00%
Maturity date									Dec. 15, 2022
7.375% Senior Subordinated Notes Due 2021
Debt Instrument [Line Items]
Aggregate principal amount issued					$ 200,000,000
Interest rate					7.375%
Debt instrument, maturity date					Jun. 15, 2021
Price to repurchase the senior subordinated notes as a percentage of the aggregate principal amount outstanding plus accrued and unpaid interest in case of change of control						101.00%
Debt covenants, required minimum coverage ratio						200.00%
Actual coverage ratio						7.70%
Senior notes indenture, amount that could have distributed						$ 2,072,800
Maximum percentage of principal amount of the senior subordinated notes that can be redeemed prior to specific date						35.00%
Price to repurchase the senior subordinated notes as a percentage of principal amount plus a make-whole premium in case of redemption at option of company prior to specific date						100.00%
8.625% senior note
Debt Instrument [Line Items]
Aggregate principal amount issued				$ 470,000,000
Interest rate				8.625%
Proceed from Issuance of Debt Instrument				$ 458,532,000
Discount on issue		$ 8,054,000		$ 11,468,000
Percentage of debt repayment premium		112.035%
Write off of unamortization of debt issuance cost		$ 7,634,000
Early retirement of debt		56,564,000
Loss on early retirement of debt		$ 50,000

Long-Term Debt Maturities (Deta

Long-Term Debt Maturities (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Long Term Debt Maturities Repayments Of Principal [Line Items]
2,016	$ 8,405
2,017	8,389
2,018	8,389
2,019	8,389
2,020	7,000
Thereafter	1,774,000
Total	$ 1,814,572	$ 1,822,997

Interest Rate Swap Agreement -

Interest Rate Swap Agreement - Additional Information (Detail)	Dec. 31, 2015Agreement
Derivative [Line Items]
Number of interest rate swap agreements	1

Summary of Interest Rate Swap A

Summary of Interest Rate Swap Agreement Designated as Hedge Agreement (Detail) - Interest Rate Swap Agreement One $ in Thousands	12 Months Ended
	Dec. 31, 2015USD ($)
Interest Rate Swaps [Line Items]
Nominal Amount	$ 100,000
Effective Date	Nov. 1, 2011
Pay Rate	1.715%
Receive Rate	1-Month LIBOR
Expiration Date	Apr. 1, 2016
Estimated Total Fair Value at December 31, 2015	$ 373	[1]

[1]	Included in accrued other current liabilities on the consolidated balance sheet as of December 31, 2015.

Changes in Accumulated Other Co

Changes in Accumulated Other Comprehensive Loss, Net of Taxes, Related to Interest Rate Swap Agreements (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications, net of taxes	$ 2,636	$ 2,846	$ 3,151
Interest Rate Swap
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balances	(2,870)	(5,716)	(8,867)
Other comprehensive income (loss) before reclassifications, net of taxes	(2,154)	(3,169)	(2,668)
Amounts reclassified from accumulated other comprehensive loss to interest expense, net of taxes	4,790	6,015	5,819
Net other comprehensive income	2,636	2,846	3,151
Ending balances	$ (234)	$ (2,870)	$ (5,716)

Summary of Assets and Liabiliti

Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swap liabilities - current	$ (373)	$ (4,255)
Interest rate swap liabilities - long term		(317)
Other investments	94,973	77,658
RealD
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other investments	12,900	14,429
Level 1 \| RealD
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other investments	12,900	14,429
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swap liabilities - current	$ (373)	(4,255)
Interest rate swap liabilities - long term		$ (317)

Reconciliation of Beginning and

Reconciliation of Beginning and Ending Balance for Liabilities Measured at Fair Value on Recurring Basis Unobservable Inputs (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balances - Liabilities	$ 4,572	$ 9,176
Total (gain) loss included in accumulated other comprehensive loss	(155)	1,411
Settlements	(4,790)	(6,015)
Ending balance - Liabilities	$ 373	$ 4,572

Foreign Currency Translation -

Foreign Currency Translation - Additional Information (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014	Nov. 30, 2013
Foreign Currency Translation [Line Items]
Accumulated other comprehensive income (loss)	$ (271,686)	$ (144,772)
Cumulative foreign currency adjustments	$ (273,404)	$ (147,930)
Mexico
Foreign Currency Translation [Line Items]
Accumulated other comprehensive income (loss)			$ (22,088)

Summary of Impact of Translatin

Summary of Impact of Translating Financial Statements of Certain of Company's International Subsidiaries (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)
Brazil
Foreign Currency Translation [Line Items]
Exchange Rate	3.96	2.69	2.36
Other comprehensive Income (Loss)	$ (74,559)	$ (30,723)	$ (34,451)
Colombia
Foreign Currency Translation [Line Items]
Exchange Rate	3,149.47	2,392.46	1,926.83
Other comprehensive Income (Loss)	$ (8,043)	$ (7,632)	$ (2,969)
Argentina
Foreign Currency Translation [Line Items]
Exchange Rate	12.95	8.55	6.52
Other comprehensive Income (Loss)	$ (30,520)	$ (20,197)	$ (24,845)
Chile
Foreign Currency Translation [Line Items]
Exchange Rate	709.16	606.2	525.5
Other comprehensive Income (Loss)	$ (6,572)	$ (5,580)	$ (3,570)
All Other
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)	$ (898)	$ (2,066)	$ (185)
Peru
Foreign Currency Translation [Line Items]
Exchange Rate	3.46	3.05	2.84
Other comprehensive Income (Loss)	$ (4,882)	$ (2,785)	$ (3,685)
Mexico
Foreign Currency Translation [Line Items]
Impact of sale of Mexican subsidiaries on other comprehensive income loss			22,088
Total International Subsidiaries \| Cinemark USA, Inc. Stockholder's Equity
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)	$ (125,474)	$ (68,983)	$ (47,617)

Non-controlling Interests in Su

Non-controlling Interests in Subsidiaries (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Noncontrolling Interest [Line Items]
Noncontrolling interests	$ 11,105	$ 10,329
Cinemark Partners II
Noncontrolling Interest [Line Items]
Noncontrolling interests	7,753	7,769
Laredo Theatres
Noncontrolling Interest [Line Items]
Noncontrolling interests	1,761	1,112
Greeley Ltd
Noncontrolling Interest [Line Items]
Noncontrolling interests	740	589
Other
Noncontrolling Interest [Line Items]
Noncontrolling interests	$ 851	$ 859

Non-controlling Interests in 91

Non-controlling Interests in Subsidiaries (Parenthetical) (Detail)	Dec. 31, 2015	Dec. 31, 2014
Cinemark Partners II
Noncontrolling Interest [Line Items]
Ownership share	24.60%	24.60%
Laredo Theatres
Noncontrolling Interest [Line Items]
Ownership share	25.00%	25.00%
Greeley Ltd
Noncontrolling Interest [Line Items]
Ownership share	49.00%	49.00%

Noncontrolling Interests in S92

Noncontrolling Interests in Subsidiaries - Additional Information (Detail) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Aug. 31, 2013	Dec. 31, 2013
Noncontrolling Interest [Line Items]
Percentage of share purchased	49.90%
Purchase of noncontrolling interest	$ 5,621
Decrease in additional paid-in-capital		$ 5,621
Ownership percentage	100.00%
Cinemark USA, Inc. Stockholder's Equity
Noncontrolling Interest [Line Items]
Decrease in additional paid-in-capital	$ 4,618	$ 4,618

Summary of Impact of Changes in

Summary of Impact of Changes in Company's Ownership Interests in Subsidiary (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Noncontrolling Interest [Line Items]
Net income attributable to Cinemark USA, Inc.	$ 218,532	$ 194,380	$ 149,843
Net transfers from non-controlling interests			(4,618)
Change from net income attributable to Cinemark USA, Inc. and transfers from noncontrolling interests	$ 218,532	$ 194,380	145,225
Brazil
Noncontrolling Interest [Line Items]
Decrease in Cinemark USA, Inc. additional paid-in-capital for the buyout of noncontrolling interests			$ (4,618)

Capital Stock - Additional Info

Capital Stock - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Stockholders Equity Note [Line Items]
Preferred stock, shares	1,000,000
Preferred stock, par value	$ 1
Preferred stock, issued	0
Preferred stock, outstanding	0
Intrinsic value of options exercised		$ 296	$ 168
Tax benefit recognized on stock option exercised		$ 124	$ 71
Class A common stock
Stockholders Equity Note [Line Items]
Common stock, shares outstanding	1,500	1,500
Class B Common Stock
Stockholders Equity Note [Line Items]
Common stock, shares outstanding	182,648	182,648
Restricted Stock
Stockholders Equity Note [Line Items]
Shares of Restricted Stock, Granted	226,212	269,774	271,532
Weighted average grant date fair value per share	$ 42.79	$ 28.93	$ 30.09
Minimum forfeiture rate for restricted stock awards	0.00%
Maximum forfeiture rate for restricted stock awards	10.00%
Unrecognized compensation expense	$ 11,944
Compensation expense recognition period (in years)	2 years
Restricted Stock \| Cinemark USA Inc
Stockholders Equity Note [Line Items]
Unrecognized compensation expense	$ 11,490
Restricted Stock \| Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Unrecognized compensation expense	$ 454
Restricted Stock \| Director
Stockholders Equity Note [Line Items]
Award vesting period for restricted stock granted	1 year
Restricted Stock \| Minimum
Stockholders Equity Note [Line Items]
Weighted average grant date fair value per share	$ 40.75
Restricted Stock \| Minimum \| Employees
Stockholders Equity Note [Line Items]
Award vesting period for restricted stock granted	1 year
Restricted Stock \| Maximum
Stockholders Equity Note [Line Items]
Weighted average grant date fair value per share	$ 43.28
Restricted Stock \| Maximum \| Employees
Stockholders Equity Note [Line Items]
Award vesting period for restricted stock granted	4 years
Restricted Stock Units
Stockholders Equity Note [Line Items]
Weighted average grant date fair value per share	$ 43.19	$ 28.54	$ 29.44
Unrecognized compensation expense	$ 6,600
Compensation expense recognition period (in years)	2 years
Number of hypothetical shares of common stock issued to employees	142,917	197,515	115,107
Percentage of IRR, which is the threshold	8.50%
Estimated IRR level for grant	10.50%
Percentage of IRR, which is the maximum	12.50%
Percentage of restricted stock units vest	100.00%
Percentage of IRR expected	11.50%
Number of hypothetical shares of common stock	544,076
Actual cumulative forfeitures (in units)	22,985
Restricted Stock Units \| Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Stock price at the date of modification	$ 33.02
Incremental compensation cost	$ 2,460
Restricted Stock Units \| 2015 Grants
Stockholders Equity Note [Line Items]
Estimated IRR level for grant	9.50%
Restricted Stock Units \| 2012 Grants
Stockholders Equity Note [Line Items]
Actual IRR calculated for grant	11.10%
Restricted Stock Units \| Minimum
Stockholders Equity Note [Line Items]
Expected forfeiture rate	0.00%
Restricted Stock Units \| Maximum
Stockholders Equity Note [Line Items]
Expected forfeiture rate	5.00%

Summary of Stock Option Activit

Summary of Stock Option Activity (Detail) - $ / shares	12 Months Ended
Summary of Stock Option Activity (Detail) - $ / shares	Dec. 31, 2014	Dec. 31, 2013
Number of Options
Number of Options, Beginning balance	14,584	22,022
Number of Options, Exercised	(14,584)	(7,438)
Number of Options, Ending balance		14,584
Number of Options Vested at December 31,		14,584
Weighted Average Exercise Price
Weighted Average Exercise Price, Beginning balance	$ 7.63	$ 7.63
Weighted Average Exercise Price, Exercised	$ 7.63	7.63
Weighted Average Exercise Price, Ending balance		7.63
Weighted Average Exercise Price, Options vested		$ 7.63

Summary of Restricted Stock Act

Summary of Restricted Stock Activity (Detail) - Restricted Stock - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Shares of Restricted Stock
Shares of Restricted Stock, Beginning balance	878,897	1,260,913	1,534,163
Shares of Restricted Stock, Granted	226,212	269,774	271,532
Shares of Restricted Stock, Vested	(329,437)	(625,843)	(522,129)
Shares of Restricted Stock, Forfeited	(17,897)	(25,947)	(22,653)
Shares of Restricted Stock, Ending balance	757,775	878,897	1,260,913
Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value Outstanding, Beginning	$ 24.92	$ 21.86	$ 18.85
Weighted Average Grant Date Fair Value, Granted	42.79	28.93	30.09
Weighted Average Grant Date Fair Value, Vested	23.72	20.53	17.27
Weighted Average Grant Date Fair Value, Forfeited	27.58	22.94	22.92
Weighted Average Grant Date Fair Value Outstanding, Ending	$ 30.73	$ 24.92	$ 21.86

Summary of Restricted Stock Awa

Summary of Restricted Stock Award Activity (Detail) - Restricted Stock - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized during the period	[1]	$ 8,715	$ 8,591	$ 11,898
Fair value of restricted shares that vested during the period	[2]	13,276	17,692	9,161
Income tax deduction upon vesting of restricted stock awards	[3]	$ 3,341	$ 5,171	$ 3,848

[1]	Cinemark Holdings, Inc. recorded an additional $840, $943 and $885 of compensation expense related to these restricted stock awards during the years ended December 31, 2013, 2014 and 2015, respectively.
[2]	The fair value of shares in which Cinemark Holdings, Inc.'s directors vested was $1,000, $1,081 and $1,148 during the years ended December 31, 2013, 2014 and 2015, respectively.
[3]	Cinemark Holdings, Inc. recognized an additional tax benefit of $420, $454 and $482 on these vested awards during the years ended December 31, 2013, 2014 and 2015, respectively.

Summary of Restricted Stock A98

Summary of Restricted Stock Award Activity (Parenthetical) (Detail) - Restricted Stock - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized by the Company during the period	[1]	$ 8,715	$ 8,591	$ 11,898
Fair value of restricted shares that vested during the period	[2]	13,276	17,692	9,161
Income tax deduction upon vesting of restricted stock awards	[3]	3,341	5,171	3,848
Cinemark Holdings, Inc.
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized by the Company during the period		885	943	840
Fair value of restricted shares that vested during the period		1,148	1,081	1,000
Income tax deduction upon vesting of restricted stock awards		$ 482	$ 454	$ 420

[1]	Cinemark Holdings, Inc. recorded an additional $840, $943 and $885 of compensation expense related to these restricted stock awards during the years ended December 31, 2013, 2014 and 2015, respectively.
[2]	The fair value of shares in which Cinemark Holdings, Inc.'s directors vested was $1,000, $1,081 and $1,148 during the years ended December 31, 2013, 2014 and 2015, respectively.
[3]	Cinemark Holdings, Inc. recognized an additional tax benefit of $420, $454 and $482 on these vested awards during the years ended December 31, 2013, 2014 and 2015, respectively.

Summary of Potential Number of

Summary of Potential Number of Shares Vesting under Restricted Stock Unit Awards (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Schedule of Restricted Stock Unit [Line Items]
Number of units at IRR level of at least 8.5%		38,366	65,832	47,640
Number of units at IRR level of at least 10.5%		76,741	131,683	95,282
Number of units at IRR level of at least 12.5%		115,107	197,515	142,917
Fair value of units at IRR level of at least 8.5%	[1]	$ 1,129	$ 1,879	$ 2,057
Fair value of units at IRR level of at least 10.5%	[1]	2,259	3,758	4,115
Fair value of units at IRR level of at least 12.5%	[1]	$ 3,389	$ 5,637	$ 6,173
At IRR of at least 7.5%		47,640	65,832	38,366
At IRR of at least 9.5%		95,282	131,683	76,741
At IRR of at least 11.5%		142,917	197,515	115,107
IRR of at least 7.5%		$ 2,057	$ 1,879	$ 1,129
IRR of at least 9.5%		4,115	3,758	2,259
IRR of at least 11.5%		$ 6,173	$ 5,637	$ 3,389

[1]	The weighted average grant date fair values for units issued during the years ended December 31, 2013, 2014, and 2015 were $29.44, $28.54 and $43.19, respectively.

Summary of Potential Number 100

Summary of Potential Number of Shares Vesting under Restricted Stock Unit Awards (Parenthetical) (Detail) - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Restricted Stock Units
Schedule of Restricted Stock Unit [Line Items]
Weighted average grant date fair value per share	$ 43.19	$ 28.54	$ 29.44

Summary of Restricted Stock Uni

Summary of Restricted Stock Unit Award Activity (Detail) - Restricted Stock Units - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of restricted stock unit awards that vested during the period	123,769	395,751	295,751
Fair value of share based awards that vested during the period	$ 5,483	$ 11,420	$ 8,723
Accumulated dividends paid upon vesting of restricted stock unit awards	442	1,352	939
Income tax benefit recognized upon vesting of share based awards	2,303	4,796	3,663
Compensation expense recognized during the period	$ 6,158	$ 3,284	$ 4,148

Supplemental Information to Con

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Schedule of Cash Flow, Supplemental [Line Items]
Cash paid for interest		$ 105,155	$ 107,926	$ 116,890
Cash paid for income taxes, net of refunds received		108,435	122,972	136,124
Noncash investing and financing activities:
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment	[1]	2,491	(1,225)	(7,325)
Theatre properties and equipment acquired under capital lease		36,544	19,908	69,541
Investment in NCM - receipt of common units (see Note 4)		15,421	8,216	98,797
Noncash distributions to Cinemark Holdings, Inc.		(17,935)	$ 0	(4,971)
Receipt of promissory note related to sale of investment in Taiwan joint venture		2,634
Other Affiliates
Noncash investing and financing activities:
Issuance of promissory note related to investment in AC JV, LLC (see Note 5)				(8,333)
Other Affiliates \| AC JV, LLC
Noncash investing and financing activities:
Investment in AC JV, LLC (see Note 5)				8,333
Issuance of promissory note related to investment in AC JV, LLC (see Note 5)				$ (8,333)
Other Affiliates \| Taiwan Joint Venture
Noncash investing and financing activities:
Receipt of promissory note related to sale of investment in Taiwan joint venture		$ 2,304

[1]	Additions to theatre properties and equipment included in accounts payable as of December 31, 2014 and 2015 were $13,235 and $10,744, respectively.

Supplemental Information to 103

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Schedule of Cash Flow, Supplemental [Line Items]
Additions to theatre properties and equipment included in accounts payable	$ 10,744	$ 13,235

Income Before Income Taxes (Det

Income Before Income Taxes (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Taxes [Line Items]
Income before income taxes	$ 262,336	$ 208,377	$ 164,904
Income before income taxes	88,015	84,542	101,177
Income before income taxes	350,351	292,919	266,081
Current:
Federal	72,185	62,686	98,206
Foreign	35,874	27,681	42,690
State	10,806	6,256	11,056
Total current expense	118,865	96,623	151,952
Deferred:
Federal	10,420	6,322	(30,833)
Foreign	(3,339)	(6,437)	2,653
State	4,014	642	(9,612)
Total deferred taxes	11,095	527	(37,792)
Income taxes	$ 129,960	$ 97,150	$ 114,160

Reconciliation between Income T

Reconciliation between Income Tax Expenses (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Taxes [Line Items]
Computed statutory tax expense	$ 122,623	$ 102,522	$ 93,128
Foreign inflation adjustments	(1,295)	641	67
State and local income taxes, net of federal income tax impact	9,640	4,634	858
Foreign losses not benefited and other changes in valuation allowance	(2,408)	(275)	(2,052)
Foreign tax rate differential	(2,660)	(2,125)	(336)
Foreign dividends		1,083	3,294
Sale of Mexican subsidiaries and related changes in intangible assets		(10,065)	21,406
Changes in uncertain tax positions	3,717	(1,540)	(2,024)
Other - net	343	2,275	(181)
Income taxes	$ 129,960	$ 97,150	$ 114,160

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Income Tax [Line Items]
Undistributed earnings	$ 316,000
Gross unrecognized tax benefits, including interest and penalties	17,008	$ 15,693
Unrecognized tax benefit that if recognized would impact effective tax rate	17,008	15,693
Accrued for interest and penalties	$ 3,198	$ 2,500
Foreign \| Minimum
Income Tax [Line Items]
Tax credit carryforwards expiring year	2,015
State and Local Jurisdiction [Member] \| Minimum
Income Tax [Line Items]
Net operating losses carried forward expiring period	5 years
State and Local Jurisdiction [Member] \| Maximum
Income Tax [Line Items]
Net operating losses carried forward expiring period	20 years
Net operating losses carried forward expiring year	2,035

Net Long- Term Deferred Income

Net Long- Term Deferred Income Tax Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Deferred liabilities:
Theatre properties and equipment	$ 141,155	$ 127,010
Tax impact of items in accumulated other comprehensive income (loss)	158	55
Intangible asset - other	28,889	29,342
Intangible asset - tradenames	112,413	111,726
Investment in partnerships	108,733	111,328
Total deferred liabilities	391,348	379,461
Deferred assets:
Deferred lease expenses	26,966	27,341
Exchange loss	3,736
Deferred revenue - NCM	128,642	124,366
Capital lease obligations	75,966	73,306
Tax loss carryforwards	7,379	7,764
Alternative minimum tax and other credit carryforwards	41,300	43,384
Other expenses, not currently deductible for tax purposes	20,204	25,807
Total deferred assets	304,193	301,968
Net deferred income tax liability before valuation allowance	87,155	77,493
Valuation allowance against deferred assets - current		2,384
Valuation allowance against deferred assets - non-current	50,636	50,489
Net deferred income tax liability	137,791	130,366
Foreign
Deferred assets:
Net deferred income tax liability	4,212	12,213
U.S.
Deferred assets:
Net deferred income tax liability	$ 133,579	$ 118,153

Reconciliation of Unrecognized

Reconciliation of Unrecognized Tax Benefits (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Reconciliation of Unrecognized Tax Benefits [Line Items]
Beginning Balance	$ 16,515	$ 18,780	$ 33,222
Gross increases-tax positions in prior periods	40	10	413
Gross decreases-tax positions in prior periods		(2,379)
Gross increases - current period tax positions	2,112	1,324	1,476
Gross decreases - current period tax positions	0	0	0
Settlements	(871)	(963)	(15,444)
Foreign currency translation adjustments	(663)	(257)	(887)
Ending Balance	$ 17,133	$ 16,515	$ 18,780

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Commitments and Contingencies Disclosure [Line Items]
Liability for deferred lease expenses	$ 43,333	$ 46,003
Employment agreements term extension	1 year
Contribution payments	$ 3,043	$ 2,718
Liability recorded for contribution payments	$ 3,333
Tim Warner
Commitments and Contingencies Disclosure [Line Items]
Employment agreement termination date	Apr. 1, 2016
Minimum
Commitments and Contingencies Disclosure [Line Items]
Operating and capital leases with terms generally ranging	10 years
Maximum
Commitments and Contingencies Disclosure [Line Items]
Operating and capital leases with terms generally ranging	25 years

Rent Expenses (Detail)

Rent Expenses (Detail) - USD ($) $ in Thousands	12 Months Ended
Rent Expenses (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Lease and Rental Expense [Line Items]
Fixed rent expense	$ 240,057	$ 237,891	$ 224,056
Contingent rent and other facility lease expenses	79,704	79,205	83,795
Total facility lease expense	$ 319,761	$ 317,096	$ 307,851

Future Minimum Lease Payments (

Future Minimum Lease Payments (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Leases Future Minimum Payments [Line Items]
Future minimum operating lease payments, current	$ 248,498
Future minimum operating lease payments, in two years	236,630
Future minimum operating lease payments, in three years	210,089
Future minimum operating lease payments, in four years	181,967
Future minimum operating lease payments, in five years	161,279
Future minimum operating lease payments, thereafter	661,398
Future minimum operating lease payments, total	1,699,861
Future minimum capital leases payments, current	35,156
Future minimum capital leases payments, in two years	33,640
Future minimum capital leases payments, in three years	34,050
Future minimum capital leases payments, in four years	33,394
Future minimum capital leases payments, in five years	32,441
Future minimum capital leases payments, thereafter	155,164
Future minimum capital leases payments, total	323,845
Amounts representing interest payments	(96,113)
Present value of future minimum payments	227,732
Current portion of capital lease obligations	(18,780)	$ (16,494)
Capital lease obligations, less current portion	$ 208,952	$ 201,978

Selected Financial Information

Selected Financial Information by Reportable Operating Segment (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Segment Reporting Information [Line Items]
Revenues		$ 2,852,609	$ 2,626,990	$ 2,682,894
Adjusted EBITDA		665,554	598,438	626,700
Capital expenditures		331,726	244,705	259,670
Operating Segments \| U.S. Operating Segment
Segment Reporting Information [Line Items]
Revenues		2,137,733	1,934,990	1,912,674
Adjusted EBITDA	[1]	499,138	438,776	456,866
Capital expenditures		223,213	148,532	117,488
Operating Segments \| International Operating Segment
Segment Reporting Information [Line Items]
Revenues		728,735	704,623	783,053
Adjusted EBITDA		166,416	159,662	169,834
Capital expenditures		108,513	96,173	142,182
Eliminations
Segment Reporting Information [Line Items]
Revenues		$ (13,859)	$ (12,623)	$ (12,833)

[1]	Distributions from NCM are reported entirely within the U.S. operating segment.

Reconciliation of Net Income to

Reconciliation of Net Income to Adjusted EBITDA (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Segment Reporting Information [Line Items]
Net income		$ 220,391	$ 195,769	$ 151,921
Add (deduct):
Income taxes		129,960	97,150	114,160
Interest expense	[1]	112,741	113,698	124,714
Loss on early retirement of debt				72,302
Loss on amendment to debt agreement		925
Other income	[2]	(20,041)	(22,150)	(24,688)
Depreciation and amortization		189,206	175,656	163,970
Impairment of long-lived assets		8,801	6,647	3,794
(Gain) loss on sale of assets and other		8,143	15,715	(3,845)
Deferred lease expenses		(1,806)	2,536	5,701
Amortization of long-term prepaid rents		2,361	1,542	2,625
Share based awards compensation expense		14,873	11,875	16,046
Adjusted EBITDA		$ 665,554	$ 598,438	$ 626,700

[1]	Includes amortization of debt issue costs.
[2]	Includes interest income, foreign currency exchange loss, and equity in income of affiliates and excludes distributions from NCM.

Selected Financial Informati114

Selected Financial Information by Geographic Area (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ 2,852,609	$ 2,626,990	$ 2,682,894
Theatre properties and equipment - net	1,505,069	1,450,812
Reportable Geographical Components \| U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	2,137,733	1,934,990	1,912,674
Theatre properties and equipment - net	1,175,535	1,094,076
Reportable Geographical Components \| Brazil
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	291,959	333,919	325,762
Theatre properties and equipment - net	163,505	204,107
Reportable Geographical Components \| Other foreign countries
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	436,776	370,704	457,291
Theatre properties and equipment - net	166,029	152,629
Eliminations
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ (13,859)	$ (12,623)	$ (12,833)

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2015USD ($)TheatreLeasesFacility	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)
Related Party Transaction [Line Items]
Distribution paid to Lone Star Theatre			$ 1,000,000
Cash dividends paid to Cinemark Holdings, Inc.	$ 115,225,000	$ 115,000,000	105,150,000
Noncash distributions to Cinemark Holdings, Inc.	$ 17,935,000	0	4,971,000
Syufy Enterprises, LP
Related Party Transaction [Line Items]
Number of theatres leased \| Theatre	15
Number of parking facilities leased \| Facility	1
Total number of leases \| Leases	16
Number of leases with minimum annual rent \| Leases	15
Number of leases without minimum annual rent \| Leases	1
Total rent paid to Syufy	$ 20,581,000	21,040,000	22,876,000
Laredo Theatre, Ltd
Related Party Transaction [Line Items]
Company's interest in Laredo	75.00%
Lone Star Theatre's interest in Laredo	25.00%
Ownership interest in Lone Star Theatres held by David Roberts	100.00%
Percentage of common stock held by Chairman of the Board of directors	9.00%
Percentage of management fees based on theatre revenues	5.00%
Maximum amount of theater revenue used to calculate management fees	$ 50,000,000
Percentage of management fees based on theatre revenues in excess	3.00%
Minimum amount of theater revenue used to calculate management fees	$ 50,000,000
Management fee revenues	567,000	564,000	558,000
Copper Beech Capital L L C
Related Party Transaction [Line Items]
Amount paid for the use of aircraft	$ 410,000	$ 74,000	$ 91,000

Valuation Allowance for Deferre

Valuation Allowance for Deferred Tax Assets (Detail) - Valuation Allowance of Deferred Tax Assets - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Valuation and Qualifying Accounts Disclosure [Line Items]
Beginning Balance	$ 52,873	$ 25,711	$ 13,326
Additions	437	28,612	14,162
Deductions	(2,674)	(1,450)	(1,777)
Ending Balance	$ 50,636	$ 52,873	$ 25,711

Subsequent Event - Additional I

Subsequent Event - Additional Information (Detail)	Feb. 19, 2016
Subsequent Event \| Chief Executive Officer
Subsequent Event [Line Items]
Minimum annual equity award as percentage of salary	200.00%

Condensed Consolidating Fina118

Condensed Consolidating Financial Statement Information of Subsidiary Guarantors - Additional Information (Detail) $ in Thousands	Dec. 31, 2015USD ($)
5.125% Senior Notes Due 2022
Condensed Consolidating Financial Information [Line Items]
Outstanding aggregate principal amount of Senior Notes	$ 400,000
Interest rate	5.125%
4.875% Senior Notes Due 2023
Condensed Consolidating Financial Information [Line Items]
Outstanding aggregate principal amount of Senior Notes	$ 530,000
Interest rate	4.875%
7.375% Senior Subordinated Notes Due 2021
Condensed Consolidating Financial Information [Line Items]
Interest rate	7.375%
Aggregate principal amount of Senior Subordinated Notes	$ 200,000

Condensed Consolidating Balance

Condensed Consolidating Balance Sheet Information (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Current assets
Cash and cash equivalents	$ 588,503	$ 638,841	$ 599,894	$ 742,095
Other current assets	126,612	102,086
Accounts receivable from parent or subsidiaries	1,171	12,638
Total current assets	716,286	753,565
Theatre properties and equipment - net	1,505,069	1,450,812
Other assets	1,906,277	1,928,739
Total assets	4,127,632	4,133,116
Current liabilities
Current portion of long-term debt	8,405	8,423
Current portion of capital lease obligations	18,780	16,494
Accounts payable and accrued expenses	411,984	388,966
Total current liabilities	439,169	413,883
Long-term liabilities
Long-term debt, less current portion	1,772,930	1,783,155
Capital lease obligations, less current portion	208,952	201,978
Other long-term liabilities and deferrals	593,330	597,377
Total long-term liabilities	$ 2,575,212	$ 2,582,510
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	$ 49,543	$ 49,543
Other stockholder's equity	1,052,603	1,076,851
Total Cinemark USA, Inc. stockholder's equity	1,102,146	1,126,394
Noncontrolling interests	11,105	10,329
Total equity	1,113,251	1,136,723	1,104,281	1,096,212
Total liabilities and equity	4,127,632	4,133,116
Parent Company
Current assets
Cash and cash equivalents	141,364	129,505	62,065	305,627
Other current assets	78,797	126,091
Accounts receivable from parent or subsidiaries	212,299	277,823
Total current assets	432,460	533,419
Theatre properties and equipment - net	539,082	498,446
Investment in subsidiaries	1,326,790	1,260,333
Other assets	1,402,062	1,389,912
Total assets	3,700,394	3,682,110
Current liabilities
Current portion of long-term debt	7,000	7,000
Current portion of capital lease obligations	6,426	5,411
Accounts payable and accrued expenses	197,268	259,973
Total current liabilities	210,694	272,384
Long-term liabilities
Long-term debt, less current portion	1,868,763	1,777,581
Capital lease obligations, less current portion	114,513	103,786
Other long-term liabilities and deferrals	404,278	401,965
Total long-term liabilities	$ 2,387,554	$ 2,283,332
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	$ 49,543	$ 49,543
Other stockholder's equity	1,052,603	1,076,851
Total Cinemark USA, Inc. stockholder's equity	1,102,146	1,126,394
Total equity	1,102,146	1,126,394
Total liabilities and equity	3,700,394	3,682,110
Subsidiary Guarantors
Current assets
Cash and cash equivalents	95,865	74,643	175,758	193,863
Other current assets	18,407	18,471
Total current assets	114,272	93,114
Theatre properties and equipment - net	614,821	575,652
Investment in subsidiaries	293,900	380,365
Other assets	135,022	140,320
Total assets	1,158,015	1,189,451
Current liabilities
Current portion of capital lease obligations	9,962	9,125
Accounts payable and accrued expenses	123,759	105,761
Accounts payable to parent and/or subsidiaries	23,965	84,555
Total current liabilities	157,686	199,441
Long-term liabilities
Capital lease obligations, less current portion	67,440	75,416
Other long-term liabilities and deferrals	77,774	79,116
Total long-term liabilities	$ 145,214	$ 154,532
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	$ 457,369	$ 457,369
Other stockholder's equity	397,746	378,109
Total Cinemark USA, Inc. stockholder's equity	855,115	835,478
Total equity	855,115	835,478
Total liabilities and equity	1,158,015	1,189,451
Subsidiary Non-Guarantors
Current assets
Cash and cash equivalents	351,274	434,693	$ 362,071	$ 242,605
Other current assets	61,432	67,826
Total current assets	412,706	502,519
Theatre properties and equipment - net	351,166	376,714
Other assets	475,187	401,783
Total assets	1,239,059	1,281,016
Current liabilities
Current portion of long-term debt	1,405	1,423
Current portion of capital lease obligations	2,392	1,958
Accounts payable and accrued expenses	116,353	125,638
Accounts payable to parent and/or subsidiaries	187,163	180,630
Total current liabilities	307,313	309,649
Long-term liabilities
Long-term debt, less current portion	9,534	7,442
Capital lease obligations, less current portion	26,999	22,776
Other long-term liabilities and deferrals	118,533	125,600
Total long-term liabilities	$ 155,066	$ 155,818
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	$ 10,240	$ 10,219
Other stockholder's equity	755,335	795,001
Total Cinemark USA, Inc. stockholder's equity	765,575	805,220
Noncontrolling interests	11,105	10,329
Total equity	776,680	815,549
Total liabilities and equity	1,239,059	1,281,016
Eliminations
Current assets
Other current assets	(32,024)	(110,302)
Accounts receivable from parent or subsidiaries	(211,128)	(265,185)
Total current assets	(243,152)	(375,487)
Investment in subsidiaries	(1,620,690)	(1,640,698)
Other assets	(105,994)	(3,276)
Total assets	(1,969,836)	(2,019,461)
Current liabilities
Accounts payable and accrued expenses	(25,396)	(102,406)
Accounts payable to parent and/or subsidiaries	(211,128)	(265,185)
Total current liabilities	(236,524)	(367,591)
Long-term liabilities
Long-term debt, less current portion	(105,367)	(1,868)
Other long-term liabilities and deferrals	(7,255)	(9,304)
Total long-term liabilities	$ (112,622)	$ (11,172)
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	$ (467,609)	$ (467,588)
Other stockholder's equity	(1,153,081)	(1,173,110)
Total Cinemark USA, Inc. stockholder's equity	(1,620,690)	(1,640,698)
Total equity	(1,620,690)	(1,640,698)
Total liabilities and equity	$ (1,969,836)	$ (2,019,461)

Condensed Consolidating Stateme

Condensed Consolidating Statement of Income Information (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Revenues		$ 2,852,609	$ 2,626,990	$ 2,682,894
Cost of operations
Theatre operating expenses		2,066,571	1,914,458	1,938,133
General and administrative expenses		154,052	148,588	163,134
Depreciation and amortization		189,206	175,656	163,970
Impairment of long-lived assets		8,801	6,647	3,794
(Gain) loss on sale of assets and other		8,143	15,715	(3,845)
Total cost of operations		2,426,773	2,261,064	2,265,186
Operating income		425,836	365,926	417,708
Other income (expense)
Interest expense	[1]	(112,741)	(113,698)	(124,714)
Loss on amendment to debt agreement		(925)
Distributions from NCM		18,140	18,541	20,701
Equity in income of affiliates		28,126	22,743	22,682
Loss on early retirement of debt				(72,302)
Other income (expense)		(8,085)	(593)	2,006
Total other income (expense)		(75,485)	(73,007)	(151,627)
Income before income taxes		350,351	292,919	266,081
Income taxes		129,960	97,150	114,160
Net income		220,391	195,769	151,921
Less: Net income attributable to noncontrolling interests		1,859	1,389	2,078
Net income attributable to Cinemark USA, Inc.		218,532	194,380	149,843
Parent Company
Revenues		959,347	851,299	816,489
Cost of operations
Theatre operating expenses		767,446	693,323	650,731
General and administrative expenses		16,152	17,978	22,275
Depreciation and amortization		59,759	50,858	43,501
Impairment of long-lived assets		6,445	6,334	2,301
(Gain) loss on sale of assets and other		6,191	8,954	99
Total cost of operations		855,993	777,447	718,907
Operating income		103,354	73,852	97,582
Other income (expense)
Interest expense		(100,608)	(101,224)	(110,484)
Loss on amendment to debt agreement		(925)
Distributions from NCM		2,116	2,375	124
Equity in income of affiliates		217,567	208,900	196,580
Loss on early retirement of debt				(72,302)
Other income (expense)		200	79	101
Total other income (expense)		118,350	110,130	14,019
Income before income taxes		221,704	183,982	111,601
Income taxes		3,172	(10,398)	(38,242)
Net income		218,532	194,380	149,843
Net income attributable to Cinemark USA, Inc.		218,532	194,380	149,843
Subsidiary Guarantors
Revenues		1,178,873	1,084,852	1,099,257
Cost of operations
Theatre operating expenses		804,236	739,686	743,531
General and administrative expenses		81,240	74,971	78,749
Depreciation and amortization		73,708	67,460	63,234
Impairment of long-lived assets		1,600	313	319
(Gain) loss on sale of assets and other		3,728	3,278	1,870
Total cost of operations		964,512	885,708	887,703
Operating income		214,361	199,144	211,554
Other income (expense)
Interest expense		(8,500)	(9,111)	(9,915)
Equity in income of affiliates		55,082	53,950	54,524
Other income (expense)		20		(8)
Total other income (expense)		46,602	44,839	44,601
Income before income taxes		260,963	243,983	256,155
Income taxes		79,131	71,687	76,938
Net income		181,832	172,296	179,217
Net income attributable to Cinemark USA, Inc.		181,832	172,296	179,217
Subsidiary Non-Guarantors
Revenues		764,631	733,435	808,972
Cost of operations
Theatre operating expenses		545,131	524,045	585,695
General and administrative expenses		56,660	55,639	62,110
Depreciation and amortization		55,739	57,338	57,235
Impairment of long-lived assets		756		1,174
(Gain) loss on sale of assets and other		(1,776)	3,483	(5,814)
Total cost of operations		656,510	640,505	700,400
Operating income		108,121	92,930	108,572
Other income (expense)
Interest expense		(4,009)	(3,392)	(4,315)
Distributions from NCM		16,024	16,166	20,577
Equity in income of affiliates		27,262	22,464	22,682
Other income (expense)		(7,929)	(643)	1,913
Total other income (expense)		31,348	34,595	40,857
Income before income taxes		139,469	127,525	149,429
Income taxes		47,657	35,861	75,464
Net income		91,812	91,664	73,965
Less: Net income attributable to noncontrolling interests		1,859	1,389	2,078
Net income attributable to Cinemark USA, Inc.		89,953	90,275	71,887
Eliminations
Revenues		(50,242)	(42,596)	(41,824)
Cost of operations
Theatre operating expenses		(50,242)	(42,596)	(41,824)
Total cost of operations		(50,242)	(42,596)	(41,824)
Other income (expense)
Interest expense		376	29
Equity in income of affiliates		(271,785)	(262,571)	(251,104)
Other income (expense)		(376)	(29)
Total other income (expense)		(271,785)	(262,571)	(251,104)
Income before income taxes		(271,785)	(262,571)	(251,104)
Net income		(271,785)	(262,571)	(251,104)
Net income attributable to Cinemark USA, Inc.		$ (271,785)	$ (262,571)	$ (251,104)

[1]	Includes amortization of debt issue costs.

Condensed Consolidating Stat121

Condensed Consolidating Statement of Comprehensive Income (Loss) Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Net income	$ 220,391	$ 195,769	$ 151,921
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes	2,636	2,846	3,151
Unrealized gain (loss) due to fair value adjustments on available-for-sale securities, net of taxes	(957)	2,507	(2,041)
Other comprehensive income in equity method investments	(3,119)	676	2,386
Foreign currency translation adjustments	(125,512)	(68,997)	(47,699)
Total other comprehensive income (loss), net of tax	(126,952)	(62,968)	(44,203)
Total comprehensive income (loss), net of tax	93,439	132,801	107,718
Comprehensive income (loss) attributable to noncontrolling interests	(1,821)	(1,374)	(1,996)
Comprehensive income (loss) attributable to Cinemark USA, Inc.	91,618	131,427	105,722
Parent Company
Net income	218,532	194,380	149,843
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes	2,636	2,846	3,151
Unrealized gain (loss) due to fair value adjustments on available-for-sale securities, net of taxes	(957)	2,507	(2,041)
Other comprehensive income in equity method investments	(3,119)	676	2,386
Foreign currency translation adjustments	(125,474)	(68,982)	(47,617)
Total other comprehensive income (loss), net of tax	(126,914)	(62,953)	(44,121)
Total comprehensive income (loss), net of tax	91,618	131,427	105,722
Comprehensive income (loss) attributable to Cinemark USA, Inc.	91,618	131,427	105,722
Subsidiary Guarantors
Net income	181,832	172,296	179,217
Other comprehensive income (loss), net of tax
Total comprehensive income (loss), net of tax	181,832	172,296	179,217
Comprehensive income (loss) attributable to Cinemark USA, Inc.	181,832	172,296	179,217
Subsidiary Non-Guarantors
Net income	91,812	91,664	73,965
Other comprehensive income (loss), net of tax
Other comprehensive income in equity method investments	(3,086)	643	2,386
Foreign currency translation adjustments	(125,512)	(68,997)	(47,699)
Total other comprehensive income (loss), net of tax	(128,598)	(68,354)	(45,313)
Total comprehensive income (loss), net of tax	(36,786)	23,310	28,652
Comprehensive income (loss) attributable to noncontrolling interests	(1,821)	(1,374)	(1,996)
Comprehensive income (loss) attributable to Cinemark USA, Inc.	(38,607)	21,936	26,656
Eliminations
Net income	(271,785)	(262,571)	(251,104)
Other comprehensive income (loss), net of tax
Other comprehensive income in equity method investments	3,086	(643)	(2,386)
Foreign currency translation adjustments	125,474	68,982	47,617
Total other comprehensive income (loss), net of tax	128,560	68,339	45,231
Total comprehensive income (loss), net of tax	(143,225)	(194,232)	(205,873)
Comprehensive income (loss) attributable to Cinemark USA, Inc.	$ (143,225)	$ (194,232)	$ (205,873)

Condensed Consolidating Stat122

Condensed Consolidating Statement of Comprehensive Income (Loss) Information (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Unrealized gain due to fair value adjustments on interest rate swap agreements, taxes	$ 1,562	$ 1,759	$ 1,865
Unrealized gain (loss) due to fair value adjustments on available-for-sale securities, taxes	572	1,479	1,223
Foreign currency translation adjustments, taxes	$ 888	$ 0	$ 0

Condensed Consolidating Stat123

Condensed Consolidating Statement of Cash Flows Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Operating activities
Net income	$ 220,391	$ 195,769	$ 151,921
Adjustments to reconcile net income to cash provided by (used for) operating activities	211,562	202,506	143,357
Changes in assets and liabilities	23,272	55,853	14,084
Net cash provided by operating activities	455,225	454,128	309,362
Net cash provided by (used for) operating activities		454,128
Investing activities
Additions to theatre properties and equipment	(331,726)	(244,705)	(259,670)
Proceeds from sale of theatre properties and equipment and other	9,966	2,545	34,271
Acquisition of theatre in Brazil	(2,651)	(7,951)	(259,247)
Proceeds from disposition of Mexico theatres			126,167
Investment in joint ventures and other	(3,711)	(3,228)	(6,222)
Net cash provided by (used for) investing activities	(328,122)	(253,339)	(364,701)
Financing activities
Dividends paid to parent	(115,225)	(115,000)	(105,150)
Payroll taxes paid as a result of restricted stock withholdings	(4,770)	(9,861)	(3,464)
Repayments of other long-term debt	(8,420)	(9,846)	(9,339)
Proceeds from issuance of notes			530,000
Redemption of senior notes			(461,946)
Net repayments of other long-term debt	(8,420)		(7,866)
Payments on capital leases	(16,513)	(14,035)	(12,015)
Payment of debt issue costs	(6,957)		(9,328)
Purchases of noncontrolling interests			(5,621)
Other	(3,394)	(7,439)	44
Net cash provided by (used for) financing activities	(150,509)	(146,320)	(75,346)
Effect of exchange rate changes on cash and cash equivalents	(26,932)	(15,522)	(11,516)
Increase (decrease) in cash and cash equivalents	(50,338)	38,947	(142,201)
Cash and cash equivalents:
Beginning of year	638,841	599,894	742,095
End of year	588,503	638,841	599,894
Parent Company
Operating activities
Net income	218,532	194,380	149,843
Adjustments to reconcile net income to cash provided by (used for) operating activities	(142,602)	(134,559)	(174,847)
Changes in assets and liabilities	67,253	232,167	115,254
Net cash provided by operating activities	143,183		90,250
Net cash provided by (used for) operating activities		291,988
Investing activities
Additions to theatre properties and equipment	(98,193)	(93,608)	(41,948)
Proceeds from sale of theatre properties and equipment and other	2,737	1,109	21,084
Acquisition of theatre in Brazil		(7,951)	(259,247)
Dividends received from subsidiaries	1,685	1,094	2,633
Intercompany note issuances	(3,500)
Investments in, and loans to, subsidiaries		(1,918)
Investment in joint ventures and other	(518)
Net cash provided by (used for) investing activities	(97,789)	(101,274)	(277,478)
Financing activities
Dividends paid to parent	(115,225)	(115,000)	(105,150)
Repayments of other long-term debt	(8,385)	(7,000)
Proceeds from issuance of notes			530,000
Redemption of senior notes			(461,946)
Net repayments of other long-term debt			(7,000)
Payments on capital leases	(5,389)	(4,082)	(2,910)
Payment of debt issue costs	(6,957)		(9,328)
Intercompany loan proceeds	100,000
Other	2,421	2,808
Net cash provided by (used for) financing activities	(33,535)	(123,274)	(56,334)
Increase (decrease) in cash and cash equivalents	11,859	67,440	(243,562)
Cash and cash equivalents:
Beginning of year	129,505	62,065	305,627
End of year	141,364	129,505	62,065
Subsidiary Guarantors
Operating activities
Net income	181,832	172,296	179,217
Adjustments to reconcile net income to cash provided by (used for) operating activities	39,156	42,620	22,276
Changes in assets and liabilities	(67,850)	(246,598)	(148,810)
Net cash provided by operating activities	153,138		52,683
Net cash provided by (used for) operating activities		(31,682)
Investing activities
Additions to theatre properties and equipment	(121,605)	(52,896)	(74,568)
Proceeds from sale of theatre properties and equipment and other	5,264	98	8,881
Dividends received from subsidiaries	15	8	3,000
Net cash provided by (used for) investing activities	(116,326)	(52,790)	(62,687)
Financing activities
Dividends paid to parent	(1,700)	(700)	(707)
Payroll taxes paid as a result of restricted stock withholdings			(3,464)
Payments on capital leases	(9,120)	(8,000)	(6,892)
Capital contributions and loans from parent		1,918
Other	(4,770)	(9,861)	2,962
Net cash provided by (used for) financing activities	(15,590)	(16,643)	(8,101)
Increase (decrease) in cash and cash equivalents	21,222	(101,115)	(18,105)
Cash and cash equivalents:
Beginning of year	74,643	175,758	193,863
End of year	95,865	74,643	175,758
Subsidiary Non-Guarantors
Operating activities
Net income	91,812	91,664	73,965
Adjustments to reconcile net income to cash provided by (used for) operating activities	43,223	31,874	44,824
Changes in assets and liabilities	23,869	70,284	47,640
Net cash provided by operating activities	158,904		166,429
Net cash provided by (used for) operating activities		193,822
Investing activities
Additions to theatre properties and equipment	(111,928)	(98,201)	(143,154)
Proceeds from sale of theatre properties and equipment and other	1,965	1,338	4,306
Acquisition of theatre in Brazil	(2,651)
Proceeds from disposition of Mexico theatres			126,167
Dividends received from subsidiaries			707
Intercompany note issuances	(100,000)
Investment in joint ventures and other	(3,211)	(3,228)	(6,222)
Net cash provided by (used for) investing activities	(215,825)	(100,091)	(18,196)
Financing activities
Dividends paid to parent		(402)	(5,633)
Repayments of other long-term debt	(35)	(2,846)
Net repayments of other long-term debt			(866)
Payments on capital leases	(2,004)	(1,953)	(2,213)
Purchases of noncontrolling interests			(5,621)
Intercompany loan proceeds	3,518
Other	(1,045)	(386)	(2,918)
Net cash provided by (used for) financing activities	434	(5,587)	(17,251)
Effect of exchange rate changes on cash and cash equivalents	(26,932)	(15,522)	(11,516)
Increase (decrease) in cash and cash equivalents	(83,419)	72,622	119,466
Cash and cash equivalents:
Beginning of year	434,693	362,071	242,605
End of year	351,274	434,693	362,071
Eliminations
Operating activities
Net income	(271,785)	(262,571)	(251,104)
Adjustments to reconcile net income to cash provided by (used for) operating activities	271,785	262,571	251,104
Investing activities
Dividends received from subsidiaries	(1,700)	(1,102)	(6,340)
Intercompany note issuances	103,500
Investments in, and loans to, subsidiaries		1,918
Investment in joint ventures and other	18
Net cash provided by (used for) investing activities	101,818	816	(6,340)
Financing activities
Dividends paid to parent	1,700	1,102	6,340
Capital contributions and loans from parent		(1,918)
Intercompany loan proceeds	(103,518)
Net cash provided by (used for) financing activities	$ (101,818)	$ (816)	$ 6,340

Supplemental Schedules - Conden

Supplemental Schedules - Condensed Consolidating Balance Sheet (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Current assets
Cash and cash equivalents	$ 588,503	$ 638,841	$ 599,894	$ 742,095
Other current assets	127,783
Total current assets	716,286	753,565
Theatre properties and equipment, net	1,505,069	1,450,812
Other assets	1,906,277	1,928,739
Total assets	4,127,632	4,133,116
Current liabilities
Current portion of long-term debt	8,405	8,423
Current portion of capital lease obligations	18,780	16,494
Accounts payable and accrued expenses	411,984
Total current liabilities	439,169	413,883
Long-term liabilities
Long-term debt, less current portion	1,772,930	1,783,155
Capital lease obligations, less current portion	208,952	201,978
Other long-term liabilities and deferrals	593,330	597,377
Total long-term liabilities	$ 2,575,212	$ 2,582,510
Commitments and contingencies
Equity	$ 1,113,251	$ 1,136,723	$ 1,104,281	$ 1,096,212
Total liabilities and equity	4,127,632	4,133,116
Restricted Subsidiaries
Current assets
Cash and cash equivalents	394,852	467,478
Other current assets	213,164
Total current assets	608,016
Theatre properties and equipment, net	1,505,069
Other assets	1,771,028
Total assets	3,884,113
Current liabilities
Current portion of long-term debt	7,016
Current portion of capital lease obligations	18,780
Accounts payable and accrued expenses	411,980
Total current liabilities	437,776
Long-term liabilities
Long-term debt, less current portion	1,768,763
Capital lease obligations, less current portion	208,952
Other long-term liabilities and deferrals	492,519
Total long-term liabilities	$ 2,470,234
Commitments and contingencies
Equity	$ 976,103
Total liabilities and equity	3,884,113
Unrestricted Subsidiaries
Current assets
Cash and cash equivalents	193,651	$ 171,363
Other current assets	(85,381)
Total current assets	108,270
Other assets	242,268
Total assets	350,538
Current liabilities
Current portion of long-term debt	1,389
Accounts payable and accrued expenses	4
Total current liabilities	1,393
Long-term liabilities
Long-term debt, less current portion	4,167
Other long-term liabilities and deferrals	100,811
Total long-term liabilities	$ 104,978
Commitments and contingencies
Equity	$ 244,167
Total liabilities and equity	350,538
Eliminations
Current assets
Other assets	(107,019)
Total assets	$ (107,019)
Long-term liabilities
Commitments and contingencies
Equity	$ (107,019)
Total liabilities and equity	$ (107,019)

Supplemental Schedules - Con125

Supplemental Schedules - Condensed Consolidating Statement of Income (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Condensed Financial Statements, Captions [Line Items]
Revenues	$ 2,852,609	$ 2,626,990	$ 2,682,894
Cost of operations
Theatre operating costs	2,066,571	1,914,458	1,938,133
General and administrative expenses	154,052	148,588	163,134
Depreciation and amortization	189,206	175,656	163,970
Impairment of long-lived assets	8,801	6,647	3,794
Loss on sale of assets and other	8,143	15,715	(3,845)
Total cost of operations	2,426,773	2,261,064	2,265,186
Operating income (loss)	425,836	365,926	417,708
Other income (expense)	(75,485)	(73,007)	(151,627)
Income before income taxes	350,351	292,919	266,081
Income taxes	129,960	97,150	114,160
Net income	220,391	195,769	151,921
Less: Net income attributable to noncontrolling interests	1,859	1,389	2,078
Net income attributable to Cinemark USA, Inc.	218,532	$ 194,380	$ 149,843
Restricted Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Revenues	2,852,609
Cost of operations
Theatre operating costs	2,066,571
General and administrative expenses	154,050
Depreciation and amortization	189,206
Impairment of long-lived assets	8,801
Loss on sale of assets and other	8,143
Total cost of operations	2,426,771
Operating income (loss)	425,838
Other income (expense)	(118,425)
Income before income taxes	307,413
Income taxes	113,472
Net income	193,941
Less: Net income attributable to noncontrolling interests	1,859
Net income attributable to Cinemark USA, Inc.	192,082
Unrestricted
Cost of operations
General and administrative expenses	2
Total cost of operations	2
Operating income (loss)	(2)
Other income (expense)	42,940
Income before income taxes	42,938
Income taxes	16,488
Net income	26,450
Net income attributable to Cinemark USA, Inc.	$ 26,450

Supplemental Schedules - Con126

Supplemental Schedules - Condensed Consolidating of Comprehensive Income (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Net income	$ 220,391	$ 195,769	$ 151,921
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes	2,636	2,846	3,151
Unrealized loss due to fair value adjustments on available-for-sale securities, net of taxes	(957)	2,507	(2,041)
Other comprehensive loss in equity method investments	(3,119)	676	2,386
Foreign currency translation adjustments, net of taxes	(125,512)	(68,997)	(47,699)
Total other comprehensive loss, net of tax	(126,952)	(62,968)	(44,203)
Total comprehensive income, net of tax	93,439	132,801	107,718
Comprehensive income attributable to noncontrolling interests	(1,821)	(1,374)	(1,996)
Comprehensive income attributable to Cinemark USA, Inc.	91,618	$ 131,427	$ 105,722
Restricted Subsidiaries
Net income	193,941
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes	2,636
Unrealized loss due to fair value adjustments on available-for-sale securities, net of taxes	(957)
Other comprehensive loss in equity method investments	(33)
Foreign currency translation adjustments, net of taxes	(125,512)
Total other comprehensive loss, net of tax	(123,866)
Total comprehensive income, net of tax	70,075
Comprehensive income attributable to noncontrolling interests	(1,821)
Comprehensive income attributable to Cinemark USA, Inc.	68,254
Unrestricted Subsidiaries
Net income	26,450
Other comprehensive income (loss), net of tax
Other comprehensive loss in equity method investments	(3,086)
Total other comprehensive loss, net of tax	(3,086)
Total comprehensive income, net of tax	23,364
Comprehensive income attributable to Cinemark USA, Inc.	$ 23,364

Supplemental Schedules - Con127

Supplemental Schedules - Condensed Consolidating of Comprehensive Income (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Unrealized gain due to fair value adjustments on interest rate swap agreements, taxes	$ 1,562	$ 1,759	$ 1,865
Unrealized loss due to fair value adjustments on available-for-sale securities, tax	572	1,479	1,223
Foreign currency translation adjustments, tax	$ 888	$ 0	$ 0

Supplemental Schedules - Con128

Supplemental Schedules - Condensed Consolidating Statement of Cash Flows (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Operating activities
Net income	$ 220,391	$ 195,769	$ 151,921
Adjustments to reconcile net income to cash provided by operating activities	211,562	202,506	143,357
Changes in assets and liabilities	23,272	55,853	14,084
Net cash provided by operating activities	455,225	454,128	309,362
Investing activities
Additions to theatre properties and equipment and other	(331,726)	(244,705)	(259,670)
Acquisition of theatre in Brazil	(2,651)	(7,951)	(259,247)
Proceeds from sale of theatre properties and equipment and other	9,966	2,545	34,271
Investment in joint ventures and other	(3,711)	(3,228)	(6,222)
Net cash provided by (used for) investing activities	(328,122)	(253,339)	(364,701)
Financing activities
Dividends paid to parent	(115,225)	(115,000)	(105,150)
Repayments of long-term debt	(8,420)		(7,866)
Payment of debt issue costs	(6,957)		(9,328)
Payments on capital leases	(16,513)	(14,035)	(12,015)
Other	(3,394)	(7,439)	44
Net cash provided by (used for) financing activities	(150,509)	(146,320)	(75,346)
Effect of exchange rate changes on cash and cash equivalents	(26,932)	(15,522)	(11,516)
Increase (decrease) in cash and cash equivalents	(50,338)	38,947	(142,201)
Cash and cash equivalents:
Beginning of year	638,841	599,894	742,095
End of year	588,503	638,841	$ 599,894
Restricted Subsidiaries
Operating activities
Net income	193,941
Adjustments to reconcile net income to cash provided by operating activities	220,661
Changes in assets and liabilities	15,124
Net cash provided by operating activities	429,726
Investing activities
Additions to theatre properties and equipment and other	(331,726)
Acquisition of theatre in Brazil	(2,651)
Proceeds from sale of theatre properties and equipment and other	9,966
Investment in joint ventures and other	(500)
Net cash provided by (used for) investing activities	(324,911)
Financing activities
Dividends paid to parent	(115,225)
Repayments of long-term debt	(8,420)
Payment of debt issue costs	(6,957)
Payments on capital leases	(16,513)
Other	(3,394)
Net cash provided by (used for) financing activities	(150,509)
Effect of exchange rate changes on cash and cash equivalents	(26,932)
Increase (decrease) in cash and cash equivalents	(72,626)
Cash and cash equivalents:
Beginning of year	467,478
End of year	394,852	467,478
Unrestricted Subsidiaries
Operating activities
Net income	26,450
Adjustments to reconcile net income to cash provided by operating activities	(9,099)
Changes in assets and liabilities	8,148
Net cash provided by operating activities	25,499
Investing activities
Investment in joint ventures and other	(3,211)
Net cash provided by (used for) investing activities	(3,211)
Financing activities
Increase (decrease) in cash and cash equivalents	22,288
Cash and cash equivalents:
Beginning of year	171,363
End of year	$ 193,651	$ 171,363